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Abstract 
Glucose homeostasis in the human body is maintained by hormones of the 
pancreas, mostly glucagon and insulin. Insulin is secreted when blood glucose 
levels are high and triggers a signalling cascade that results in glucose uptake via 
the glucose transporter GLUT4 in peripheral tissues. 
GLUT4 is the only glucose transporter that responds to insulin stimulation and it 
slowly recycles between intracellular storage compartments and the plasma 
membrane. In the basal state, the majority of GLUT4 is intracellularly localised. 
Insulin stimulation results in movement (“translocation”) of GLUT4 from these 
intracellular stores to the plasma membrane. The signalling cascade from insulin 
binding to its receptor to translocation of GLUT4 is comparatively well 
understood. Less is known about the dynamics of GLUT4 within the plasma 
membrane itself. Advances in light microscopy techniques, such as Total Internal 
Reflection Fluorescence and super-resolution microscopy, have allowed new 
insights into the events in the membrane. It has recently been proposed that 
GLUT4 is located in plasma membrane clusters and that another effect of insulin 
is the dispersal of these GLUT4 clusters. 
The main objective of this work was to develop a microscopy-based assay to 
visualise and quantify these clusters and to investigate the molecular 
mechanisms behind clustering and dispersal of the glucose transporter in 
response to insulin. The majority of this work has been carried out in 3T3 L1 
adipocytes, a widely used cell model for the study of GLUT4. However, this cell 
line is difficult to maintain, and its genetic manipulation is very challenging. For 
this reason, we investigated HeLa cells as a suitable substitute cell model for 
preliminary screenings. 
Using Total Internal Reflection Fluorescence Microscopy and Spatial Intensity 
Distribution Analysis, we gained new insight into the dynamics of plasma 
membrane GLUT4 in both 3T3 L1 adipocytes and HeLa cells. We found that the 
transporter forms an oligomer of high order in the plasma membrane in both cell 
types. Further, we compared the dynamics of GLUT4 mobilisation in response to 
insulin and found similar results. Based on these findings, we carried out an 
siRNA knock-down screening to determine proteins involved in intracellular 
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GLUT4 trafficking and found that GOSR1 and Ykt6 are promising targets for 
further examination. 
Single molecule localisation microscopy allowed us to accomplish our aim to 
assay GLUT4 clustering and dispersal. Using dSTORM and Ripley’s K-function, as 
well as Bayesian cluster analysis methods, we showed that GLUT4 is indeed 
located in clusters in the plasma membrane and that insulin stimulation leads to 
its dispersal. We found that treatment with Galectin-3, a drug that inhibits 
glucose uptake, impedes the dispersal. Building upon previous research in our 
group that identified EFR3a as a membrane-localised protein involved in glucose 
uptake, we knocked-down EFR3a in 3T3 L1 adipocytes and found that this also 
disrupts GLUT4 dispersal, which we hypothesise could be a potential drug target 
for type 2 diabetes. 
Taken together, the findings presented in this thesis suggest HeLa cells as a 
suitable cell model for initial assessments of research questions related to 
GLUT4 trafficking. Furthermore, a robust assay to measure GLUT4 dispersal was 
established. 
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Chapter 1 Introduction 
1.1 Glucose Homeostasis 
Carbohydrates are sugars and their polymers, polysaccharides. The most basic 
carbohydrates are monosaccharides and glucose is the most common 
monosaccharide. Glucose is our bodies main energy supplier. Its energy is 
released by an oxidative process called cell respiration, in which it is 
enzymatically broken down. Glycolysis and the citric acid cycle are the first two 
steps of cell respiration, in which each molecule of glucose is broken down to 
two molecules of pyruvate. Pyruvate is then converted to coenzyme A, which 
undergoes the citric acid cycle where CO2 is released. Some steps of glycolysis 
and citric acid cycle are redox reactions, in which electrons and protons are 
transferred onto substrates which are then fed into the electron transport chain, 
which ultimately ends in oxidative phosphorylation and the production of 
adenosine triphosphate (ATP). Glucose is produced by plants through 
photosynthesis, a reaction that converts CO2 and H2O to Glucose and O2 using 
light energy. But animals also produce glucose from pyruvate and oxaloacetate, 
products of the amino acid metabolism during a process called gluconeogenesis, 
which takes place mostly in the liver and in the kidney (Campbell & Reece, 
2006; Nelson & Cox, 2017). 
In healthy individuals blood glucose levels are controlled by the pancreas and 
are typically maintained at a level around 4-6 mmol l-1 (Nelson & Cox, 2017; 
Perley & Kipnis, 1967). The pancreas contains endocrine cells, α-, β-, and δ-
cells, which are located within the islets of Langerhans. When blood glucose 
levels are low during hypoglycaemia due to lack of food and continuing oxidation 
of glucose by the brain and other tissues, α-cells secrete glucagon which in turn 
facilitates the hydrolysis of glycogen to glucose in the liver, but glucose is also 
newly synthesised during gluconeogenesis as previously mentioned. In fact, the 
liver can produce up to 500 g of glucose during this process every day. After a 
meal, when blood glucose levels rise, pancreatic β-cells secrete insulin, thus 
allowing glucose transport into the liver, muscle, and adipose tissue, where it is 
converted to glycogen (liver and muscle) and triacylglycerols (adipose tissue) 
(Nelson & Cox, 2017).  
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Figure 1.1 Regulation of Blood Glucose Levels through the Pancreas. 
Blood glucose levels are regulated by the α- and β-cells of the pancreas. In case of hypoglycaemia 
α-cells secret glucagon, which initiates breakdown of glycogen in the liver to glucose. During 
hyperglycaemia β-cells release insulin, which stimulates fat and skeletal muscle cells to take up 
glucose from the blood stream. 
Figure 1.1 schematically shows glucose homeostasis as regulated by the 
pancreas. δ-cells secret somatostatin, which regulates the secretion of both 
glucagon and insulin (Gerich, 1981). 
The vast majority of insulin-stimulated glucose-uptake (~90 %) occurs in skeletal 
muscle tissue (Kraegen et al., 1985). The remaining less than 10 % that is cleared 
by adipose tissue is, however, not to be neglected. Adipose tissue is in fact 
significant for insulin sensitivity, as insulin-resistant individuals show decreased 
expression of Glucose Transporter 4 (GLUT4) in adipocytes, but not in muscle 
(Shepherd & Kahn, 1999). Abel et al. confirmed this by adipose selective knock-
down of GLUT4 in mice and found that this led to whole-body insulin-resistance 
and glucose intolerance (Abel et al., 2001). Therefore, while liver and muscle 
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take up most of the blood glucose, adipocytes play an important role in overall 
glucose homeostasis and communicate with liver and muscle in this regard. 
1.2 Diabetes Mellitus 
Diabetes is one of the most prevalent diseases worldwide, with currently about 
422 million adults affected. This number has nearly quadrupled since 1980, 
whilst the age-standardised frequency has almost doubled from 4.7 % in 1980 to 
8.5 % in 2014 and is expected to rise even further (Mathers & Loncar, 2006; 
Tareque et al., 2016). This increase has been especially steep during the last ten 
years in low- and middle-income countries. In the UK, it is estimated that 4.5 
million people currently live with diabetes (Diabetes UK, 2016). Diabetes not 
only affects patients’ personal lives but also has a huge impact on health-care 
systems and indirectly on the global economy. It is estimated that in the UK, 
about 10 % of the NHS budget is spent on diabetes care, which accounts for 
approximately £9.8bn for direct costs and £13.9bn for indirect costs. This figure 
is suspected to rise to a total cost of £39.8bn or 17 % of the NHS budget in 
2035/2036 (Hex et al., 2012; Seuring et al., 2015). 
Diabetes mellitus is a metabolic disorder, which is mainly characterised by 
chronic hyperglycaemia. Insulin plays an important role in the development of 
diabetes, because the release of insulin from the pancreatic β-cells is disturbed 
or even completely inhibited. This results in elevated blood glucose levels and 
the inability of cells to effectively take up glucose. Depending on the underlying 
mechanisms, there are different types of diabetes. 
Type I diabetes is an autoimmune disease, in which the immune system produces 
antibodies against pancreatic β-cells, which leads to β-cell destruction, 
inflammation and consequently the immediate need for external insulin 
substitution. Therefore, this form of diabetes is also referred to as insulin-
dependent diabetes. An estimated 10 % of people with diabetes suffers from this 
type. The onset is typically early on in life, where the terms juvenile and 
childhood-onset diabetes are derived from and it is not yet curable or 
preventable (Atkinson et al., 2014; Diabetes UK, 2016; Knip et al., 2005). 
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Type 2 diabetes, or non-insulin-dependent diabetes, is far more common (90 % 
of people with diabetes) and is primarily characterised by insulin resistance, 
hyper-insulinaemia. Insulin resistance is caused by a disturbance in insulin 
signalling, which results in the cell requiring increased amounts of insulin to take 
up the glucose from the blood stream. The body reacts with increased insulin 
production, which eventually leads to an impairment of the pancreas and other 
organs. This in turn will lead to pancreatic β-cell failure. Different from type 1 
diabetes, the development of type 2 is largely due to poor life-style choices, 
such as little to no exercise and the consumption of food and drinks high in fat 
and sugar, which can lead to overweight or obesity (Diabetes UK, 2016). 60 % of 
type 2 diabetics are classified as obese, although there is also a genetic 
component to the development of the disease. However, changes to a more 
active and healthier lifestyle have been shown to be effective in prevention or 
even reversal of type 2 diabetes (Chatterjee et al., 2017). Formerly also known 
as adult-onset diabetes, type 2 diabetes was long thought to be only present in 
adults, but since the first reported cases of type 2 diabetes in children in 2000, 
more and more children and adolescents are becoming affected (Ehtisham et al., 
2000). 
Where lifestyle changes and weight loss are not enough to control blood glucose 
levels in type 2 diabetics, medication can be given to treat the symptoms of the 
disease. Metformin is usually the first drug that is prescribed in this case 
(Maruthur et al., 2016). It works by inhibiting gluconeogenesis in the liver and 
increasing insulin sensitivity, thus making glucose uptake more efficient. Other 
drugs such as sulfonylureas and meglitinides stimulate the pancreas to increase 
insulin production. Eventually, with the progression of type 2 diabetes, external 
administration of insulin will be necessary (Maruthur et al., 2016; Tareque et al., 
2016). All those medications have in common that they only treat the symptoms 
of the disease; a cure for type 2 diabetes is yet to be found and relies on a 
better understanding of glucose uptake in healthy individuals as well as type 2 
diabetics. 
1.3 Glucose Transporters 
Glucose and other hexoses are transported from the blood stream into cells by 
glucose transporters (GLUTs). They are facilitative transporters that transport 
glucose and other hexoses through aqueous pores along a concentration gradient 
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into the cell. Although structurally very similar, GLUTs differ in their kinetic 
properties, substrate specificity, as well as their tissue and intracellular 
distribution (Kahn, 1992). GLUT1 was the first transporter to be characterised 
(Mueckler et al., 1985) and is mostly expressed in erythrocytes, the brain, and 
the placenta. GLUT2 has a high Km for glucose, allowing rapid glucose flux into 
the cell or out of the cell, such as after gluconeogenesis (Gould et al., 1991). 
Another transporter that is highly expressed in the brain is GLUT3. Because the 
energy demand in this tissue is relatively constant, the GLUTs in the brain are 
constitutively targeted to the plasma membrane (Duelli & Kuschinsky, 2001). In 
contrast, muscle tissue for example does not require a constant supply of 
energy, but its demand increases sharply during exercise. Muscle tissue 
therefore requires a more specialised glucose uptake system and GLUTs that can 
respond quickly to sudden changes in energy demand (Shepherd & Kahn, 1999). 
GLUT4 is found mostly in muscle and fat. It is located intracellularly and 
translocates to the plasma membrane in response to insulin stimulation, or, in 
the case of skeletal muscle, in response to muscle contraction, which is a unique 
behaviour and not exhibited by the other GLUTs (Bryant et al., 2002). In muscle 
tissue, this feature is responsible for the quick response during exercise. GLUT4 
translocation in skeletal muscle cells is related to the release of Ca2+, which is 
thought to activate other signalling molecules. Muscle contraction also results in 
the activation of AMP-activated protein kinase (AMPK), which is thought to 
decrease the rate of GLUT4 endocytosis and enhances GLUT4 regulation (Richter 
& Hargreaves, 2013). 
Currently, 13 different GLUTs are known (GLUT1-12 and HMIT (H+-coupled myo-
inositol transporter)). They are integral membrane proteins that are each unique 
in their kinetic properties and function, and are expressed in different tissues (S. 
Huang & Czech, 2007; Wood & Trayhurn, 2003). Mueckler et al. were the first 
who described the membrane topology of the transporter GLUT1, which is 
similar in all GLUTs: the proteins consist of 12 amphiphilic transmembrane 
helices that are embedded in the plasma membrane as well as an exofacial and 
a cytoplasmic loop. These domains are arranged in such a way that hydrophobic 
parts are facing the plasma membrane, while hydrophilic parts are forming the 
pore. Both, the C- and the N-terminus are located on the cytosolic side of the 
membrane as depicted in Figure 1.2 (Mueckler et al., 1985). 
Chapter 1 23 
 
 
Figure 1.2 Structure of the Membrane Protein GLUT4. 
GLUT4 spans the plasma membrane 12 times and exhibits an exofacial as well as a cytoplasmic 
loop. Both, the N- and the C-terminal region are on the cytoplasmic side. All 13 GLUTs have a 
similar structure, the specificity of GLUT4 is thought to lie in the unique N- and C-terminus (Bryant 
et al., 2002; S. Huang & Czech, 2007). 
The 13 types of GLUTs are divided into three sub-classes based on homologies in 
their primary structure: class I (GLUT1-4) contains glucose transporters, class II 
(GLUTs 5, 7, 9, 11) are fructose transporters, and the remaining GLUTs as well 
as HMIT belong to class III, they are yet to be defined in more detail (Bryant et 
al., 2002; Wood & Trayhurn, 2003).  
1.3.1 Glucose Transporter 4 
In 1980 the two independent groups of Cushman and Kono were the first to 
report that insulin-stimulated glucose transport was the result of translocation 
of pre-existing glucose transporters from intracellular storage sites to the plasma 
membrane. They observed this effect in isolated rat adipocytes (Cushman & 
Wardzala, 1980) and in cell fractions respectively (Suzuki & Kono, 1980). We now 
know that the glucose transport systems they described are in fact GLUT4 
containing vesicles and that this behaviour is specific for the GLUT4 isoform. 
Glucose transporter 4 was first identified by James et al. in 1988, when they 
identified a protein of a molecular mass of Mr = 43,000 that was expressed only 
in adipose, skeletal muscle, and heart tissue. Furthermore, they found that the 
subcellular distribution of this protein responded to insulin stimulation by 
increasing the concentration of the protein in the plasma membrane while 
decreasing the concentration in low density microsomes (James et al., 1988). 
Kayano et al. isolated the mRNA of this protein and published the result in the 
Chapter 1 24 
 
same year (Kayano et al., 1988). James et al. characterised it further by 
molecular cloning of a cDNA isolated from rat adipocyte and heart libraries, 
which shared 65 % of its nucleotide sequence with GLUT1; back then known as 
HepG2 glucose transporter. The protein encoded by this sequence exhibited an 
almost identical hydropathy plot and tertiary structure to GLUT1. Moreover, the 
protein could be found in insulin responsive tissues and in 3T3 L1 adipocytes, but 
not in fibroblasts. Interestingly, it showed translocation to the plasma 
membrane in response to insulin. They concluded that the sequence they had 
cloned belonged to a highly insulin-sensitive glucose transporter(James et al., 
1989). This transporter is today known as GLUT4. 
Around the same time, other groups from all over the world reported that they 
had isolated cDNA clones encoding GLUT4 in insulin responsive tissues from rats 
and humans (Charron et al., 1989; Fukumoto et al., 1989), other groups found 
that 3T3 L1 cells expressed GLUT4 after differentiation into adipocytes, but not 
as fibroblasts (de Herreros & Birnbaum, 1989; Kaestner et al., 1989). 
GLUT4 displays the same structure as other GLUTs shown in Figure 1.2, but has 
distinct sequences specifically in its NH2- and COOH-termini. The COOH-terminal 
domain contains an acidic motif as well as a double leucine that regulate the 
intracellular distribution of GLUT4. Mutation of the acidic region results in 
accumulation of GLUT4 at the plasma membrane (Shewan et al., 2000), while 
the dileucine is crucial for endocytosis and retention (Corvera et al., 1994). The 
NH2-terminus contains an F5QQI motif that interacts with adaptor proteins (APs) 
AP1 and AP2, which are important for endosomal sorting (Bernhardt et al., 
2009). Furthermore, mutation of a phenylalanine in the NH2-terminus leads to 
constitutive targeting of GLUT4 to the plasma membrane (Piper et al., 1993). 
While other GLUTs are mostly found in the plasma membrane of tissues that 
have consistent energy and therefore glucose requirements (e.g. GLUT1 and 3 in 
the brain) or act as a glucose sensor (GLUT2 in pancreatic β-cells), GLUT4 is 
mostly found in cardiomyocytes, skeletal muscle and adipose tissue and it is the 
only one of the 13 glucose transporters that responds to insulin and other 
stimuli, such as exercise (in muscle tissue), with increased translocation to the 
membrane; This makes sense because glucose requirements vary in these 
tissues. Muscle cells need to adapt quickly to physical activity and adipocytes 
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are responsible for post-prandial glucose uptake, so need to respond to insulin 
stimulation when blood glucose levels rise after a meal. Consequently, these cell 
types require a glucose transport system that can be regulated by the current 
glucose concentration in the blood through insulin.  
If this mechanism is defective, it contributes to insulin resistance and ultimately 
type 2 diabetes (Garvey et al., 1988; Maianu et al., 2001; Sinha et al., 1991), 
which is why GLUT4 and its associated signalling pathways are particularly 
interesting as potential drug targets. 
1.4 The GLUT4 Storage Compartment 
In the absence of stimuli, GLUT4 is mostly located in tubulo-vesicular structures 
within the cell and only a small percentage is at the cell surface (Dawson et al., 
2001; Piper et al., 1991; Slot et al., 1991). Slot et al. investigated the 
intracellular distribution of GLUT4 in rat adipose tissue of basal and insulin-
stimulated animals by immunolocalization and electron microscopy. Under basal 
conditions, they found that the majority of GLUT4 is located in small vesicles 
(60 – 100 nm) as well as tubulo-vesicular structures near the Golgi and only 1 % 
of total GLUT4 is in the plasma membrane. This increased to 40 % after insulin 
stimulation, which was not exclusive to certain regions of the membrane but 
universally distributed (Slot et al., 1991). Herman et al. confirmed the existence 
of these unusually small vesicles that are exclusive to GLUT4 by density gradient 
centrifugation (Herman et al., 1994). Using subcellular fractionation of 3T3 L1 
adipocytes, Livingstone et al. found a compartment that was separate from the 
endosomal system; 60 % of total GLUT4 did not colocalise with its marker the 
transferrin-receptor (TfR) the way other membrane proteins such as GLUT1 do. 
They concluded that there is another intracellular compartment of GLUT4 that 
does not participate in the cycling with the plasma membrane and eluded that 
this may be essential for the insulin responsiveness of GLUT4 (Livingstone et al., 
1996). In a review, Rea and James named this the GLUT4 storage compartment 
(GSC) and the small vesicles that had previously been described received the 
term GLUT4 storage vesicles (GSVs) (Rea & James, 1997).  
Because GLUT4 does only colocalise with furin, a Trans-Golgi network (TGN) 
marker, in the presence of the TfR, the Golgi was not considered to be this 
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second compartment (Karylowski et al., 2004). However, the Golgi does seem to 
play a role in insulin regulated GLUT4 trafficking. When adipocytes are 
incubated at 19 °C, a temperature where trafficking out of the TGN is inhibited, 
there is no insulin response. This finding suggests that the TGN precedes the 
sorting of GLUT4 into insulin sensitive vesicles (Robinson & James, 1992). It is 
thought that Syntaxins 6 and 16 are involved in this sorting step (Perera et al., 
2003; Proctor et al., 2006; Shewan et al., 2003). 
Subcellular fractionation of cell lysates can resolve five different fractions: the 
cytosol, mitochondria and nuclei, the plasma membrane, high density and low 
density microsomes (HDM and LDM) (I. A. Simpson et al., 1983). GLUT4 can be 
found mostly in the HDM, LDM, and the plasma membrane fractions. Insulin 
stimulation leads to a 10-fold increase of GLUT4 in the plasma membrane 
fraction (Piper et al., 1991), which mirrors the results of the previously 
discussed experiments by Slot et al. Using vesicle immunoadsorption and 
iodixanol equilibrium sedimentation analysis together with the transferrin-
horseradish peroxidase-3,3’-diaminobenzidine-mediated endosomal ablation 
technique, Hashiramoto and James managed to resolve the LDM fraction of 3T3 
L1 adipocytes further. They found two separate GLUT4 containing peaks in the 
fractions they collected. One peak was rich in markers of endosomes and the 
TGN, the other peak had a higher GLUT4 concentration and was very responsive 
to insulin stimulation. They concluded that with this peak they had found 
another vesicular population of GLUT4 that is probably derived from the 
endosomal cycle (Hashiramoto & James, 2000). The question remained whether 
GSVs are part of the known recycling pathways or if they represent a new GLUT4 
specific organelle. 
The translocation of GLUT4 to the cell surface happens quickly and reaches its 
maximum after about 10-15 minutes in 3T3 L1 adipocytes (Brewer et al., 2014; 
Govers et al., 2004). To facilitate this rapid response to insulin, GLUT4 must be 
either selectively retained in intracellular storage compartments until insulin 
triggers its release (static retention model), or it is constantly recycling between 
intracellular organelles and the plasma membrane and insulin stimulation leads 
to an increase of exocytosis and/or a decrease of endocytosis (dynamic exchange 
model) (Govers et al., 2004; Karylowski et al., 2004; O. J. Martin et al., 2006). 
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Mathematical modelling showed that either model is likely to be comprised of 
four or five pools: two intracellular compartments and two or three at the 
plasma membrane, with occluded pools that act as intermediates in endo- 
and/or exocytosis (Holman et al., 1994). Only a model with multiple 
intracellular pools accounts for the fast initial insulin response and subsequent 
slow recycling of plasma membrane GLUT4, therefore excluding a simple 2-pool 
model. The modelling results also showed that insulin must have a greater effect 
on GLUT4 exocytosis than endocytosis, because changing the latter does not 
result in a response as fast as it is observed experimentally (Holman et al., 
1994). 
It has been shown that the majority of total GLUT4 is not recycling via the 
plasma membrane in the basal state and that increasing insulin concentration 
increases the number of GLUT4 molecules participating in this pathway (Govers 
et al., 2004). However, even at maximal insulin concentration only 70 % of total 
GLUT4 is recycling with the plasma membrane. The static retention model 
argues that the proportion of GLUT4 that is not involved in recycling is therefore 
stored in a static intracellular compartment (Coster et al., 2004). Single 
molecule tracking in basal and insulin stimulated 3T3 L1 adipocytes supported 
this model, as GLUT4 molecules showed a significant increase in mobility in the 
presence of insulin (Fujita et al., 2010). 
In the basal state, the equilibrium of GLUT4 between the GSC and the 
endosomal compartment is reached much quicker (t1/2 = 20 min) than with the 
plasma membrane (t1/2 = 230 min) (Karylowski et al., 2004). This means a GSV is 
about 5 times more likely to fuse with an endosome than with the plasma 
membrane. The movement between the two compartments has been suggested 
to be part of a dynamic retention system of GLUT4 in the absence of insulin. 
Insulin stimulation then leads to an increase in the exocytosis rate, even under 
physiological insulin concentrations. Different from GLUT4 exocytosis, this 
cycling does not require intact microtubules, as it is not affected by nocodazole 
treatment (Karylowski et al., 2004; O. J. Martin et al., 2006). The rapid cycling 
between the intracellular GLUT4 containing compartments supports the dynamic 
exchange model.  
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Interestingly, the cell culture conditions also influence the size of the cycling 
GLUT4 pool in the basal state. Replating the cells for microscopy, which is a 
common practice, was shown to increase the percentage of cycling GLUT4 from 
22 % in confluent cells to 80 % in replated cells (Muretta et al., 2008). This 
illustrates further the complexity of the process and shows how different 
experimental procedures can have a significant effect on results. 
 
Figure 1.3 Model of Dynamic Exchange and Static Retention of GLUT4. 
GLUT4 is thought to be recycled within two different cycles. Cycle 1 comprises the endosomal 
system, while cycle 2 comprises the static retention model, where GLUT4 continuously cycles 
between the recycling endosome and the Trans-Golgi network until insulin stimulation leads to 
rapid translocation of GSVs to the plasma membrane (Bryant et al., 2002). 
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Currently, it is believed that in fact both models are valid and GLUT4 is indeed 
found in two different intracellular recycling pathways. (Bryant et al., 2002). 
Using flow cytometry, Muretta et al. developed an assay that allowed them to 
analyse large numbers of cells, in contrast to microscopy-based experiments. 
They found that under basal conditions the majority of GLUT4 is retained 
statically within the cell and insulin controls the population that is actively 
cycling through the plasma membrane through quantal release; i.e. the amount 
of GLUT4 in the actively cycling pool is proportional to the concentration of 
insulin. When insulin is withdrawn, GLUT4 returns to the static compartment 
very slowly. Only after 12 hours post insulin, the static GLUT4 pool has returned 
to its original size. However, GLUT4 is cleared from the plasma membrane in a 
much faster manner by adjusting the endo- and exocytosis rates accordingly, 
suggesting that GLUT4 remains within this cycling pool until it has fully returned 
to the intracellular static pool. Under physiological conditions this might mean 
that the mode of GLUT4 cycling depends on the fluctuation of serum insulin. 
When insulin levels are fluctuating rapidly, the dynamic exchange model applies, 
and in the case of slow insulin level fluctuation, such as in basal versus 
stimulated model cell culture systems, the static retention model is valid 
(Muretta et al., 2008). 
 
Figure 1.3 shows the model of the two cycling pathways that are thought to be 
comprising both the static retention and the dynamic exchange model previously 
described, which was first thought of as early as 1996 by Martin et al. (S. Martin 
et al., 1996). After synthesis and post-translational modifications in the Golgi 
network, GLUT4 is packaged into GSVs, which upon insulin stimulation rapidly 
translocate to and fuse with the plasma membrane. In the absence of insulin 
GLUT4 enters the endosomal system, but it is selectively held back in favour of 
other membrane proteins, such as TfR, and only a small portion of GLUT4 
recycles between the plasma membrane and the endosomes, while the majority 
is in a second cycle between transport vesicles, the TGN, and newly formed 
GSVs, ready for translocation in the event of insulin stimulation. This second 
cycle is unique to insulin-responsive cells and forms during the early stages of 
3T3 L1 differentiation into adipocytes, even before GLUT4 is expressed in these 
cells (Bryant et al., 2002; El-Jack et al., 1999) 
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1.4.1 Endocytosis of GLUT4 
Clathrin, a protein that is involved in the formation of coated vesicles and 
endocytosis (Pearse, 1976), appears to be involved in the intracellular retention 
of GLUT4. GLUT4 is present in clathrin-coated vesicles derived from both, the 
plasma membrane and the TGN (Robinson et al., 1992). About 5 % of total GLUT4 
is in clathrin-coated vesicles at the plasma membrane, which is noteworthy, and 
it is hypothesised that insulin has an effect on the coating and uncoating of GSVs 
with clathrin, thus regulating their endocytosis (Chakrabarti et al., 1994). It has 
also been shown that the GTPase dynamin is involved in the endocytosis of 
GLUT4, since expression of dynamin decreases the GLUT4 levels in the plasma 
membrane. In contrast, maximal expression of a GTPase-negative mutant form 
of dynamin leads to the majority of GLUT4 being located in the plasma 
membrane and insulin has no further effect (Al-hasani et al., 1998). 
Blot and McGraw found that GLUT4 can be internalised by two different 
mechanisms: a cholesterol- and an AP2-dependent pathway. Under basal 
conditions a cholesterol-dependent pathway is favoured. Insulin-stimulation 
results in preferred GLUT4 uptake by the AP2-dependent mechanism. The latter 
involves the FQQI motif and is less rapid than basal GLUT4 endocytosis (Blot & 
McGraw, 2006). 
By determining the half-time for internalisation of labelled surface GLUT4, the 
endocytosis rate of the transporter could be calculated. It was found that insulin 
has a small effect on GLUT4 endocytosis. The endocytosis rate constant is about 
30 % slower after insulin stimulation compared to the basal state. The main 
effect of insulin however, is on the exocytosis rate (J. Yang & Holman, 1993). 
1.4.2 Other Components and Biogenesis of GSVs 
In undifferentiated 3T3 L1 adipocytes exogenous GLUT4 does not translocate to 
the plasma membrane in response to insulin. Instead, it enters the lysosomal 
pathway and degrades quickly (Haney et al., 1991; Shi & Kandror, 2005). GSVs 
begin to form between day 2 and 3 of differentiation (El-Jack et al., 1999; Shi et 
al., 2008). After this point, increased insulin-responsiveness and insulin-
stimulated glucose uptake can be observed. Moreover, exogenous GLUT4 is now 
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stable and can be found within small vesicles that do not sediment after 
centrifugation at 16,000 × g: the GSVs. At the same time the concentration of 
the membrane protein sortilin increases dramatically (Lin et al., 1997; N. J. 
Morris et al., 1998; Shi & Kandror, 2005). This discovery led to the hypothesis 
that sortilin is in fact involved in the biogenesis of GSVs. Indeed, overexpression 
of sortilin in 3T3 L1 adipocytes leads to increased GSV formation. 
Correspondingly, knock-down of sortilin results in a decrease of total GLUT4 
expression, insulin-stimulated glucose-uptake and formation of GSVs (Shi & 
Kandror, 2005). Interestingly, if undifferentiated 3T3 L1 fibroblasts are 
transfected with both GLUT4 and sortilin, they form GSVs and become insulin-
responsive. These findings suggest that sortilin is in fact not only necessary but 
also sufficient for the biogenesis of GSVs (Kandror, 2018; Shi & Kandror, 2005). 
After GLUT4 itself, the insulin-responsive aminopeptidase (IRAP) is probably the 
most significant component of GSVs (Kupriyanova et al., 2002; Shi et al., 2008). 
It was discovered in traditional protein sequencing studies and was found to 
colocalise with GLUT4 almost completely (Kandror & Pilch, 1994; Mastick et al., 
1994). It is expressed in the same tissues as GLUT4, namely fat and skeletal 
muscle, but it was also found in other tissues and cells that do not express 
GLUT4 (Albiston et al., 2001; Nikolaou et al., 2014). IRAP is a zinc-dependent 
membrane aminopeptidase, which features large extracellular and cytoplasmic 
domains and spans the membrane once (Rogi et al., 1996). Interestingly, the 
intracellular domain features two dileucine motives, like the C-terminus of 
GLUT4, which may be involved in trafficking of the protein similar to the glucose 
transporter (Keller et al., 1995). Chinese Hamster Ovary (CHO) cells express 
IRAP, but not GLUT4. Johnson et al. expressed a fusion protein of C-terminal 
IRAP and N-terminal TfR in this cell line and found that the chimera recycled 
slowly through the endosomal compartment to the plasma membrane. Insulin 
stimulation increased this 2-3-fold (Johnson et al., 1998). The chimera expressed 
in undifferentiated 3T3 L1 fibroblasts behaves the same way (Lampson et al., 
2000). The fact that IRAP and GLUT4 are so similar in their localisation and their 
response to insulin makes IRAP a popular protein for the study of GSVs (Stenkula 
et al., 2010). It is debated whether IRAP and GLUT4 physically interact with 
each other. The two proteins do not co-precipitate, eliminating the possibility of 
a strong interaction (Keller, 2003). However, experiments with a yeast two-
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hybrid system showed that there is an interaction between the luminal domain 
of IRAP and the first luminal loop of GLUT4 (Shi et al., 2008), although it has 
now been suggested that this is via a retromer that binds to GLUT4 and IRAP 
(Pan et al., 2017; Z. Yang et al., 2016). When IRAP is knocked down in 3T3 L1 
adipocytes, intracellular GLUT4 retention under basal conditions is not as 
effective, while membrane trafficking of other proteins, such as TfR, is not 
affected (Jordens et al., 2010). Determination of the exocytosis rate constants 
revealed that it is in fact the exocytosis rate that is elevated after IRAP knock-
down. Using the endosome ablation assay, it could be shown that IRAP knock-
down specifically leads to an increased amount of GLUT4 within endosomes, 
which led to the conclusion that IRAP plays a crucial role in the sorting of GLUT4 
into GSVs. On the other hand, knock-down of GLUT4 does not alter the 
intracellular distribution of IRAP, suggesting that IRAP traffics independently of 
GLUT4 (Jordens et al., 2010). 
Low density lipoprotein receptor-related protein 1 (LRP1) is a large (~500 kDa) 
protein, also known as α2-macroglobulin receptor (Corvera et al., 1989). 
Crosslinking experiments have shown a direct interaction between the luminal 
domains of LRP1 with GLUT4, IRAP, and sortilin. It also binds AS160, a protein 
that is part of the insulin signalling pathway (see 1.5 Insulin Signalling) Knock-
down of the protein inhibits the formation of fully functional GSVs, which means 
it must play a role in the biogenesis of the vesicles (Brewer et al., 2014; 
Jedrychowski et al., 2010). 
GLUT4, IRAP, sortilin, and LRP1 are thought to interact with each other via their 
luminal domains and form an oligomeric complex. Golgi-localized, gamma-ear 
containing, ADP-ribosylation factor binding (GGA) proteins then recognise the 
DXXLL sequence of sortilin and enable the sorting into GSVs. All four proteins 
contain amino acid sequences that are known to bind clathrin APs, which then 
facilitate budding off the donor membrane (Kandror & Pilch, 2011). 
Other proteins that are associated with GSVs and show significant colocalisation 
with GLUT4 in microscopy images are TfR (Davis et al., 1986), mannose-6-
phosphate receptor (M6PR) (Oka et al., 1984), syntaxins 6 (Perera et al., 2003) 
and 16 (Proctor et al., 2006), and Vti1a (Kandror & Pilch, 2011). These proteins, 
particularly TfR and M6PR have long been known to translocate to the cell 
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surface in response to insulin stimulation (Kandror & Pilch, 1996). About 50 % of 
total TfR and 10 – 15 % of total M6PR is associated with GSVs in adipocytes. It 
was hypothesised that they recycle in GSVs to fulfil general nutritional 
requirements of the cell during insulin stimulation (Kandror & Pilch, 1996). More 
recently it has been suggested that these proteins are not actively sorted into 
GSVs but rather end up there “by chance” because they share the same donor 
membrane (recycling endosome and/or TGN) (Kandror & Pilch, 2011). 
1.5 Insulin Signalling 
Since this work has been mostly carried out in adipocytes, the following section 
will concentrate on insulin signalling leading to GLUT4 translocation and omit 
the signalling pathways that are mediated by muscle contraction. 
The insulin receptor is located in the plasma membrane and consists of two 
subunits α and β. The α domain is located extracellularly and binds insulin, while 
the intracellular β domain has tyrosine kinase activity. When insulin binds to the 
α subunit of the receptor, this leads to autophosphorylation of a tyrosine residue 
in the β subunit (Kasuga et al., 1982; Shia & Pilch, 1983). Autophosphorylation 
initiates two different signalling cascades: the adaptor protein with pleckstrin 
homology and Src homology 2 domains (APS) pathway and the phosphoinositide 
3-kinase (PI3K) pathway. 
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1.5.1 The APS Pathway 
 
Figure 1.4 Schematic of the APS Pathway 
(1) Insulin binds to its receptor (2) Autophosphorylation of the insulin receptor (3) Recruitment of 
APS, CAP, and c-CBL (4) Phosphorylation of c-CBL (5) Recruitment of C3G and CRK 
(6) Activation of TC10 (7) Interaction with exocyst subunit (enabling exocytosis) (8) Interaction with 
CIP4/2 (inhibiting GSV retention) (9) GSV translocation and exocytosis. (Saltiel & Kahn, 2001) 
Autophosphorylation of the insulin receptor leads to the recruitment of APS, the 
proto-oncogene c-CBL and c-CBL-associated protein (CAP). C-CBL is then 
phosphorylated on three different tyrosines by the insulin receptor (Liu et al., 
2002). Activated c-CBL recruits a complex of CRK and C3G (Ribon et al., 1996) 
which in turn leads to the activation of the GTPase TC10. The active form of 
TC10 interacts with CIP4/2, which is involved in GSV retention (Chang et al., 
2002). It also interacts with EXO70, a subunit of the exocyst, which plays a role 
in the exocytosis of vesicles (Leto & Saltiel, 2012). 
1.5.2 The PI3K Pathway 
The second pathway initiated by binding of insulin to its receptor is the PI3K 
pathway. Autophosphorylation of the insulin receptor is followed by 
phosphorylation of several insulin receptor substrates (IRS). IRS1 and IRS2 are 
the most common IRS in fat cells (White, 2002). IRS do not have any inherent 
enzymatic activity, but enable the recruitment of other proteins, such as PI3K, 
to the membrane (Sun et al., 1991). The PI3K family consists of various 
structurally related enzymes that are divided into four subgroups based on the 
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structure of their catalytic subunits and substrate specificity (Leevers et al., 
1999). The activation of PI3K has multiple consequences that are not yet all 
known. An obvious effect is the phosphorylation of phosphoinositides (PIs), which 
generates PI-3,4,5-triphosphate (PIP3) (Saltiel & Kahn, 2001). The 
serine/threonine kinase Akt, also known as protein kinase B (PKB) is downstream 
off PI3K and is an important regulator of glucose uptake (Kohn et al., 1996). It 
binds to PIP3 at the plasma membrane via the pleckstrin homology domain at its 
N-terminus and is phosphorylated by phosphoinositide-dependent kinase 1 
(PDK1) and mTOR complex2 (mTORC2) (Stephens et al., 1998). The Rab GTPase-
activating protein (GAP) AS160 (Akt substrate of 160 kDa) is one of the many 
substrates of phosphorylated Akt (Kane et al., 2002). Rab proteins are GTPases 
that are associated with membrane trafficking, they switch between an active 
form (GTP loaded) and an inactive form (GDP loaded) (Zerial & McBride, 2001). 
Phosphorylation of AS160 inhibits its GAP activity, which activates the GSV 
associated Rab proteins and allows translocation of GSVs to the plasma 
membrane (Manning & Toker, 2007; Zeigerer et al., 2002). This process is likely 
linked to the fact that AS160 is associated with IRAP in the membrane of GSVs in 
the basal state but separates after insulin stimulation. 
 
Figure 1.5 Schematic of the PI3K Pathway. 
(1) Insulin binds to its receptor (2) Autophosphorylation of the insulin receptor (3) Phosphorylation 
of several insulin receptor substrates (4) Activation of PI3K (5) Production of PIP3 in the plasma 
membrane (6) Recruitment of Akt to the plasma membrane (7) Phosphorylation of Akt by PDK1 
and mTORC2 (8) Phosphorylation of AS160 (9) Activation of GSV associated Rab proteins 
(10) Translocation of GSVs to the plasma membrane (Bryant et al., 2002; Saltiel & Kahn, 2001; 
Shepherd & Kahn, 1999). 
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Knock-down of AS160 in adipocytes indeed leads to GLUT4 translocation even 
under basal conditions (Larance et al., 2005) and overexpression of a dominant-
negative mutated form of AS160 in which each of the phosphorylation sites are 
mutated, hinders GLUT4 translocation (Sano et al., 2003).The signalling 
pathways associated with insulin-mediated GLUT4 translocation to the plasma 
membrane are not yet fully resolved and are far more complex than outlined in 
this chapter (Bryant et al., 2002; S. Huang & Czech, 2007; Tavaré et al., 2001). 
Figure 1.5 shows a simplified representation as described here.  
Funaki et al. found that the PI-binding peptide (PBP10) can induce GLUT4 
translocation to the plasma membrane but does not affect glucose uptake, 
indicating that insulin stimulation has these two different effects. Pre-treatment 
of 3T3 L1 adipocytes with PBP10 before insulin stimulation showed that the 
insulin response was faster than without PBP10 pre-treatment. Thus, activation 
of GLUT4 for glucose uptake by insulin must happen while the transporter is 
already in the membrane. Both, the translocation and activation of GLUT4 
involve PI3K (Funaki et al., 2004). 
1.6 GLUT4 Trafficking Proteins 
The cargo of GSVs was discussed in chapter 1.4.2, but there are other proteins 
associated with GSVs that enable translocation and fusion with membranes. 
1.6.1 Rab Proteins 
Rab proteins are monomeric small GTPases that are involved in most, if not all 
steps of intracellular vesicle transport. They play an important role in the 
tethering/docking and fusion of vesicles with acceptor membranes but are also 
implicated in the budding off donator membranes and transport along the 
cytoskeleton. Their intracellular location is very specific and different Rab 
proteins are linked to different organelles. Some Rab proteins even show cell- or 
tissue-specificity (Zerial & McBride, 2001). Subcellular membrane fractionation 
and immunopurification studies have revealed a number of Rab proteins that are 
associated with the GSC or GSVs, among them are Rab2A, Rab3A, Rab8A, Rab10, 
Rab11, and Rab14 (Koumanov et al., 2015; Larance et al., 2005; Mîinea et al., 
2005). 
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Rab10 is thought to be the key Rab protein for GSV translocation (Sadacca et al., 
2013; Sano et al., 2007). It is a downstream target of AS160, which has a Rab 
GAP domain. Rab GAPs interact with Rabs and trigger their GTPase activity, thus 
increasing the proportion of inactive GDP-bound Rab proteins (Zerial & McBride, 
2001). In the basal state, AS160 is active, which leads to the inactivation of the 
associated Rab and consequently retention of GSVs (Kane et al., 2002). 
Expression of mutated Rab10 that lacks the ability to hydrolyse GTP to GDP, 
leads to increased levels of GLUT4 in the plasma membrane. Knock-down inhibits 
insulin-induced translocation (Sano et al., 2007). 
Using total internal reflection fluorescence (TIRF) microscopy (TIRFM), Chen et 
al. developed an assay that allowed them to link the different Rabs to specific 
steps in insulin-mediated GLUT4 trafficking. They visualised GSVs in the TIRF 
zone using mCherry-tagged GLUT4 and determined the colocalisation with GFP-
tagged Rabs. In the basal state Rab4A, Rab4B, Rab14, and Rab8A colocalised 
with GLUT4 to a high degree. Interestingly, Rab10 showed only little 
colocalisation under basal conditions (Yu Chen et al., 2012). To distinguish 
between GSVs close to the membrane and fusing GSVs, they tagged IRAP with 
the pH-sensitive fluorescent protein pHluorin. Within the acidic environment of 
the GSVs the fluorescence of pHluorin is quenched. Upon fusing with the 
membrane, the protein comes into contact with the neutral pH of the medium, 
which turns on fluorescence (Yu Chen & Lippincott-Schwartz, 2015; Jiang et al., 
2008). After insulin stimulation >90 % of the fusion events they observed 
colocalised with Rab10, while Rab4A and Rab4B did not. This result led to the 
hypothesis that Rab10 is a mediator of GSV fusion, while Rab4A and Rab4B are 
involved in GLUT4 recycling with the early endosome. Rab14 showed moderate 
association with fusing vesicles but little overlap with Rab10. Further 
investigation revealed that Rab14 is indeed present in endosomal vesicles and 
thus probably associated with the recycling of GSVs within the endosomal cycle 
(Yu Chen et al., 2012). Rab10 in its active GTP-form was also found to be 
associated with the exocyst subunits Exoc6 and Exoc6b (Sano et al., 2015). 
In a study investigating GTP loading of Rabs in response to insulin in primary rat 
adipocytes, Rab3A was found to play a role in GLUT4 translocation. Rab3A is 
inhibited by Noc2 and insulin-mediated loading of Rab3 with GTP disrupts this 
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complex, allowing translocation of GSVs to the plasma membrane (Koumanov et 
al., 2015). The number of Rabs colocalising with GSVs may be even higher, as 
GSV trafficking is comprised of many different steps, that may be regulated by 
different Rabs. 
1.6.2 SNARE and SM Proteins 
Most membranes in eukaryotic cells consist of phospholipid bilayers. Water 
molecules arrange themselves around the hydrophilic head groups and are 
difficult to separate, which makes two membranes repel each other. To 
overcome this hydration repulsion and enable fusion, it requires the membranes 
to be in very close proximity to each other. This is mediated by SNARE (soluble 
N-ethylmaleimide sensitive fusion protein attachment protein receptor) 
proteins. This family consists of syntaxins, vesicle-associated membrane proteins 
(VAMPs), and synaptosome-associated proteins (SNAPs) (Malsam et al., 2008). 
SNAP25 is not to be confused with soluble NSF attachment proteins (SNAPs) also 
termed N-ethylmaleimide-sensitive factor Attachment Protein Alpha (NAPA), which 
recruit NSF to the membrane 
1.6.2.1 The SNARE Complex 
SNAREs are anchored to their membrane via their C-terminus or in the case of 
SNAPs by palmitoylation and can be divided into two groups, depending on their 
location: v-(vesicle)-SNAREs and t-(target)-SNAREs (Malsam et al., 2008). They 
contain a ~60 amino acid sequence made up of heptads, the SNARE motif 
(Laidlaw et al., 2017). When a v- and a t-SNARE come into close proximity to 
each other they form the SNARE complex, a tight alpha helical bundle consisting 
of four helices, one each from VAMP and syntaxin, two from SNAP. The side 
chains of the amino acids in the SNARE domains interact with each other and 
form hydrophobic layers (Sutton et al., 1998). The formation of a SNARE complex 
from these components is energetically favourable, as this occurs spontaneously 
in vitro. These experiments have also shown that SNARE complexes are not only 
necessary but also sufficient for vesicle fusion with a target membrane (Weber 
et al., 1998). The SNARE hypothesis postulates that the specificity of fusion 
events is derived from the pairing of a v-SNARE with its cognate t-SNARE 
(Söllner, Bennett, et al., 1993; Söllner, Whiteheart, et al., 1993). 
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Figure 1.6 Formation of the SNARE Complex and Vesicle Fusion 
A: GSV containing the v-SNARE VAMP2 approaches the plasma membrane with embedded 
t-SNAREs syntaxin4 and SNAP23 B: SNAREs form the SNARE complex and zipper up, bringing 
the vesicle and plasma membrane into close proximity to each other C: Vesicle fusion and 
disassembly of the complex using energy provided by ATPase (Y. A. Chen & Scheller, 2001). 
The zippering up of the complex is thought to provide the energy that brings the 
two membranes close together, overcoming hydration repulsion, and thus 
allowing fusion. Figure 1.6 demonstrates this process. 
The key t-SNAREs involved in GSV fusion with the plasma membrane are 
syntaxin4 and SNAP23. Knock-down of either of these proteins results in 
inhibition of vesicle tethering to the membrane. Knock-down of the v-SNARE 
VAMP2 on the other hand does not interfere with the tethering process but 
inhibits vesicle fusion (Kawaguchi et al., 2010; Kioumourtzoglou, Sadler, et al., 
2014). 
Other SNAREs are involved in intracellular GSV trafficking, which will be 
expanded on in more detail in Chapter 6. 
1.6.2.2 VAMPs 
VAMPs 2, 3, 4, 5, 7, and 8 are all expressed in 3T3 L1 fibroblasts, but they are 
selectively up-regulated during differentiation into adipocytes, which indicates a 
role in insulin-sensitivity (Larance et al., 2005; Sadler et al., 2014; Volchuk et 
al., 1995). Levels of VAMP 2, 3, and 4 increase significantly, while VAMPs 5, 7, 
and 8 remain unchanged. Subcellular fractionation showed that VAMPs 2, 5, and 
8 are present in both GSVs and recycling endosomes, while VAMPs 3,4, and 7 are 
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mostly found in recycling endosomes. Insulin stimulation leads to an increase of 
VAMP2 and 3 in the plasma membrane, suggesting that these two VAMPs are 
present in GSVs and are involved in GSV fusion with the plasma membrane 
(Cheatham et al., 1996; Sadler et al., 2014). It is thought that VAMP2 is the v-
SNARE that mediates membrane fusion, since depletion of the protein inhibits 
GLUT4 translocation and glucose uptake (Bryant & Gould, 2011). On the other 
hand, in vitro experiments have shown that all VAMPs can form SNARE 
complexes with syntaxin4 and SNAP23 (Sadler et al., 2014). Suggesting that 
VAMPs can be redundant, it was found that when inhibiting GSV fusion by 
disruption of the VAMPs 2, 3, and 8, insulin sensitivity could be restored by 
either of these VAMPs (Zhao et al., 2009). 
Contradictory, other studies found that VAMP2 depletion alone can impair GSV 
translocation (L. B. Martin et al., 1998) and, more specifically, fusion 
(Kawaguchi et al., 2010). Moreover, while both, VAMP2 and VAMP3 translocate 
to the plasma membrane in response to insulin, VAMP2 is more abundant in GSVs 
and it also co-precipitates with syntaxin4 in immunoprecipitation experiments, 
while VAMP3 does not (Sadler et al., 2014). These studies indicate, that VAMP2 
plays a major role in GLUT4 exocytosis. 
1.6.2.3 SM Proteins 
Sec1/Munc18 (SM) proteins are known to control the assembly of SNARE 
complexes (Toonen & Verhage, 2003). Adipocytes express two Munc18 
homologues: Munc18b and c, while Munc18a is neuronal specific and not found in 
fat cells (Tellam et al., 1995). While Munc18a and b have been shown to bind to 
syntaxins 1A, 2, and 3 in in vitro binding assays, only Munc18c binds to 
syntaxin4. In addition, both proteins translocate to the plasma membrane from 
intracellular membranes in response to insulin in 3T3 L1 adipocytes, as assessed 
by subcellular fractionation (Tellam et al., 1997). Munc18c is an arch-shaped 
protein that can bind to the regulatory domain Habc of syntaxin4. The Habc 
domain binds to the SNARE motif of the syntaxin, which inhibits SNARE complex 
assembly. The arch-shape of the SM protein holds the syntaxin in this closed 
conformation (Bracher & Weissenhorn, 2002). The relationship between SNAREs 
and SM proteins is however more complicated than this, as there are different 
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modes of interaction, which can in fact enable fusion of vesicles with target 
membranes (Laidlaw et al., 2017). 
Using the microscopy-based proximity ligation assay, Kioumourtzoglou et al. 
found that insulin does indeed facilitate the formation of SNARE complexes 
containing syntaxin4, SNAP23, VAMP2, as well as the SM protein Munc18c in 3T3 
L1 adipocytes. Tyrosin phosphorylation of Munc18c on Tyr521 allows SNARE 
complex assembly in vitro and this residue is also a direct target of the insulin 
receptor (Jewell et al., 2011; Schmelzle et al., 2006). This data has led to the 
hypothesis that phosphorylation of Munc18c in response to an insulin stimulus 
enables SNARE complex formation and thus allows GSV fusion with the 
membrane (Kioumourtzoglou, Gould, et al., 2014). 
1.6.3 Translocation of GSVs Along Filaments and Microtubules 
Using high-speed microscopy, Patki et al. were the first to live image individual 
cells expressing GLUT4-GFP under the influence of insulin. Within six minutes of 
insulin stimulation, individual GSVs can be observed to translocate from the 
perinuclear region of 3T3 L1 adipocytes towards the plasma membrane with a 
speed of 0.180 to 0.707 µm s-1. This movement is enabled by the interaction with 
both, actin and the microtubulin network, since disruption of either inhibits 
translocation as well as intracellular compartmentalisation (Patki et al., 2001). 
When treated with nocodazole, a potent drug that disrupts microtubulin 
filaments, 3T3 L1 adipocytes do not show the typical distribution of GLUT4 in 
the basal state that includes concentration around the nucleus. Instead, GLUT4 
is homogenously distributed in the cytoplasm (J. Huang et al., 2005; Karylowski 
et al., 2004). Another effect of the drug is diminished glucose uptake in response 
to insulin. Similarly, the addition of the actin-depolymerising toxin Lat-A stops 
all movement of GLUT4 within 3T3 L1 adipocytes, resulting in accumulation of 
the transporter in the juxtanuclear region and also inhibits glucose uptake. On 
the base of their findings, Patki et al. hypothesised that actin enables the 
interaction of GSVs with microtubules, thus allowing GSV translocation, and that 
insulin stimulation supports this interaction (Patki et al., 2001). This and other 
studies found that microtubules are necessary for insulin induced GSV 
translocation (J. Huang et al., 2005; Karylowski et al., 2004; Molero et al., 
2001). The entire process, however, is clearly not regulated by microtubules 
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alone. Stabilisation of microtubules has no increasing effect on GSV translocation 
in the absence of insulin (Molero et al., 2001). 
In fact, microtubules at the membrane appear to be involved in GSV fusion itself 
and not only transport to the membrane as microtubule density near the plasma 
membrane increases with insulin stimulation and fusion events colocalise with 
microtubules. This colocalisation is not due to previous transport of the GSV 
along microtubules (Dawicki-McKenna et al., 2012).  
Studying isolated rat adipocytes via TIRFM, Lizunov et al. found that GSVs are 
indeed moving rapidly along microtubules close to the plasma membrane, but 
this movement is decelerated significantly after addition of insulin when GSVs 
are tethered to the membrane in preparation for fusion (Lizunov et al., 2005). 
These results illustrate the important role that the cytoskeleton plays in the 
insulin-induced translocation of GSVs. Particularly microtubules are involved in 
GSV trafficking near the membrane, how exactly insulin stimulation inhibits 
these movements remains to be discovered.  
1.7 GLUT4 in the Plasma Membrane 
While GLUT4 signalling pathways have been studied extensively since the 
discovery of the transporter, its dynamics within the plasma membrane have 
been mostly neglected, which has been due to the lack of a suitable 
experimental setup to study exocytosed GLUT4. Classical biochemical 
approaches do not or only partially allow differentiation between intracellular 
and plasma membrane GLUT4. The discovery of the green fluorescent protein 
(GFP) and the ability to express it in living organisms opened up new ways for 
the study of all kinds of proteins (C. Martin et al., 1994; Shimomura et al., 
1962). Enhanced GFP (eGFP) is a variant of GFP (Cormack et al., 1996). Two 
years after GFP had first been expressed in Escherichia coli (E.coli) by Martin et 
al. (C. Martin et al., 1994), Dobson et al. used the back then revolutionary 
technology to express the fusion protein GLUT4-GFP in CHO cells, thus allowing 
visualisation of GLUT4 in single cells. For the first time, GLUT4 translocation to 
the plasma membrane upon insulin stimulation was observed (Dobson et al., 
1996). Shortly afterwards the same group managed to express their construct in 
3T3 L1 adipocytes (Powell et al., 1999). 
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By inserting a haemagglutinin (HA) tag into the first exofacial loop of GLUT4-GFP 
and visualise this by non-permeable immunofluorescent surface staining, it was 
furthermore possible to distinguish between intracellular GLUT4 and GLUT4 that 
had been inserted into the plasma membrane (Dawson et al., 2001), making HA-
GLUT4-GFP the most commonly used genetically modified variant of GLUT4. 
Engineering of GLUT4-GFP and later HA-GLUT4-GFP lay the foundation for most 
of the work that involves GLUT4 and fluorescence microscopy. 
The development of light microscopy techniques such as TIRFM and super-
resolution microscopy allowed to characterise GLUT4 in the plasma membrane. 
This field is still very young and the key studies that will be described in more 
detail in this section are summarised in Table 1.1. 
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Table 1.1 Studies on GLUT4 in the Plasma Membrane 
Studies used Total Reflection Fluorescence Microscopy (TIRFM), Fluorescence Photoactivation 
Localisation Microscopy (FPALM), and direct Stochastic Optical Reconstruction Microscopy 
(dSTORM) 
Study Microscopy 
Method and Main 
Probe 
Cell System Key findings 
Li et al. 2004 TIRFM 
GLUT4-EGFP 
3T3 L1 adipocytes Movement of 
GLUT4 in the 
membrane is 
restricted 
Lizunov et al. 
2005 
TIRFM 
HA-GLUT4-GFP 
Rat adipocytes Insulin induces 
vesicle tethering 
to the membrane 
Huang et al. 
2007 
TIRFM 
GLUT4-EGFP 
3T3 L1 adipocytes GLUT4 colocalises 
with clathrin in 
the membrane 
Bai et al. 2007 TIRFM 
GLUT4-EGFP 
3T3 L1 adipocytes Insulin regulates 
the fusion of GSVs 
with the 
membrane 
Jiang et al. 2008 TIRFM 
TDimer2-IRAP-
pHluorin 
3T3 L1 adipocytes Some fusion 
events are of the 
kiss-and-run type 
Stenkula et al. 
2010 
TIRFM 
IRAP-pHluorin 
Rat adipocytes Insulin induces 
dispersal of 
GLUT4 in the 
membrane 
Xu et al. 2011 TIRFM 
VAMP2-pHluorin 
3T3 L1 adipocytes Insulin 
stimulation 
decreases the 
number of kiss-
and-run events 
Lizunov, Lee et 
al. 2013 
TIRFM 
HA-GLUT4-GFP 
Human adipocytes Insulin resistance 
in humans results 
in impaired GSV 
tethering 
Lizunov, 
Stenkula et al. 
2013 
FPALM 
HA-GLUT4-EOS 
Rat adipocytes Further 
characterisation 
of GLUT4 
clusters. 
Eliminating some 
possible 
clustering 
mechanisms, such 
as clathrin 
Gao et al. 2017 dSTORM 
HA-GLUT4-GFP 
3T3 L1 adipocytes Insulin-induced 
dispersal of 
GLUT4 is impaired 
in insulin-
resistance 
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1.7.1 GSVs in the TIRF Zone 
TIRFM has been a valuable tool in the study of GLUT4 near the plasma 
membrane. The evanescent wave that is formed when the laser beam is totally 
reflected off the glass coverslip illuminates only the plasma membrane and a 
thin layer of cytosol adjacent to the coverslip, allowing the examination of 
fluorescent labelled proteins less than 100 nm away from the membrane while 
fluorescence of intracellularly located proteins does not disturb the image 
(Axelrod, 2001a; Mattheyses et al., 2010). The principles of TIRFM are described 
in more detail in Chapter 3. 
Li et al. were the first to employ TIRFM to track single GSVs near the plasma 
membrane and study their mobility and dynamics. Another characteristic of the 
evanescent wave generated in TIRFM is that it is exponentially decreasing with 
the distance from the coverslip (Axelrod, 2001a). This means that a GSV 
containing GFP-tagged GLUT4 can be seen approaching by its increasing 
fluorescence (C. H. Li et al., 2004). Li et al. used this attribute to study the 
vertical movement of GSVs. They found that most GSVs move up and down in the 
TIRF zone repeatedly, which indicates that they are not docked to the plasma 
membrane. Laterally, GSVs moved in a constrained or caged fashion, usually not 
more than 100 nm away from their initial site, indicating some sort of tethering 
(C. H. Li et al., 2004). 
Under basal conditions, GSVs can be seen moving near the plasma membrane in 
the manner previously described. A lot of this movement is along trajectories 
that are likely related to the microtubule network. One study found that insulin 
stimulation reduced this movement by a factor of 8, which is due to the 
immobilisation of GSVs to the membrane. Immobilised vesicles also “wriggle” to 
a lesser degree in the presence of insulin than they do in the basal state 
(Lizunov et al., 2005). 
With TIRF microscopy, it was possible to investigate processes happening directly 
at the plasma membrane in response to an insulin stimulus. Specifically, the 
docking and fusion of GSVs could be examined more closely and differences 
between the basal and insulin stimulated state could be observed on a much 
more resolved level. 
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1.7.2 GLUT4 Clustering in Response to Insulin 
In their first TIRFM experiments, Lizunov et al. noticed that insulin stimulation 
leads to immobilisation of GLUT4 in the plasma membrane. While the 
distribution is relatively homogenous in the basal state, insulin stimulation 
results in accumulation of glucose transporters in specific areas of the 
membrane (Lizunov et al., 2005). This immobilisation could be due to two 
reasons: Tethering of GSVs in these regions prior to fusion as suggested by 
Lizunov et al. or the movement of GLUT4 into relatively static regions within the 
plasma membrane. Clathrin has been shown to localise to mostly immobile 
domains within the plasma membrane (Bellve et al., 2006) and GLUT4 indeed 
colocalises with these static patches after insulin stimulation but to a much 
lesser degree in the basal state (S. Huang et al., 2007). Contradicting this 
finding, more recent data using surface staining has revealed that most of the 
GLUT4 that colocalises with clathrin is found in close proximity to the membrane 
but is not actually exocytosed. Instead, clathrin is probably involved in the 
endocytosis of existing GLUT4 clusters (Stenkula et al., 2010). 
1.7.3 Tethering and Fusion of GSVs with the Plasma Membrane 
The single steps that happen at the plasma membrane are thought to be 
reversible docking and fusion of the vesicle (Bai et al., 2007). When imaging 
GLUT4-GFP expressing adipocytes in TIRF, a docking event is characterised by a 
fluorescent spot, the GSV, approaching the membrane and then remaining static 
for a defined period. After docking the fluorescence can disperse in the field of 
view, which signifies fusion of the vesicle. In other cases, the fluorescence 
decreases again, meaning that the vesicle has undocked. Bai et al. described 
this behaviour with the following reaction scheme: 
MV  DV
k−1
←  
k   1
→  
k  2
→ Fusion 
According to this scheme, moving vesicles (MV) are mobile fluorescent GSVs 
within the TIRF zone. They dock to the membrane with the docking rate k1 and 
become docked vesicles (DV). From this state they can either undergo fusion 
with the fusion rate k2 or they undock again with the undocking rate k-1. Kinetic 
analysis of these steps revealed that insulin increases the fusion rate by 
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approximately 8-fold, but the docking rate only about 2-fold. The time the 
vesicles remained in the docked state, the mean dwell time, decreased by about 
30 %. The docking step appears to be regulated by PI3K, since treatment with 
the PI3K inhibitor Wortmannin reduces the docking rate significantly. In 
conclusion, insulin stimulates mainly the fusion of vesicles with the membrane 
and there may be an insulin-regulated priming step after docking that prepares 
the GSVs for fusion (Bai et al., 2007). 
Fusion of other GSV specific proteins such as IRAP and VAMP2 with the pH 
sensitive fluorescent protein pHluorin offered the opportunity to witness fusion 
events of GSVs with the membrane based on the protein’s fluorescent properties 
(Ashby et al., 2004). If fused with the C-terminus of IRAP or VAMP2, pHluorin is 
located inside the GSV where the pH is acidic. Fusion of the GSV with the plasma 
membrane exposes the protein to the neutral pH of the extracellular culture 
medium, which activates fluorescence (Yu Chen & Lippincott-Schwartz, 2015; 
Jiang et al., 2008). Using pHluorin tagged GSV proteins is a very elegant way to 
visualise fusion. Fusion events are much easier to witness by a sudden increase 
in fluorescence than by simply observing a spreading of fluorescence as Bai et al. 
did. It is also less ambiguous whether a vesicle is indeed fused with the 
membrane or only docked to it. 
Jiang et al. used the unique properties of IRAP-pHluorin and engineered the 
fusion protein further by adding the red fluorescent protein Tdimer2 to its 
N-terminus. With the help of this construct and dual-colour TIRFM they could 
observe the docking and fusion of GSVs in real time and reported that some of 
the fusion events were of the “kiss-and-run” type, meaning that the vesicles 
fused briefly with the membrane to be endocytosed again shortly after. 
According to their observations, 15 % of fusion events in the basal state were of 
the kiss-and-run type. By expressing a mutated form of AS160 in adipocytes, the 
four times phosphorylated AS160-4P, they found out that this leads to the 
inhibition of insulin stimulated GSV docking, indicating that AS160 is crucial for 
the docking, but not the fusion of GSVs (Jiang et al., 2008). 
Using a similar probe, VAMP2-pHluorin, Xu et al. also reported kiss-and-run 
events. In contrast to the findings of Jiang et al., with almost 40 % of fusion 
events they found them to be very common in unstimulated cells. This number 
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dropped to about 5 % after insulin stimulation. Disruption of the phospholipase 
D1 (PLD) increased the number of kiss-and-run events in both the basal and the 
insulin-stimulated state. In another experiment they quantified fusion events 
further by determining the duration between docking and fusion. This fusion 
pore duration was significantly shorter in insulin stimulated cells than in basal 
cells. They concluded that insulin must lower the energy barrier for full fusion 
after vesicle pore formation, possibly in correlation with PLD. Thus, insulin not 
only regulates GSV translocation to the plasma membrane, but it also appears to 
have a direct effect at the fusion pore itself (Y. Xu et al., 2011). 
Figure 1.7 shows the process of vesicle fusion schematically. When the GSV 
approaches the plasma membrane (A) it can dock, and a fusion pore opens up 
(B). From here, there are two possibilities: the fusion pore can either close again 
and the vesicle undocks in a kiss-and-run like fashion (C), this is more likely in 
the basal state. During insulin stimulation the likelihood of the vesicle fusing 
entirely is increased, allowing dispersal of GLUT4 in the membrane (D). 
Defective tethering of GSVs has been linked to type 2 diabetes (Lizunov, Lee, et 
al., 2013). Human adipocytes from subjects with varying systemic insulin 
sensitivity and body mass index (BMI) were transfected with fluorescently tagged 
GLUT4 and observed via TIRFM in the basal state and after insulin stimulation. 
Interestingly, cells from all subjects behaved the same under basal conditions, 
whether they were derived from lean, obese, insulin-sensitive, or insulin-
resistant subjects. GSVs all translocated, tethered, and fused in the same 
manner, indicating that the machinery that is required for basal GSV trafficking 
is not affected by either BMI or insulin-sensitivity. Insulin-stimulated GLUT4 
translocation, however, was significantly impaired in insulin-resistant subjects. 
Surface staining of GLUT4 revealed that there was less total GLUT4 present in 
the plasma membrane after insulin stimulation at low systemic insulin-
sensitivity. This is due to fewer fusion events as a result of impaired vesicle 
tethering. BMI alone did not have such drastic effect (Lizunov, Lee, et al., 2013). 
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Figure 1.7 Fusion of GSV with the Plasma Membrane 
A: A GSV is approaching the membrane. B: Docking of the vesicle and opening of the fusion pore. 
C: Retreat of the GSV in a kiss-and-run like fashion D: Full vesicle fusion with the membrane 
1.7.4 GLUT4 Clustering and Dispersal 
Although insulin has been shown to regulate many steps from GLUT4 recycling to 
translocation to the membrane, it is now thought that it has a major effect on 
the distribution of GLUT4 in the plasma membrane itself. Stenkula et al. 
delivered evidence for this when they reported that in the basal state GLUT4 can 
be mostly found in clusters, whereas insulin stimulation leads to a much more 
dispersed distribution of the transporter. Importantly, this is not an artefact of 
fixation or labelling. What exactly mediates the formation of clusters and their 
dispersal remains unknown, but it has been shown that they are associated with 
neither caveola, nor clathrin (Stenkula et al., 2010). The latter however is 
involved in the endocytosis of pre-existing clusters particularly in the basal 
state. In terms of exocytosis, Stenkula et al. described two different modes: 
fusion-with-retention (previously referred to as kiss-and-run) and fusion-with-
release. In the basal state 95 % of all fusion events were attributed to the 
fusion-with-retention type. Insulin stimulation then not only increased the 
overall fusion rate from 0.03 events/µm2/min in the basal state to 
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0.15 events/µm2/min after only 2 minutes, but it also led to a 60-fold increase 
of fusion-with-release events, while only having a very small effect on the 
number of fusion-with-retention events. This indicates that fusion-with-
retention events form clusters of GLUT4 in the plasma membrane. The group 
developed a mathematical model that assumes that insulin only affects the 
dispersal of GLUT4 and assumes GLUT4 to be relatively constant in all other 
GLUT4 containing compartments in response to insulin. Remarkably, this model 
fits experimental data of number of fusion events over time very well. Based on 
their observations, Stenkula et al. proposed a new mode of insulin-regulated 
glucose uptake. In unstimulated cells GLUT4 is mostly found in clusters which 
can be readily re-endocytosed. Insulin-stimulation leads to a dispersal of these 
clusters and monomeric GLUT4 takes up glucose more efficiently (Stenkula et 
al., 2010). 
1.7.5 Single Molecule Imaging of GLUT4 in the Plasma Membrane 
Single molecule imaging had been used in the past to describe the trafficking 
kinetics of GLUT4 inside the cell (Fujita et al., 2010; Hatakeyama & Kanzaki, 
2011), but not to investigate the dynamics of GLUT4 in the plasma membrane. 
Single molecule localisation microscopy (SMLM) is a form of light microscopy in 
which super-resolution is achieved by localising single molecules based on the 
centre of a fluorescent tag’s point-spread function (Betzig et al., 2006; Hess et 
al., 2006; van de Linde, Löschberger, et al., 2011). In short, structures of 
interest are labelled either externally with a fluorescently tagged antibody, or 
internally fused to a fluorescent protein. This fluorophore has the ability to 
switch between the dark and the light state, which results in blinking when 
excited. Blinking means that not all fluorophores are “switched on” at the same 
time, which makes it possible to detect single molecules in different frames (for 
a more detailed explanation refer to Chapter 5). Two SMLM techniques have 
been applied to address the clustering and dispersal of GLUT4: Fluorescence 
Photoactivation Localisation Microscopy (FPALM) (Lizunov, Stenkula, et al., 
2013) and Direct Stochastic Optical Reconstruction Microscopy (dSTORM) (Gao et 
al., 2017). 
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In order to characterise the nature of GLUT4 clusters further, the same group 
that first reported them developed a GLUT4 variant tagged with a 
photoswitchable fluorophore: HA-GLUT4-EOS. This allowed the tracking of single 
GLUT4 molecules in live cells. Using the probe in FPALM, they found three 
different types of GLUT4 movement in the plasma membrane: directed motion, 
free lateral diffusion, and constrained diffusion within clusters. In the basal 
state, almost half of all trajectories were of the constrained diffusion type, this 
decreased to 27 % after insulin stimulation, while more than 70 % were freely 
diffusing in the membrane. This process is not ATP-dependent. Single molecules 
can enter and leave the clusters, but formation of new clusters from freely 
diffusing molecules was not observed. Interestingly, the rate at which single 
GLUT4 molecules leave clusters more than doubles with insulin stimulation. 
When imaging adipocytes expressing HA-GLUT4-EOS as well as IRAP-pHluorin, it 
becomes clear that cluster formation happens upon fusion of GSVs with the 
plasma membrane as the previously described fusion-with-retention events. The 
retention and subsequent cluster formation is specific for GLUT4, as IRAP 
diffuses after exocytosis and is not retained (Lizunov, Stenkula, et al., 2013). 
Recently, dSTORM has been deployed to confirm the formation of GLUT4 clusters 
and their dispersal upon insulin stimulation in 3T3 L1 adipocytes (Gao et al., 
2017). Compared to the basal state, insulin stimulated cells show more clusters, 
which is due to the higher GLUT4 concentration. However, the degree of 
clustering is clearly reduced, and the transporters tend to a more dispersed 
distribution. The cluster size itself is unchanged, but the proportion of GLUT4 
molecules in small clusters is increased. This data strongly supports the 
hypothesis that insulin induces dispersal of GLUT4 in the cell membrane of 
adipocytes. When insulin-resistance is induced by incubation with insulin 
overnight, both insulin-resistant basal and insulin-resistant insulin-stimulated 
cells show a more clustered pattern. This is a ground-breaking revelation, as it 
indicates that GLUT4 cluster formation and dispersal is involved in the 
development of insulin-resistance and therefore diabetes. 
The clustering appears to be linked to the N-terminal F5QQI motif of GLUT4, 
indicating that this region is involved in the maintenance of GLUT4 clusters. 
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Cells expressing a mutant of this motif exhibit less clustering than the wild-type, 
while size and shape of the clusters remains unaltered. (Gao et al., 2017).  
To my knowledge, Lizunov et al. and Gao et al. are the only research groups 
that have investigated the clustering and dispersal of GLUT4 via SMLM. Both 
their studies deliver compelling evidence that insulin-sensitivity of adipocytes 
relies on the ability of GLUT4 to form clusters and disperse in the plasma 
membrane. The question remains how clusters are formed and maintained in the 
absence of insulin on a molecular basis. 
1.7.6 Possible Mechanisms of GLUT4 Clustering 
GLUT4 clusters appear to be elongated rather than round and have a diameter of 
approximately 90-170 nm, which does not change in the presence of insulin. The 
elongated shape of the clusters suggests that they are not maintained by cross-
linked structures. Solid-phase domains can be excluded as a reason, as this 
would not allow mobility of single GLUT4 molecules within them, which is, 
however, the case. Nor are they dependent on lipid rafts, as disruption of 
cholesterol does not alter the cluster shape or size (Lizunov, Stenkula, et al., 
2013). Contradicting this conclusion, Gao et al. find that disruption of 
cholesterol does indeed lead to loss of clusters. This could be explained by the 
higher methyl-β-cyclodextrin concentration they used or by the fact that they 
conducted this experiment in cells expressing the mutated form of the F5QQI 
motif (Gao et al., 2017). This needs to be addressed further, however the lipid 
raft theory itself is heavily disputed amongst scientists (Shaw, 2006). It is likely 
that GLUT4 clusters form in the GSVs before fusion with the membrane and 
components retaining GLUT4 inside the clusters are present in GSVs but not 
necessarily at the plasma membrane. The elongated shape of the clusters could 
therefore also be explained by fusion of tubular-vesicular GSVs (Lizunov, 
Stenkula, et al., 2013). 
The picket fence model was originally proposed to explain why the diffusion 
velocity is much slower in biological membranes than in artificial phospholipid 
bilayers. According to this model, membranes are compartmentalised, and 
regions are separated from each other by molecular “picket fences”. The pickets 
in these fences are proteins anchored to the actin cytoskeleton (Fujiwara et al., 
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2002). It is conceivable that the clustering of GLUT4 is based on its confinement 
within a molecular picket fence, however, the disruption of actin structures 
does not lead to a change in cluster features (Lizunov, Stenkula, et al., 2013). 
This means that the fence around GLUT4 clusters must be maintained 
independently of the actin cytoskeleton. The idea of a protein structure 
corralling GLUT4 in the basal state is nevertheless plausible. The fact that IRAP 
can diffuse from newly formed clusters, but GLUT4 cannot (Lizunov, Stenkula, et 
al., 2013), excludes the classical picket-fence hypothesis, since this would not 
allow for diffusion of any proteins. Stenkula et al. instead proposed a slightly 
altered protein-specific confinement model. It is possible that GLUT4, but not 
IRAP, interacts directly with a component of the molecular picket-fence. 
1.7.7 EFR3 and its Potential Role in GLUT4 Dispersal 
A genetic screen of the yeast Saccharomyces cerevisiae has revealed a potential 
role of the protein EFR3 in the dynamics of GLUT4 in the plasma membrane 
(Wieczorke et al., 2003). EFR3 is a highly conserved membrane protein that has 
been shown to be involved in the formation of Stt4 phosphoinositide kinase (PIK) 
clusters in yeast. It binds to Ypp1, which binds to Stt4. This complex is held at 
the plasma membrane via palmitoylation of the N-terminus of EFR3 (Baird et al., 
2008; Wu et al., 2014). The mammalian homologues of Ypp1 and Stt4, are TTC7 
and phosphatidylinositol 4-kinase type III α (PI4KIIIα) respectively (Nakatsu et 
al., 2012). In mammalian cells, another protein, FAM126A, is part of the PI4KIIIα 
complex (Baskin et al., 2016). Phosphatidylinositols are glycerphospholipids that 
contain a myo-inositol head group, which can be phosphorylated or 
dephosphosphorylated at the 3’, 4’, and/or 5’ hydroxyl group, allowing for 
diversity in signalling pathways (Falkenburger et al., 2010). When 
phosphorylated, phosphatidylinositols are referred to as phosphoinositides (PIs). 
The location of each PI is specific to a cellular membrane and their principal role 
is to interact with proteins that have a function in the respective membrane 
(Tan & Brill, 2014). PI3K for example can be found in the late endosome and 
plays an important role in insulin signalling as has been discussed in chapter 1.5. 
PI4K is predominantly found in the TGN but it is also part of GSVs (DelVecchio & 
Pilch, 1991) It catalyses the conversion of PI to phosphatidylinositol 4-phosphate 
(PI4P) and generates pools of this in the plasma membrane (Tan & Brill, 2014). 
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Recent studies in our laboratory have revealed that the homolog EFR3a plays a 
role in glucose uptake in 3T3 L1 adipocytes. It is localised at the plasma 
membrane and has a regulating effect on GLUT4. Overexpression of EFR3a leads 
to increased GLUT4 translocation and glucose uptake, which is probably due to 
its association with PI4KIIIα. Inhibition of PI4KIIIα with phenylarsine oxide (PAO) 
inhibits glucose uptake, indicating that PI4P is involved in the process. The 
subcellular localisation of PI4KIIIα does not change in response to insulin, 
however, knock-down of PI4KIIIα in 3T3 L1 adipocytes leads to a significant 
decrease in insulin-stimulated glucose uptake, indicating that insulin signalling 
leads to the activation of PI4KIIIα and thus enabling glucose uptake via GLUT4 
(Laidlaw, 2018). 
1.8 Working Hypothesis and Aims of this Study 
Since the discovery of GLUT4 and its association with type 2 diabetes, research 
in the field has come a long way. Numerous effects insulin has on the glucose 
transporter and its associated signalling pathway have been found and analysed 
and the malfunction of either of them may or may not be involved in the 
development of the disease. There is still no cure for type 2 diabetes and 
therapies and medication mostly target the symptoms but not the underlying 
cause. During the previous years it has become clear that insulin has a 
considerable effect on GLUT4 translocation and specifically on its dynamics in 
the plasma membrane. In the basal state, GLUT4 can be found in clusters which 
can be readily endocytosed, which was observed as so-called kiss-and-run 
events. Insulin stimulation then leads to dispersal of the transporter and this is 
thought to facilitate glucose uptake. The exact mechanisms of these clustering 
and dispersal processes remain unclear but could provide a valuable drug target 
for the treatment of type 2 diabetes. 
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Figure 1.8 Clustering and Dispersal of GLUT4 in Response to Insulin. 
In the basal state the majority of GSVs is located in the perinuclear region and GLUT4 in the 
plasma membrane is mostly clustered. Insulin stimulation leads to increased translocation of GSVs 
to the plasma membrane and dispersal of GLUT4. 
 
 
Figure 1.9 Schematic of the Working Hypothesis Involving EFR3a and PI4P. 
A: In the basal state PI4KIIIα is inactive and GLUT4 is corralled in clusters by PI. B: Activation of 
PI4KIIIα by mobilisation of EFR3a, TTC7, and FAM126A after insulin stimulation leads to 
phosphorylation of PI at the 4’ position, resulting in the generation of PI4P. This releases GLUT4 
clusters and allows dispersal of the transporter. 
Based on the research that has been described in the previous sections, we have 
developed a working hypothesis that is illustrated in Figure 1.8 and Figure 1.9. A 
small percentage of GLUT4 is located in the plasma membrane under basal 
conditions. Those molecules can be found in clusters, which enable the 
transporter to be easily re-endocytosed and undergo recycling with the 
endosomal system. We propose that these clusters are maintained by lipid 
domains in the plasma membrane containing unphosphorylated PI. The binding 
of insulin to its receptor leads to a signalling cascade that eventually results in 
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the translocation of GSVs to the plasma membrane and an increase in fusion 
events. We believe that insulin also has an effect on the EFR3 machinery by 
activating PI4KIIIα. This results in the phosphorylation of PI in the plasma 
membrane to PI4P, which loses the ability to coral GLUT4 clusters. 
Consequently, GLUT4 disperses from its clusters, which not only prevents re-
endocytosis but also allows efficient glucose uptake. 
The main objective of this work was to develop a microscopy-based assay to 
observe and quantify the clustering and dispersal of GLUT4 and to shed light on 
its molecular mechanisms. This will be further discussed in Chapter 4 and 
Chapter 5. The majority of experiments have been carried out in 3T3 L1 
adipocytes, which can be challenging to work with. For this reason, the human 
HeLa cell line, expressing HA-GLUT4-GFP has been studied and compared to 3T3 
L1 adipocytes to determine whether it could be used as a suitable cell model 
that is easier to work with. For this study TIRFM has been used, which is 
discussed in Chapter 3. Based on the results of this chapter, a different angle of 
GLUT4 signalling in human cells has been illuminated by focusing on SNARE 
proteins facilitating GLUT4 transport between the endoplasmic reticulum (ER), 
the Golgi, and the ER-to-Golgi intermediate compartment (ERGIC). This is 
discussed in Chapter 6. 
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Chapter 2 General Materials and Methods 
2.1 Materials 
2.1.1 Reagents and Enzymes 
Table 2.1 Reagents and Enzymes 
Reagent/Enzyme Supplier Catalogue 
Number 
Acetic Acid VWR Chemicals 
(Leicestershire, UK) 
20104.334 
Acetone VWR Chemicals 
(Leicestershire, UK) 
20066.330 
Acrylamide BDH (Dubai, UAE) 442993Y 
30 % Acrylamide Mix Severn Biotech 
(Worcestershire, UK) 
20-2100-10 
Agar  Formedium (Norfolk, UK) A6A02 
Agarose Invitrogen (Paisley, UK) 16500 
6-aminocaproic acid Sigma-Aldrich (Dorset, UK) A2504 
Ammonium Persulfate 
(APS) 
ThermoFisher Scientific 
(Leicestershire, UK) 
A/6160/60 
Ampicillin Sigma-Aldrich (Dorset, UK) A0166 
β-mercaptoethanol Sigma-Aldrich (Dorset, UK) M6250 
Bisacrylamide Sigma-Aldrich (Dorset, UK) 146072 
Bis-tris Sigma-Aldrich (Dorset, UK) B9754 
Blasticidin Sigma-Aldrich (Dorset, UK) 15205 
BN-PAGE marker GE Healthcare BioSciences 
(Chalfont, UK) 
17044501 
Bovine Serum Albumin 
(BSA) 
ThermoFisher Scientific 
(Leicestershire, UK) 
BP9702 
Bromophenol blue Sigma-Aldrich (Dorset, UK) B8026 
BSA Promega (Southampton, UK) R396E 
CaCl2 BDH (Dubai, UAE) 275844L 
Collagenase Type I 
 
 
Worthington Biochemical 
Corporation (Lakewood, USA) 
4197 
Coomassie Brilliant Blue 
G-250 
Serva (Heidelberg, Germany) 35050 
Cysteamine Sigma-Aldrich (Dorset, UK) 30070 
Cytochalasin B Sigma-Aldrich (Dorset, UK) C6762 
[3H]Deoxy-D-Glucose Perkin Elmer (Massachusetts, 
USA) 
NET328A001MC 
4′,6-diamidino-20-
phenylindole (DAPI) 
Sigma-Aldrich (Dorset, UK) D9542 
Dexamethasone Sigma-Aldrich (Dorset, UK) D4902 
Digitonin Calbiochem (San Diego, USA) 300411 
Dimethyl Sulfoxide (DMSO) ThermoFisher Scientific 
(Leicestershire, UK) 
D/4120/PB08 
Dithiothreitol (DTT) Melford Laboratories (Suffolk, 
UK) 
3483-12-3 
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Reagent/Enzyme Supplier Catalogue 
Number 
DNA Marker 1kb Promega (Southampton, UK) G571A 
DNA 6x sample buffer Promega (Southampton, UK) G1881 
Donkey Serum Sigma-Aldrich (Dorset, UK) D9663 
Doxycycline Sigma-Aldrich (Dorset, UK) D1822 
Dulbecco’s Modified 
Eagle’s Medium (DMEM) 
Gibco (Paisley, UK) 41965-039 
Dulbecco’s Phosphate 
Buffered Saline (DPBS) 
Gibco (Paisley, UK) 14190-094 
Enhanced 
Chemiluminescence (ECL) 
Western Blotting Substrate 
ThermoFisher Scientific 
(Leicestershire, UK) 
32106 
Ethanol VWR Chemicals 
(Leicestershire, UK) 
20821.330 
Ethylenediaminetetraacetic 
acid (EDTA) 
Sigma-Aldrich (Dorset, UK) E4884 
Ethylene glycol-bis(2-
aminoethylether)-
N,N,N′,N′-tetraacetic acid 
(EGTA) 
Sigma-Aldrich (Dorset, UK) E4378 
Foetal Calf Serum (FCS) Gibco (Paisley, UK) 10500-064 
Galectin 3 R&D Systems (Minneapolis, 
USA) 
1197-GA 
Gelatin from cold water 
fish 
Sigma-Aldrich (Dorset, UK) G7765 
Glucose ThermoFisher Scientific 
(Leicestershire, UK) 
G/0500/53 
Glycerol ThermoFisher Scientific 
(Leicestershire, UK) 
G/0650/17 
Glycine ThermoFisher Scientific 
(Leicestershire, UK) 
G/0800/60 
Goat Serum Sigma-Aldrich (Dorset, UK) G9023 
HCl ThermoFisher Scientific 
(Leicestershire, UK) 
H/1200/PB17 
4-(2-hydroxyethyl)-1-
piperazineethanesulfonic 
acid (HEPES) 
VWR Chemicals 
(Leicestershire, UK) 
441485H 
Hygromycin Sigma-Aldrich (Dorset, UK) H3274 
Insulin Sigma-Aldrich (Dorset, UK) I5523 
3-isobutyl-1-
methylxanthine (IBMX) 
Sigma-Aldrich (Dorset, UK) I5879 
Isopropanol Riedel-de Haën (Seelze, 
Germany) 
24137 
Kanamycin Sigma-Aldrich (Dorset, UK) 60615 
KCl VWR Chemicals 
(Leicestershire, UK) 
26764.260 
KH2PO4 ThermoFisher Scientific 
(Leicestershire, UK) 
P/4800/53 
Lentiviral Packaging Kit 
pPACKH1 
System Biosciences (Palo Alto, 
USA) 
LV510A-1 
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Reagent/Enzyme Supplier Catalogue 
Number 
Lenti-X GoStix Clontech (Mountain View, USA) 631244 
L-Glutamine Sigma-Aldrich (Dorset, UK) G7513 
Ligase Buffer Invitrogen (Paisley, UK) P/N Y 90001 
Lipofectamine 2000 Invitrogen (Paisley, UK) 11668-022 
Maxiprep Kit Quiagen (Crawley, UK) 12163 
Methanol ThermoFisher Scientific 
(Leicestershire, UK) 
M/4000/PC17 
MgCl2 VWR Chemicals 
(Leicestershire, UK) 
25108.260 
MgSO4 BDH (Dubai, UAE) 1015144 
Milk Powder Marvel (London, UK) n.a. 
Miniprep Kit Promega (Southampton, UK) A1330 
Mounting Medium Ibidi (Martinsried, Germany) 50001 
Immu-Mount ThermoFisher Scientific 
(Leicestershire, UK) 
9990402 
Mycoplasma Detection Kit Minerva Biolabs (Berlin, 
Germany) 
11-1100 
Na2HPO4 VWR Chemicals 
(Leicestershire, UK) 
102494C 
NaCl Merck (Darmstadt, Germany) 1.06404 
NaH2PO4 Merck (Darmstadt, Germany) 1.06345 
NaOH ThermoFisher Scientific 
(Leicestershire, UK) 
S/4920/60 
Newborn Calf Serum (NCS) Gibco (Paisley, UK) 16010-159 
NH4Cl Fisons (Loughborough, UK) A/3920 
One Shot® Stbl3™ 
Chemically Competent 
E. coli 
ThermoFisher Scientific 
(Leicestershire, UK) 
C737303 
Opti-MEM Gibco (Paisley, UK) 31985-062 
Paraformaldehyde (PFA) Sigma-Aldrich (Dorset, UK) P6148 
Penicillin/Streptomycin Gibco (Paisley, UK) 15140122 
Pirenzepine Tocris Bioscience (Abingdon, 
UK) 
1071 
Polybrene Sigma-Aldrich (Dorset, UK) TR-1003 
Ponceau S Sigma-Aldrich (Dorset, UK) P3504 
Protease Inhibitor Tablet ThermoFisher Scientific 
(Leicestershire, UK) 
A32965 
Protein Marker Bio-Rad Laboratories 
(Hertfordshire, UK) 
161-0373 
PureFection Transfection 
Reagent 
System Biosciences (Palo Alto, 
USA) 
LV750A 
Puromycin Sigma-Aldrich (Dorset, UK) P8833 
Restriction Endonuclease 
BamHI 
New England Biolabs 
(Massachusetts, USA) 
R3136 
Restriction Endonuclease 
NotI 
New England Biolabs 
(Massachusetts, USA) 
R3189 
Shrimp alkaline 
phosphatase 
New England Biolabs 
(Massachusetts, USA) 
M0371 
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Reagent/Enzyme Supplier Catalogue 
Number 
Sodium dodecyl sulfate 
(SDS) 
VWR Chemicals 
(Leicestershire, UK) 
442444H 
Sodium Pyruvate Gibco (Paisley, UK) 11360070 
Sucrose Sigma-Aldrich (Dorset, UK) S9378 
SYBRTM Safe DNA Gel Stain Invitrogen (Paisley, UK) S33102 
T4 DNA Ligase Invitrogen (Paisley, UK) 15224-017 
Temed  Sigma-Aldrich (Dorset, UK) T9281 
Tricine Sigma-Aldrich (Dorset, UK) T0377 
Tris Base ThermoFisher Scientific 
(Leicestershire, UK) 
BP152-1 
Tris acetate Sigma-Aldrich (Dorset, UK) T1258 
Triton X-100 Sigma-Aldrich (Dorset, UK) T9284 
Troglitazone Tocris Bioscience (Abingdon, 
UK) 
3114 
Trypan Blue Sigma-Aldrich (Dorset, UK) T6146 
Trypsin-EDTA (0.05 %) Gibco (Paisley, UK) 25300054 
Tryptone Formedium (Norfolk, UK) TRP02 
Tween-20 Sigma-Aldrich (Dorset, UK) P7949 
Twinsil® Picodent (Wipperfürth, 
Germany) 
1300 1000 
Virapower Invitrogen (Paisley, UK) A11145 
Virkon Rely+On Lanxess (Köln, Germany) 12358662 
Wizard® SV Gel and PCR 
Clean-Up System 
Promega (Southampton, UK) A9281 
Yeast Extract Sigma-Aldrich (Dorset, UK) M6250 
 
2.1.2 Buffers and Solutions 
If not stated otherwise, all buffers and solutions were made up in demineralised 
water. If necessary, pH was adjusted using HCl or NaOH. 
Table 2.2 Buffers and Solutions 
Buffer Components 
2 Yeast Tryptone (2YT) Medium 1.6 % (w/v) Tryptone 
1 % (w/v) Yeast extract 
0.5 % (w/v) NaCl 
(2 % (w/v) Agar for plates) 
Blue Native Polyacrylamide Gel 
Electrophoresis (BN-PAGE) Acrylamide 
Solution 
48 % Acrylamide 
1.5 % Bisacrylamide 
BN-PAGE Anode Buffer 50 mM BisTris/HCl 
pH 7.0 
BN-PAGE Cathode Buffer 50 mM Tricine 
15 mM BisTris/HCl pH 7.0 
0.02 % (w/v) Coomassie Blue G-250 
BN-PAGE Cathode Buffer (colourless) 50 mM Tricine 
15 mM BisTris/HCl pH 7.0 
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Buffer Components 
BN-PAGE Destain Solution 25 % (v/v) Methanol 
10 % (v/v) Acetic Acid 
BN-PAGE Gel Buffer 100 mM BisTris/HCl pH 7.0 
1 M 6-aminocaproic acid 
BN-PAGE 10x Sample Buffer 5 % (w/v) Coomassie Brilliant Blue 
G-250 
0.5 M 6-aminocaproic acid 
100 mM BisTris/HCl pH 7.0 
Glycine in PBS (Gly) 20 mM Glycine 
In PBS 
HEPES-EDTA-Sucrose (HES) Buffer 250 mM Sucrose 
20 mM HEPES 
1 mM EDTA 
pH 7.4 
Immunofluorescence (IF) Buffer 0.2 % (w/v) Fish skin gelatin 
0.1 % (v/v) Goat serum 
In PBS 
Laemmli Sample Buffer (LSB) 100 mM Tris/HCl pH6.8 
4 % (w/v) SDS 
20 % (v/v) Glycerol 
0.2 % (w/v) bromophenol blue 
10 % β-mercaptoethanol 
Lysis Buffer 50 mM HEPES pH 7.2 
100 mM KCl 
5 mM NaCl 
1 mM MgCl2 
0.5 mM EGTA 
1 mM EDTA 
0.1 % (v/v) Triton X-100 
Complete protease inhibitor (1 tablet 
per 50 ml) 
Mercaptoethylamine (MEA) Buffer 10 mM Cysteamine 
In PBS 
pH 7.4 
Phosphate Buffered Saline (PBS) 170 mM NaCl 
3.4 mM KCl 
10 mM Na2HPO4 
1.8 mM KH2PO4 
pH 7.2 
Phosphate Buffered Saline with Tween 
(PBST) 
170 mM NaCl 
3.4 mM KCl 
10 mM Na2HPO4 
1.8 mM KH2PO4 
0.1 % Tween-20 
pH 7.2 
Permeabilisation Buffer 0.1 % Triton X-100 
In PBS 
PFA solution 3 % (w/v) PFA 
1 mM CaCl2 
1 mM MgCl2 
In PBS 
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Buffer Components 
Ponceau S 0.2 % Ponceau S 
1 % (v/v) acetic acid 
SDS-Polyacrylamide Gel 
Electrophoresis (PAGE) Running Buffer 
25 mM Tris 
192 mM Glycine 
0.1 % (w/v) SDS 
SDS-PAGE Transfer Buffer 25 mM Tris 
192 mM Glycine 
20 % (v/v) Ethanol 
Semi-Dry Transfer Buffer 9.6 mM Tris 
7.8 mM Glycine 
0.26 mM SDS 
20 % Methanol 
Super Optimal broth with Catabolite 
repression (SOC) medium 
2 % (w/v) Tryptone 
0.5 % (w/v) Yeast extract 
0.05 % (w/v) NaCl 
0.02 % (w/v) KCl 
2 mM MgCl2 
8 mM Glucose 
pH 7.0 
Tris-acetate EDTA (TAE) Buffer 40 mM Tris acetate 
1 mM EDTA 
Quenching Buffer 50 mM NH4Cl 
In PBS 
 
2.1.3 Antibodies 
2.1.3.1 Primary Antibodies 
Primary antibodies were used for immunoblotting (IB) and IF. 
Table 2.3 Primary Antibodies 
Antigen Details Working Dilution Supplier 
EFR3a Rabbit 
polyclonal 
IB 
1:250 
Sigma-Aldrich 
(HPA023092) 
ID3 Mouse monoclonal 
Cell Culture 
Supernatant 
IF 
1:2 
Gift from Neil 
Bulleid 
ERGIC-53/p58 Rabbit 
Polyclonal 
IF 
1:200 
Sigma Aldrich 
(E1031) 
GAPDH Mouse 
monoclonal 
IB 
1:10,000 
Applied 
Biosystems 
(AM4300) 
GLUT4 Rabbit 
polyclonal 
IB 
1:1000 
AbCam 
(ab654) 
GM130 Mouse 
Monoclonal 
IF 
1:200 
BD Biosciences 
(610823) 
HA Mouse 
Monoclonal 
IF 
1:500 
Covance Research 
Products 
(MMS 101P) 
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Antigen Details Working Dilution Supplier 
HA Mouse 
Monoclonal 
IF/dSTORM 
20 μg·ml-1 
Invitrogen 
(26183-A647) 
IRAP Mouse 
Polyclonal 
IB 
1:1000 
Cell Signalling 
(3808) 
SNAP23 Rabbit 
Polyclonal 
IB 
1:1000 
Synaptic Systems 
(111202) 
Syntaxin 5 Rabbit 
Polyclonal 
IB 
1:1000 
Synaptic Systems 
(110053) 
Syntaxin 6 Mouse 
Monoclonal 
IB 
1:1000 
BD Biosciences 
(610635) 
Syntaxin 16 Rabbit 
Polyclonal 
IB 
1:1000 
Synaptic Systems 
(110162) 
 
2.1.3.2 Secondary Antibodies for Western Blotting 
Table 2.4 Secondary Antibodies for Western Blotting 
Antigen Details Working Dilution Supplier 
Mouse IgG Donkey 
IRDye 680LT 
1:10,000 LI-COR 
Biosciences 
(926 68022) 
Rabbit IgG Donkey 
IRDye 800CW 
1:10,000 LI-COR 
Biosciences 
(925 32213) 
Rabbit IgG Donkey 
Horseradish 
peroxidase (HRP) 
linked 
1:3000 GE Healthcare 
(RPN1004) 
 
2.1.3.3 Secondary Antibodies for Immunofluorescence 
Table 2.5 Secondary Antibodies for Immunofluorescence 
Antigen Details Working Dilution Supplier 
Mouse IgG Goat 
Alexa Fluor 647 
1:500 Invitrogen 
(A21235) 
Mouse IgG Goat 
Alexa Fluor 568 
1:500 Invitrogen  
(A11004) 
Rabbit IgG Goat 
Alexa Fluor 568 
1:500 Invitrogen  
(A11011) 
 
  
Chapter 2 64 
 
2.1.4 Plasmids and siRNA 
Table 2.6 Plasmids 
Plasmid Details Supplier 
Synthetic 
HA-GLUT4-eGFP 
 
Synthetic plasmid 
Vector: pcDNA3.1(+) 
Cloning Site BamHI-EcoRI 
Ampicillin Resistance 
Genscript, custom-made 
pCDH-CMV-MCS-EF1-Puro Cloning and Expression 
Lentiviral Vector 
System Biosciences 
(CD510) 
 
All siRNAs were purchased from ThermoFisher Scientific 
Table 2.7 siRNAs 
siRNA - Target Catalogue Number 
BET1 s20092 
s20093 
BET1L s226724 
s226725 
EFR3a s94605 
GOSR1 s18278 
s18279 
GOSR2 s18383 
s18384 
SEC22A s25658 
s25659 
SEC22B s18347 
s18348 
SEC22C s17398 
s17399 
Syntaxin 5 s13598 
s13599 
Syntaxin 6 s19958 
s19959 
Syntaxin 16 s16528 
s16529 
Ykt6 s20936 
s80937 
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2.1.5 Mammalian Cell Lines 
Table 2.8 Mammalian Cell Lines 
Cell Line Source 
3T3 L1 American Tissue Culture Collection (ATCC)  
HeLa American Tissue Culture Collection (ATCC)  
HA-GLUT4-GFP 3T3 Previously generated in our laboratory 
HA-GLUT4-GFP HeLa Previously generated in our laboratory 
HEK293TN American Tissue Culture Collection (ATCC) 
M1mEGFP T-Rex 293 cells Provided by Richard Ward 
 
2.1.6 Materials 
Table 2.9 Materials 
Material Supplier 
3 mm filter paper ThermoFisher Scientific 
(Leicestershire, UK) 
96 well plates with glass bottom Mat Tek (Ashland, USA) 
Cavity Microscope Slides Agar Scientific (Stansted, UK) 
Cell Culture Dishes and Flasks (for 
HeLa and HEK293TN) 
Corning (Maine, USA) 
Cell Culture Dishes and Flasks (for 
3T3 L1) 
Falcon by Corning (Maine, USA) 
Chamber Slides Ibidi (Martinsried, Germany) 
Electroporation cuvettes 
 
Bio-Rad Laboratories (Hertfordshire, 
UK) 
Glass cover slips for confocal 
microscopy (13 mm) 
VWR Chemicals (Leicestershire, UK) 
High performance glass cover slips for 
dSTORM (18 mm) 
Marienfeld-Superior 
(Lauda-Königshofen, Germany) 
Microscope Slides VWR Chemicals (Leicestershire, UK) 
Needles BD Biosciences (Oxford, UK) 
Nitrocellulose transfer membrane, 
0.2 μm pore size 
Pall Life Sciences (Portsmouth, UK) 
 
Syringe filters Sartorius (Göttingen, Germany) 
Syringes BD Biosciences (Oxford, UK) 
μ-dishes Ibidi (Martinsried, Germany) 
 
2.2 Methods 
2.2.1 Cell Culture Methods 
Cell culture was carried out in laminar airflow cabinets under sterile conditions. 
Testing for mycoplasma contamination was carried out for all cell lines at 
regular intervals. 
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2.2.1.1 Growth and Maintenance of HeLa and HEK Cells 
HeLa, HEK293TN, and M1mEGFP T-Rex 293 cells were routinely cultured on 
Corning tissue culture flasks and dishes in a 5 % CO2 humidified incubator at 
37 °C. HeLa cells were cultured in DMEM containing 10 % FCS and 1 % 
L-Glutamine. HEK293TN cells were cultured in DMEM containing 10 % FCS, 1 % 
L-Glutamine and 1 % sodium pyruvate. M1mEGFP T-Rex 293 cells were cultured 
in DMEM containing 10 % FCS, 1 % Penicillin/Streptomycin, 10 μg·ml-1 blasticidin, 
and 200 μg·ml-1 hygromycin. Medium was changed every second day and cells 
were passaged when they reached approximately 70 % confluency. Passaging was 
undertaken by washing the cells with DPBS and detaching them off the plastic 
surface with trypsin-EDTA. If cells had to be counted for subsequent 
experiments, this was done using a haemocytometer and trypan blue solution.  
2.2.1.2 Growth and Maintenance of 3T3 L1 Cells 
3T3 L1 cells were routinely cultured on Falcon tissue culture flasks and dishes in 
a 10 % CO2 humidified incubator at 37 °C. Fibroblasts were cultured in DMEM 
containing 10 % NCS. Medium was changed every second day and cells were 
passaged when they reached approximately 70 % confluency. Passaging was 
undertaken by washing the cells with DPBS and detaching them off the plastic 
surface with trypsin-EDTA. 
2.2.1.3 Differentiation of 3T3 L1 Cells 
3T3 L1 fibroblasts were differentiated into adipocytes 2 days post-confluency, 
referred to as “day 0”, using differentiation medium. Day 0 differentiation 
medium consisted of DMEM supplemented with 10 % FCS, 250 μM IBMX, 170 nM 
insulin, 0.25 μM dexamethasone, and 5 μM troglitazone. After three days, this 
was replaced with Day 3 differentiation medium, which consisted of DMEM 
supplemented with 10 % FCS, 170 nM insulin, and 5 μM troglitazone. After day 6 
post differentiation the medium was replaced with DMEM with 10 %FCS, which 
was then replaced every second day until day 8-12 post differentiation. If cells 
were used for electroporation, day 0 medium contained 680 nM insulin and day 3 
medium did not contain insulin (Miller, 2006). 
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2.2.1.4 Freezing and Resurrecting Cells 
To ensure the maintenance of stocks of all cell lines, cells were frozen down 
regularly. For this, they were grown in flasks until 70 % confluence, washed with 
DPBS and detached with trypsin-EDTA. The cell suspension was centrifuged, and 
the resulting cell pellet washed with DPBS and resuspended in freezing medium 
consisting of FCS with 10 % DMSO. Aliquots were immediately transferred into a 
cryogenic freezing container and kept at -80 °C overnight before long term 
storage in liquid nitrogen. 
Fresh cells were resurrected by thawing an aliquot rapidly at 37 °C and 
transferred into prewarmed cell culture medium. Medium was changed after 
24 h when the cells had attached to remove DMSO. 
2.2.1.5 Cleaning and Seeding on Cover Glasses 
Cells that were to be stained and examined by either confocal microscopy or 
dSTORM were seeded onto cover glasses. Prior to this cover glasses were 
sterilised by dipping them in 100 % ethanol and dried in a safety cabinet under 
UV light. 
For dSTORM an extensive cleaning protocol of the cover glasses was carried out. 
Cover glasses were submerged in the following solutions under constant 
sonication in an ultrasound bath for 90 seconds each: 0.1 M NaOH, 0.1 % Virkon, 
deionised water 3x, 100 % ethanol, 100 % acetone, deionised water. After this 
the cover glasses were dipped in 100 % ethanol to sterilise and left to dry under 
UV light in a safety cabinet for a minimum of 1 h. 
2.2.1.6 Transfection 
Transfection of HeLa cells was carried out using Lipofectamine 2000 according to 
the manufacturer’s instructions. For transfection with plasmid DNA, cells were 
plated on cover glasses in a 12 well tissue culture plate. 4 μg of plasmid DNA per 
well was used and diluted in 100 μl Opti-MEM, 4 μl Lipofectamine was used per 
reaction and also diluted in 100 μl Opti-MEM. Diluted DNA and Lipofectamine 
were combined and incubated at room temperature for 5 min before being 
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added to the cells. After transfection, cells were incubated for 1-3 days before 
further analysis. 
For transfection with siRNA, HA-GLUT4-GFP HeLa cells were cultured on 96 well 
tissue culture plates with glass bottom. The day prior to transfection 9000 cells 
per well were plated. Per well 1.5 pmol of siRNA and 0.5 μl Lipofectamine were 
used and diluted in Opti-MEM prior to transfection. Lipofectamine was incubated 
in Opti-MEM for 7 min and the combined Lipofectamine and siRNA were 
incubated for 20 min before being added to the cells. Cells were incubated with 
the Lipofectamine and siRNA in serum-free DMEM for 4 h before adding 30 % FCS 
medium and cells were incubated for another 48 h before analysis. 
2.2.1.7 siRNA Electroporation of 3T3 L1 Adipocytes 
siRNA knock-down of EFR3a in 3T3 L1 adipocytes was carried out by 
electroporation. Cells were cultured in 10 cm dishes and differentiated as 
described in 2.2.1.2 and 2.2.1.3. Electroporation was carried out on day 5 of 
differentiation using the Bio-Rad Gene Pulser® II. All solutions were prewarmed 
to 37 °C. Cells were washed twice with DPBS and detached by adding a 
detaching solution made up of equal parts trypsin-EDTA and 2 mg·ml-1 
collagenase type I. The detaching solution was neutralised with complete 
medium and cells centrifuged for 2 min at 500 x g. The resulting cell pellet was 
washed 3x with DPBS and resuspended in DPBS (0.5 ml per 10 cm dish). 3 nmol of 
siRNA and 400 μl of this cell suspension were added in an electroporation 
cuvette and electroporation was carried out at 0.25 kV and 950 μF. Dead cells 
that had floated to the top were discarded and remaining cells were re-plated 
on glass cover slips for dSTORM. 
2.2.2 IF Staining 
IF staining was carried out using antibodies described in 2.1.3.1 and 2.1.3.3. 
2.2.2.1 IF Staining for Permeabilised Cells 
Cells were cultured on cover glasses as described in 2.2.1.5 or on 96 well plates 
with glass bottom. For cells expressing a GFP construct the following incubations 
were carried out in the dark. Prior to staining, cells were washed 3x with PBS 
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and fixed with PFA for 20 min at room temperature. Cover glasses were washed 
3x with PBS and any residual PFA activity was removed by incubation in 
quenching buffer for 10 min. Cover glasses were washed again 3x with PBS and 
incubated in permeabilisation buffer for 4 min. Cover glasses were washed 3x 
with PBS and blocked in IF buffer for 30 min. Staining was then carried out by 
incubating the cover glasses with the primary antibody in IF buffer for 60 min. 
Cover glasses were washed 3x with IF buffer and incubated with the secondary 
antibody in IF buffer. Cover glasses were washed 3x with IF buffer and if nucleus 
staining was required, they were incubated in 1 μg·ml-1 DAPI in IF buffer for 
5 min. Cover glasses were then washed again 3x with IF buffer and mounted onto 
microscope slides using Immu-Mount mounting medium. Cover glasses were left 
to dry at room temperature for at least 12 h prior to imaging. 
2.2.2.2 IF Surface Staining for Confocal Microscopy 
Cells were cultured on cover glasses as described in 2.2.1.5. For cells expressing 
a GFP construct the following incubations were carried out in the dark. Prior to 
staining, cover glasses were washed 3x with ice-cold PBS and fixed with PFA for 
20 min on ice. Cover glasses were washed 3x with PBS and PFA activity was 
quenched by incubating in Gly for 10 min. Cover glasses were washed 3x with 
Gly and blocked by incubating in Gly with 2 % BSA and 5 % goat serum for 30 min. 
Staining was then carried out by incubating the cover glasses with the primary 
antibody in the blocking solution for 45 min. Cover glasses were washed 3x in 
the blocking solution and incubated with the secondary antibody in the blocking 
solution for 30 min. Cover glasses were then washed again 3x with blocking 
solution and mounted onto microscope slides using Immu-Mount mounting 
medium. Cover glasses were left to dry at room temperature for at least 12 h 
prior to imaging.  
2.2.2.3 IF Surface Staining for dSTORM 
Cells were cultured on high performance cover glasses as described in 2.2.1.5. 
Prior to staining, cover glasses were washed 3x with ice-cold PBS and fixed with 
PFA at 4 °C for at least 12 h. Cover glasses were washed 3x with PBS and PFA 
activity was quenched by incubating in Gly for 10 min. Cover glasses were 
washed 3x with Gly and blocked by incubating in Gly with 2 % BSA and 5 % goat 
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serum for 30 min. Staining was then carried out by incubating the cover glasses 
with the Alexa Fluor 647 tagged HA antibody in the blocking solution for 45 min. 
Cover glasses were washed 3x with PBS, returned to a fresh 12 well dish in PBS, 
and stored in the dark at 4 °C. On the day of imaging, cover glasses were 
mounted on cavity microscope slides containing MEA buffer and sealed using 
Picodent Twinsil®. 
2.2.3 Lentivirus 
2.2.3.1 Lentivirus Production 
Lentivirus was produced using HEK 293TN cells and the pPACKH1 Lentiviral 
packaging kit according to the manufacturer’s instructions. 7 x 106 HEK 293TN 
cells were seeded per T150 cell culture flask one day prior to transfection. 45 μl 
of the commercially provided pPACKH1 and 4.5 μg of plasmid DNA were 
incubated in serum-free DMEM for 15 min at room temperature. 55 μl 
PureFection transfection reagent was added and incubated for another 15 min 
before being added to the cell culture flask. Supernatant containing lentivirus 
was collected at 48 h and 72 h after transfection and presence of lentiviral 
particles was confirmed with Lenti-X GoStix. Supernatants were stored at -80 °C 
prior to further use. 
Custom-made lentivirus was purchased from VectorBuilder and stored at -80 °C. 
2.2.3.2 Lentiviral Infection 
HeLa cells were infected with lentivirus at 70 % confluence. 3T3 L1 adipocytes 
were infected on day 6 of differentiation. 0.5 ml untreated lentiviral 
supernatant from 2.2.3.1 was used per ml of serum-free DMEM. 5 μg·ml-1 
polybrene was included to increase infection efficiency. After 5-6 h, the medium 
was diluted 2:1 with FCS containing DMEM. Medium was replaced with fresh 
DMEM after 24 h and incubated for an additional 48-96 h before analysis. 
2.2.3.3 Generation of a Stable Cell Line Using Lentivirus. 
A 3T3 L1 cell line stably expressing HA-GLUT4-eGFP was generated using custom-
made lentivirus. Undifferentiated cells of a low passage number were infected 
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with the virus at a multiplicity of infection (MOI) of 100-200 as described in 
2.2.3.2. Selection pressure was applied by adding selection medium containing 
1.5 μg·ml-1 puromycin. This concentration had previously been determined to kill 
cells not expressing the lentiviral plasmid. Selection medium was added every 
other day until all cells in a negative control well (not infected) had died. The 
stable cell line was maintained by continual addition of 0.15 μg·ml-1 puromycin. 
2.2.4 Molecular Biology Methods 
2.2.4.1 Transformation 
Transformation was carried out under semi-sterile conditions in the vicinity of a 
Bunsen burner flame. 
50 μmol of One Shot® Stbl3™ or XLO-1 (generated by Alexandra Kaupisch or Laura 
Stirrat) chemically competent E. coli was used per transformation. Depending on 
the DNA concentration, 1-50 ng of plasmid was added to the cells and incubated 
on ice for 30 min. DNA was then taking up by cells during a heat-shock at 42 °C 
for 30 sec and cells were returned on ice for another 2 min. 450 μl of prewarmed 
SOC medium was added to the cells and incubated at 37 °C in a shaking 
incubator for at least 30 min. 1-100 μl of the cell suspension was then streaked 
out onto agar plates containing 2YT medium and 1 μg·ml-1 ampicillin and 
colonies grew at 37 °C overnight. 
2.2.4.2 Plasmid DNA Purification 
Bacterial cultures were grown in 2YT medium supplemented with 1 μg·ml-1 
ampicillin. Cultures were inoculated with single colonies from agar plates and 
grown at 37 °C in a shaking incubator. 
Depending on the growth culture volume, plasmids were purified either by 
Miniprep (Promega, A1330) or Maxiprep (Quiagen, 12163) according to the 
manufacturer’s instructions. DNA concentration was determined by NanoDrop 
1000 spectrophotometry.  
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2.2.4.3 Agarose Gel Electrophoresis 
Agarose gels were made up of 1 % (w/v) agarose in TAE buffer. SYBRTM safe DNA 
stain was added at a dilution of 1:10,000 to enable visualisation of DNA bands. 
DNA 6x sample buffer was added to the samples and run on the gel alongside the 
1 kb DNA marker at a constant voltage of 100 V. Gels were visualised under UV 
light with the Bio-Rad Gel DocTM System. 
2.2.4.4 Restriction Endonuclease Digest 
Restriction endonuclease digest was carried out using enzymes and the 
corresponding buffers from New England Biolabs in 50 μl reaction volume, using 
1 μl plasmid DNA. The components of the reaction mix were mixed by pipetting 
and incubated for at least 60 min at the enzyme-specific temperature. 
2.2.4.5 Cloning 
Vector and insert plasmids were both digested as described in 2.2.4.4 in a “big” 
reaction, using at least 2 μg of DNA and leaving the reaction overnight. The 
reaction mix was run by agarose gel electrophoresis as described in 2.2.4.3 and 
bands visualised under UV. The bands containing the cut vector and insert were 
cut out and purified using the Wizard® SV Gel and PCR Clean-Up System 
according to the manufacturer’s instructions. 
The vector was dephosphorylated to prevent re-ligation using shrimp alkaline 
phosphatase at 37 °C for 30 min and the reaction was subsequently heat-
inactivated at 65 °C for 5 min. Vector and insert were combined at a 1:1 and 1:2 
molar ratio and ligated using T4 DNA ligase at room temperature for 15 min. The 
ligation mix was used to transform XLO-1 cells as described in 2.2.4.1 and the 
complete reaction was streaked out onto a 2YT agar plate containing ampicillin. 
Single colonies were picked and grown in liquid cultures. Plasmids were then 
purified by Miniprep and successful clones were determined by restriction 
endonuclease digest and agarose gel electrophoresis as described in 2.2.4.4 and 
2.2.4.3. 
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2.2.5 Gel Electrophoresis and Western Blotting 
2.2.5.1 Cell Lysates 
Cells in cell culture dishes were placed on ice and washed 3x with ice-cold PBS. 
Lysis buffer was added and the cells were scraped off the surface of the well. 
The cell suspension was passed through a 26G needle 10x, incubated on ice for 
20 min and passed through the needle 10x again. Cell debris was removed by 
centrifugation at 14,000 rpm for 10 min at 4 °C and lysates were stored 
at -20 °C prior to further use. 
2.2.5.2 SDS-PAGE 
Table 2.10 SDS-PAGE Gel Components 
Gel  Components (For 10 ml) 
5 % polyacrylamide stacking gel 6.8 ml H2O 
1.7 ml 30 % acrylamide 
1.25 ml 1 M Tris (pH 6.8) 
100 μl 10 % SDS 
100 μl 10 % APS 
10 μl TEMED 
12 % polyacrylamide resolving gel 3.3 ml H2O 
4 ml 30 % acrylamide 
2.5 ml 1.5 M Tris (pH 8.8) 
100 μl 10 % SDS 
100 μl 10 % APS 
4 μl TEMED 
 
Polyacrylamide mini gels were cast on the Bio-Rad mini-Protean III equipment 
and consisted of 12 % resolving gels and 5 % stacking gels, as described in Table 
2.10. Cell lysates (see 2.2.5.1) were combined with LSB in a ratio of 1:1 and 
samples were boiled at 95 °C (GLUT4 at 65 °C) for 10 min. Samples were then 
run alongside a protein marker at a constant voltage of 120 V until the blue dye 
had run off the gel. 
2.2.5.3 Immunoblotting 
Protein bands were transferred from SDS-PAGE gels onto nitrocellulose 
membranes by wet transfer. The gel and the membrane were sandwiched 
together with sponges and 3 mm filter paper in a transfer cassette and placed 
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into a tank filled with transfer buffer. Transfer was then carried out at a 
constant current of 200 mA for 2 h or at 30 mA overnight.  
After transfer, the nitrocellulose membrane was stained with Ponceau S to verify 
that transfer had worked. Ponceau S was washed off with PBS and the membrane 
was blocked with 5 % milk in PBS for 30 min while constantly moving on a roller. 
The membrane was then incubated with the primary antibody at 4 °C overnight. 
The next day, the antibody was removed and frozen at -20 °C for the next use. 
The membrane was washed 3x with PBST and incubated with the secondary 
antibody for 1 h at room temperature in the dark. The antibody was removed 
and refrozen, while the membrane was again washed 3x with PBST. Blots were 
then visualised with the Odyssey infra-red LICOR imaging system. 
2.2.6 BN-PAGE 
2.2.6.1 BN-PAGE Sample Preparation 
3T3 L1 cells were differentiated into adipocytes and cultured on 10 cm dishes 
and lysed for BN-PAGE immediately before loading on the gel. Every step was 
carried out at 4 °C to avoid sample denaturation. Cell lysates were prepared by 
scraping the cells into HES buffer containing protease inhibitor (1 tablet per 
50 ml). They were lysed mechanically with a dounce glass homogeniser and by 
passing through a 26G needle. The cell lysate was then mixed with either triton 
or digitonin in varying concentrations and incubated on a vortex for 30 min at 
4 °C before mixing with BN-PAGE sample buffer and loading on the gel. 
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2.2.6.2 BN-PAGE 
Table 2.11 BN-PAGE Gel Components 
Gel  Components (For 10 ml) 
4 % polyacrylamide stacking gel 4.15 ml H2O 
5 ml Gel Buffer 
800 μl BN-PAGE polyacrylamide 
solution 
80 μl APS 
8 μl TEMED 
6 % polyacrylamide resolving gel 3.7 ml H2O 
5 ml Gel Buffer 
1.25 ml BN-PAGE polyacrylamide 
solution 
80 μl APS 
8 μl TEMED 
16 % polyacrylamide resolving gel 5 ml Gel Buffer 
3.3 ml BN-PAGE polyacrylamide 
solution 
1.7 ml 87 % Glycerol 
80 μl APS 
8 μl TEMED 
 
6-16 % gradient mini polyacrylamide gels were cast with the help of a gradient 
mixer and the Bio-Rad mini-Protean III equipment. The gradient mixer was 
placed on a stirrer above the gel cast and both chambers filled with the gel 
solutions. The 16 % gel solution poured into the cast by gravity flow. Once the 
bottom of the gel had poured, the valve on the gradient mixer was opened to 
allow mixing of the two gel solutions. The gradient gel was left to polymerise for 
one hour covered with isopropanol before the stacking gel was added. 
Every step after preparing the gels was carried out at 4 °C to avoid denaturation 
of the samples. 
Gels were run in a dedicated gel tank for BN-PAGE to avoid Coomassie 
contamination of SDS-PAGE gels. The cathode compartment between the gels 
was filled with blue cathode buffer and the anode compartment around the gels 
was filled with anode buffer. Samples were mixed with BN-PAGE 10x sample 
buffer and loaded in the dry gel wells before they were topped up with blue 
cathode buffer. Samples were run alongside a BN-PAGE protein marker at 100 V 
for 90 min. Then the blue cathode buffer was replaced with the colourless 
cathode buffer and the run continued for 60 min at 300 V. 
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2.2.6.3 BN-PAGE Immunoblotting 
BN-PAGE gels were transferred onto PVDF membranes by semi-dry transfer. PVDF 
membranes were soaked in methanol prior to transfer and gels were destained 
using BN-PAGE destain solution for 10 min. Semi-dry transfer was carried out 
using the Bio-Rad Trans-Blot® SD Semi-Dry Transfer Cell and semi-dry transfer 
buffer. The gel and PVDF membrane were wedged between moistened filter 
papers and transfer was carried out at a constant voltage of 15 V for 50 min. 
Antibody incubation was carried out as in 2.2.5.3, except the secondary antibody 
was HRP-tagged and blots were visualised via ECL. 
2.2.7 Microscopy 
The microscopy-based techniques are described in more detail in the 
corresponding chapters of this thesis. 
2.2.7.1 Confocal Microscopy 
Live and fixed cells were imaged by confocal microscopy using a 63x plan 
apochromat oil-immersion objective lens with a numerical aperture of 1.4 fitted 
to a Zeiss LSM 5 Pascal Exciter laser scanning head coupled to a Zeiss Axiovert 
200M inverted microscope and the corresponding software. 
2.2.7.2 TIRF Microscopy 
TIRFM was carried out using an objective based TIRFM system constructed by 
Niall Geoghegan (Geoghegan, 2015). The light from a Horiba 481 nm diode laser 
was directed to the far aperture of a Zeiss objective lens with a numerical 
aperture of 1.45 using a Till Photonics TIRF condenser. The condenser contained 
a micrometre screw gauge for lateral manipulation of the beam relative to the 
optical axis. The resultant fluorescence light was collected by the same 
objective and focussed to an Andor Ixon EMCCD using a C-mount 1.6x expansion 
lens. 
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2.2.7.3 dSTORM 
dSTORM experiments were performed on an Olympus IX-81 microscope equipped 
with Olympus Cell^R acquisition software, an ImageEM EM-CCD 512 × 512 camera 
(Hamamatsu) and an Olympus × 150 UAPO oil lens with a numerical aperture of 
1.45 and a resulting pixel size of 106 nm. 
2.2.8 Image Analysis 
Images acquired by confocal and TIRF microscopy were analysed and processed 
using ImageJ/Fiji.  
2.2.8.1 HA/GLUT4 Ratio 
HA/GLUT4 ratios of cells expressing HA-GLUT4-GFP were determined by dividing 
the fluorescence intensity of the blue channel (HA signal, plasma membrane 
located GLUT4) by the fluorescence intensity of the green channel (GFP signal, 
intracellular GLUT4). 
2.2.8.2 Spatial Intensity Distribution Analysis 
For Spatial Intensity Distribution Analysis (SpIDA), the stand-alone MATLAB 
Graphical User Interface program, available at the Neurophotonics Web site 
(Godin et al., 2011) was used. The pixel size was 0.09 μm and the beam size was 
set to 0.2215 μm. These values had previously been determined by John Pediani.  
2.2.8.3 Colocalisation Analysis 
Colocalisation analysis was carried out using the JaCoP plugin in ImageJ (Bolte & 
Cordelières, 2006). Each image was recorded twice and the Pearsons coefficient, 
which relates to colocalisation, was determined for the two images of the green 
and the red channel respectively (Pgreen and Pred). These values were used to 
determine the correction factor C: 
 C =
1
√Pgreen ∙ Pred
 (2-1) 
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Then the Pearsons coefficients for all four combinations of red and green 
channels were calculated. The colocalisation value was the average of all four 
coefficients multiplied by the correction factor C. 
2.2.8.4 dSTORM Analysis 
dSTORM images were processed using the ThunderSTORM plugin in ImageJ 
(Ovesný et al., 2014). The base level A/D counts was 1693, as determined by 
recording an image with the camera cap on. The EM gain for all images was 300. 
Default values of the software were used for all other input values. 
Localisation density was determined using the Plugin LocFileVisualizer_v1.1 (van 
de Linde, 2019). Cluster analysis was carried out using Bayesian cluster analysis 
(Griffié et al., 2016) and Ripley’s K-function analysis (Levet et al., 2015). 
2.2.9 Statistical Analysis 
Statistical analysis was carried out using GraphPad Prism (version 5). Depending 
on the data, unpaired t-test, 2-way ANOVA, or Chi Square test was performed, 
all with 95 % confidence levels. Details are given in the respective figure 
legends. The values reported are mean ± standard error unless stated otherwise. 
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Chapter 3 Comparison of HeLa Cells and 3T3 L1 
Adipocytes Using TIRFM 
3.1 Introduction 
3.1.1 Principles of Fluorescence Microscopy 
Fluorescence microscopy is a very common technique that has been used for 
many years to visualise biological mechanisms on a cellular and even molecular 
level. Cells can be either genetically modified to express a fluorescent protein 
such as GFP or stained with an external fluorophore, which can be essentially 
any fluorescent molecule (Combs, 2010). A fluorescent molecule absorbs light of 
a certain wavelength and in response, emits light of a slightly longer 
wavelength. The shift between the absorption and emission spectrum is known 
as the Stokes shift and is characteristic for each fluorophore (Coling & Kachar, 
1997). The absorption maximum of GFP, for example, is 489 nm and its emission 
peaks at 508 nm (Patterson et al., 2001). This characteristic is used in 
fluorescence microscopy.  
Figure 3.1 shows a schematic of an epifluorescence widefield microscope. The 
excitation light is passed through a filter that only permits a specific 
wavelength. The light is reflected off a dichroic mirror and directed to the 
sample through an objective lens. The light excites the fluorophores in the 
sample, which upon return from their excited state emit light of a longer 
wavelength than the excitation light. This light passes through the dichroic 
mirror and an emission filter and is collected in a tube lens before the image is 
generated either digitally or in the eyepiece. In epifluorescence microscopy, 
both, the excitation and the emission light are passed through the same 
objective lens (Webb & Brown, 2013). 
Widefield microscopy provides good temporal and spatial resolution in XY. It 
does not require high laser power and is therefore less phototoxic for live cell 
imaging. Another advantage is its relatively low cost. The biggest disadvantage 
in widefield microscopy is the poor resolution in Z. Since the excitation light 
passes through the entire sample every fluorophore gets excited and emits light 
(Combs, 2010). This is particularly problematic for cells with high expression 
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levels of fluorescent proteins, as this leads to a very high background from 
fluorescence from outside the focal plane and blurred images. 
 
Figure 3.1 Schematic of an Epifluorescence Widefield Microscope 
Excitation light passes through a filter and reflects off a dichroic mirror through the objective lens 
onto the sample. Emission light from the excited fluorophores then passes through the same lens 
and mirror and through another filter and the tube lens to the eyepiece or a camera to generate the 
image. 
  
Chapter 3 81 
 
With the development of the confocal microscope, this problem was 
circumvented (Paddock, 1999). In this technique, a small pinhole is placed 
between the tube lens and the detector, which excludes light that originates 
from outside the focal plane. This allows the user to take images of optical 
sections with much better resolution along the Z-axis, which is typically between 
600 nm and 1 μm (Combs, 2010). Although this is a significant improvement 
compared to widefield microscopy, this axial resolution is not good enough to 
resolve processes inside or close to the plasma membrane. For such applications, 
Daniel Axelrod developed TIRFM in 1981 (Axelrod, 1981). 
3.1.2 Principles of Total Internal Reflection Fluorescence 
Microscopy 
The first imaging technique using total internal reflection (TIR) was already 
described in 1961 as “Surface Contact Microscopy”. It was used to study the 
movements of fibroblasts (E. J. Ambrose, 1961). 
The principle of TIR is demonstrated in Figure 3.2. 
 
Figure 3.2 Principle of TIR 
Incident light arrives at the interface of two media with refractive indices n1 and n2, with n1<n2, at an 
angle θ that is equal to or greater than the critical angle θc and is totally internally reflected, which 
generates an exponentially decaying evanescent wave. 
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Two factors are crucial for TIR: the refractive indices n1 and n2 of the liquid and 
the solid medium and the incidence angle θ at which the light arrives at the 
surface between the two media. The incident light beam propagates through the 
solid medium, e.g. glass, which has a high refractive index n2 at an incident 
angle θ that exceeds the critical angle θc. The refractive index n1 of the liquid 
medium, e.g. water, is lower, which means the light beam will undergo TIR 
(Axelrod, 2001b). The critical angle θc depends on n1 and n2 and is given by 
If n1<n2 and θ>θc, the incident light beam is totally reflected back into the solid 
medium except for a small amount of light which propagates perpendicularly to 
the interface between the two media as a so-called evanescent wave. 
The evanescent wave is an electromagnetic field that decays exponentially 
(Axelrod, 2001b). The intensity I at a given distance z from the interface is 
defined by  
Where I0 is the intensity at the interface and d is the penetration depth, which 
depends on the wavelength λ of the incidence light beam as well as n1, n2, and θ 
It is incurred from equation 3-3 that the penetration depth decreases with 
increasing incidence angle. Practically, this means that the evanescent wave can 
illuminate an area of less than 100 nm (Martin-Fernandez et al., 2013). 
With Ambrose’s technique, cells were imaged in brightfield and the contrast was 
very low. 20 years later, the technique was therefore developed further by 
changing the light source to a laser beam, which allowed imaging of 
fluorescently labelled targets near the plasma membrane and also increased the 
accuracy of the penetration depth d, as a laser beam with a defined wavelength 
was used rather than the whole range of visible light (Axelrod, 1981). 
 θc = sin
−1(n1 n2)⁄  (3-1) 
 I(z) = I0e
−z d⁄  (3-2) 
 d =
λ
4π
∙
1
√n1
2sin2θ − n2
2
 (3-3) 
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TIR can be achieved by two different means: in prism based TIRFM, the 
evanescent wave is generated on top of the sample through a prism, while the 
objective is placed underneath. This allows for a large incidence angle of the 
laser beam, which results in a very small penetration depth (see equation 3-3). 
The other advantage is that the reflected light is directed away from the 
objective and is not collected (W. P. Ambrose et al., 1999). This set-up, 
however, can only be used for very thin samples and is unsuitable for thick cell 
lines such as adipocytes. An easier and more versatile set-up is objective based 
TIRFM. Here, excitation and emission light are both passing through the 
objective lens, which makes the system easier to manipulate and suitable for 
thick cell types or even tissue samples. The obvious disadvantage is that the 
angle of the incidence light beam is limited and penetration depth is therefore 
higher (Martin-Fernandez et al., 2013). 
Figure 3.3 summarises the difference between widefield, confocal, and TIRF 
illumination. In widefield, the laser beam penetrates the entire cell and all 
fluorophores are equally excited, which leads to a high background and very 
poor axial resolution. This is less of an issue in confocal microscopy, where out-
of-focus light is eliminated by a pinhole in front of the detector and only 
fluorophores along the focal plane are imaged. TIRF illumination allows imaging 
of a very thin area adjacent to the coverslip and is ideal for imaging of 
membrane proteins. 
 
Figure 3.3 Widefield vs Confocal vs TIRF 
A: Widefield illumination, the laser penetrates the entire sample and excites all fluorophores. B: 
Confocal illumination, the sample is rastered through along the focal plane. C: TIRF illumination, 
the laser beam is totally reflected, and the surface is illuminated by an evanescent wave. 
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Since its first implementation (Axelrod, 1981), TIRFM has been used in many 
studies. An obvious application is the spatial and temporal imaging of processes 
near the plasma membrane that would otherwise be dominated by a high 
background signal from the cytosol (Mattheyses et al., 2010). Examples are 
vesicle trafficking along the cytoskeleton (Schmoranzer & Simon, 2003) and 
clathrin-mediated endocytosis (Rappoport, 2008). The intensity decay of the 
evanescent wave also allows improved axial resolution; fluorescence is more 
intense closer to the membrane, which has thus allowed the characterisation of 
exocytotic events (Schmoranzer et al., 2000), paving the way for the analysis of 
GSVs, which has been discussed in detail in section 1.7. 
3.1.3 The Built In-House TIRFM System 
The TIRF microscope used in this work was the one built by Dr Niall Geoghegan 
in the context of his PhD Thesis (Geoghegan, 2015). A 481 nm pulsed laser diode 
was used for illumination, which was attached to a TIRF condenser. This 
instrument allowed the alignment of the laser and manipulation of the TIR 
angle. The laser beam was directed to a mask in the condenser that consisted of 
two side slits and a pinhole in the middle, as shown in Figure 3.4. Alignment of 
the laser was achieved by directing the laser beam through the central pinhole. 
A micrometre at the bottom of the condenser enabled the manipulation of the 
angle at which the laser beam met the substrate, and therefore TIR. With this 
set-up, a penetration depth of as little as 118 nm could be achieved 
(Geoghegan, 2015) 
 
Figure 3.4 TIR Alignment Mask 
The laser beam is directed through the central pinhole for alignment of the laser. When focused 
through the slits, the TIR angle can be manipulated. 
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It is important to emphasize that this is a home-built set-up that comes with 
certain limitations. Most importantly, the TIR angle had to be adjusted manually 
by turning the micrometre, which was located in the back of instrument, while 
simultaneously observing the sample through the eyepiece at the front of the 
instrument. This was not only physically challenging, but also meant that 
settings from previous experiments could not be adopted. Consequently, the TIR 
angle was not precisely the same for each experiment. Another limitation was 
the lack of a suitable stage-top incubator, which made imaging of live cells more 
challenging. 
3.1.4 Hypothesis and Aims 
TIRFM has been a valuable tool and 3T3 L1 adipocytes are a well characterised 
model cell line to study GLUT4 trafficking (Bai et al., 2007; S. Huang et al., 
2007; Jiang et al., 2008; C. H. Li et al., 2004; Y. Xu et al., 2011). 3T3 L1 cells 
are a murine fibroblasts line that can differentiate into adipocytes in vitro by 
differentiation (Green & Kehinde, 1974; Green & Meuth, 1974). Compared to 
primary cells, they are much easier and cheaper to use, differentiation into 
adipocytes is relatively simple and experiments are relatively robust (Ruiz-Ojeda 
et al., 2016). A major shortcoming of the cell line is that it is very difficult to 
transfect (Carlotti et al., 2004; Ross et al., 2003) and although the cell line is 
not too difficult to maintain, differentiation into adipocytes is time-consuming 
(see section 2.2.1.3) and requires a certain level of expertise to avoid 
contamination of the culture when being grown over such a long period. 
The HeLa cell line is the oldest and most frequently used human cell line (Lucey 
et al., 2009). The cells are very easy to culture and to genetically modify. The 
cell line does not express endogenous GLUT4, but when transfected with HA-
GLUT4-GFP, cells show the characteristic intracellular retention of GLUT4 in the 
absence of insulin and translocation to the cell membrane after insulin 
stimulation (Haga et al., 2011; Kioumourtzoglou et al., 2015). This observation 
raises the question whether HA-GLUT4-GFP HeLa cells could be a valid model for 
GLUT4 trafficking. Another advantage of HeLa is that this is a human cell line, 
whereas 3T3 L1 is of murine origin. A human model cell line may be a more valid 
model for the study of a disease that is common in humans. In a recent study, 
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Camus et al. (2020) have indeed found that the formation of the GSC differs in 
human cells compared to rodents (see Chapter 6). 
The aim of this chapter was to compare HeLa cells to 3T3 L1 adipocytes with 
regards to GSV translocation to the plasma membrane in response to insulin. For 
this, we used the built in-house TIRFM system described in section 3.1.3. 
3.2 Results 
3.2.1 HA-GLUT4-GFP Expression in HeLa Cells and 3T3 L1 
Adipocytes 
The cell lines that were used in this study were HeLa cells and 3T3 L1 adipocytes 
stably expressing HA-GLUT4-GFP. Expression of the glucose transporter as HA-
GLUT4-GFP allows imagining of the molecule via green fluorescence in both, live 
and fixed cells. Translocation in response to insulin stimulation can be visualised 
by surface HA-staining in fixed cells as outlined in 1.7 and 2.2.2. This is shown in 
Figure 3.5 for HeLa cells and in Figure 3.6 for 3T3 L1 adipocytes. 
The two figures outline the differences and similarities between the two cell 
lines. In the basal state, GLUT4 is located intracellularly mostly near the 
nucleus, and there is only a weak HA signal on the cell surface. In response to 
insulin, the GFP signal is more dispersed in the cytoplasm and the characteristic 
blue HA-ring can be seen, which signifies GLUT4 translocation and subsequent 
exocytosis. This is also reflected in the HA/GLUT4 ratio, which significantly 
increases after insulin stimulation in both cell types. 
HeLa cells clearly respond to insulin, even though they require longer 
stimulation (60 min vs 20 min in 3T3 L1). The translocation of GLUT4 is, 
however, visually not as clear as in 3T3 L1 adipocytes. 
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Figure 3.5 HA Surface Staining of HA-GLUT4-GFP HeLa Cells in Response to Insulin 
HA-GLUT4-GFP HeLa cells were incubated in serum-free medium for 2 h prior to the experiment 
and stimulated with 100 nM insulin for 60 min or left untreated. Cells were then fixed and stained 
for surface HA as described in section 2.2.2. The HA/G4 ratio was determined as described in 
2.2.8.1 A: Representative image of basal cells B: Representative image of cells after stimulation 
with insulin C: HA/G4 ratio, Basal: 0.57 ± 0.07 (n = 14) Insulin: 0.81 ± 0.08 (n = 14). Mean ± SE. 
Unpaired two-tailed t-test 95 % confidence intervals p = 0.0329 
  
GFP GFP HA HA 
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Figure 3.6 HA Surface Staining of HA-GLUT4-GFP 3T3 L1 Adipocytes in Response to Insulin 
HA-GLUT4-GFP 3T3 L1 adipocytes were incubated in serum-free medium for 2 h prior to the 
experiment and stimulated with 100 nM insulin for 20 min or left untreated. Cells were then fixed 
and stained for surface HA as described in section 2.2.2. The HA/G4 ratio was determined as 
described in 2.2.8.1 A: Representative image of basal cells B: Representative image of cells after 
stimulation with insulin C: HA/G4 ratio, Basal: 0.71 ± 0.14 (n = 11) Insulin: 1.21 ± 0.09 (n = 19). 
Mean ± SE. Unpaired two-tailed t-test 95 % confidence intervals p = 0.0037 
3.2.2 Fluorescence Intensity in the TIRF Zone 
Building up on the results from section 3.2.1, we studied the translocation of 
HA-GLUT4-GFP upon insulin stimulation in the TIRF zone via the GFP tag of the 
protein. For this, cells were grown and differentiated if applicable on Ibidi 
μ-dishes and imaged live. As imaging took place over a period of at least 30 min, 
appropriate cell culture conditions had to be maintained. Cell culture medium 
was therefore supplemented with 25 mM HEPES to avoid pH dropping and the 
dish was placed in a heated microscope stage insert to sustain a temperature of 
37 °C within the culture dish. Figure 3.7 shows representative images of a single 
HeLa cell just before insulin administration (t = 0 min) and at different time 
points thereafter. The rise in fluorescence intensity in the TIRF zone over time is 
evident, which suggests that HeLa cells indeed respond to an insulin stimulus 
with the translocation of exogenous HA-GUT4-GFP. This was quantified by 
GFP GFP HA HA 
Merge Merge 
A B 
C 
Chapter 3 89 
 
measuring the fluorescence intensity within the footprint of the cell and 
normalising the result to the intensity at t = 0 min. The result of this experiment 
is depicted in Figure 3.8. 
 
Figure 3.7 Time Course of Insulin Stimulated HeLa Cells in TIRFM 
HeLa cells were grown on Ibidi μ-dishes and imaged live in TIRFM after stimulation with 100 nM 
insulin. Images were acquired in 5 min intervals with an exposure time of 500 ms and a frame rate 
of 2 Hz. Shown are representative images of a single HeLa cell at t = 0 min (immediately before 
insulin administration), t = 5min, t = 15min, t = 20min, t = 25min, and t = 30min. Scalebar: 50 μm. 
 
Figure 3.8 Normalised Fluorescence Intensity in HeLa Cells in TIRFM 
HeLa cells were grown on Ibidi μ-dishes and imaged live in TIRFM after stimulation with 100 nM 
insulin (blue) or remained in the basal state (red). Images were acquired in 5 min intervals for 
insulin stimulated cells and 10 min intervals for control cells with an exposure time of 500 ms and a 
frame rate of 2 Hz. Fluorescence intensity of the cell footprint was measured in each image and 
normalised to the value at t = 0 min, immediately before insulin stimulation. Blue line: Insulin 
stimulated (n = 7). Red line: Basal (n = 1). Data points are Mean ± SE. Black dashed line: 
mathematical modelling of the fluorescence intensity increase according to equation (3-4) with 
Fmax = 1.25 and r = 0.1. 
0.5
1
1.5
0 10 20 30 40 50 60
N
o
rm
. 
F
lu
o
re
s
c
e
n
c
e
 I
n
te
n
s
it
y
 [
-]
Time [min]
t = 0 min t = 5 min t = 15 min 
t = 20 min t = 25 min t = 30 min 
Chapter 3 90 
 
Insulin stimulation lead to an increase of fluorescence intensity due to GSV 
translocation to the plasma membrane by about 25 % after 30 min. 
Mathematically, this increase appears to obey a logistic function (see equation 
(3-4)), which means, there is a steep increase at first, then it slows down and 
converges to a maximum. In this case 1.25, which is the maximal normalised 
fluorescence intensity after stimulation with 100 nm insulin in this cell type. In 
F(t0) is the fluorescence intensity at t = 0 min, which is 1 for normalised values, 
and Fmax is the maximal fluorescence intensity, in this case 1.25. The growth 
rate r corresponds to the initial steepness of the curve and is the only parameter 
in this equation that remains to be determined. When r is assumed to be 0.1, the 
graph follows the black dashed line in Figure 3.8. 
A control experiment was carried out, in which cell culture medium instead of 
insulin was added to the cells. As expected, the fluorescence intensity did not 
increase in the basal state, which means that the increase in insulin stimulated 
cells was solely due to insulin-induced HA-GLUT4-GFP translocation. In fact, the 
fluorescence intensity in the basal control decreased by approximately 13 %, 
which was probably a result of photobleaching. 
The same experiment was carried out in 3T3 L1 adipocytes. Representative 
images of a single cell over the course of 30 min are shown in Figure 3.9. After 
the administration of insulin, the fluorescence intensity increased considerably, 
which was unmistakably obvious by eye. Immediately before insulin stimulation, 
clearly defined green fluorescent spots were visible in the TIRF zone. These 
were likely GSVs near the plasma membrane. With the addition of insulin, more 
spots emerged in the TIRF zone and those already present seemed to increase in 
size, until an almost ‘cauliflower-like’ appearance was achieved. This 
phenomenon was likely due to the limited resolution of the system, when the 
number of GSVs got so high that single vesicles could not be resolved anymore. 
This is likely also a result of increased dispersal of GLUT4 in the plasma 
membrane. 
 
F(t) =
Fmax
1 + (
Fmax − F(t0)
F(t0)
) e−rt
 
(3-4) 
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Figure 3.9 Time Course of Insulin Stimulated 3T3 L1 Adipocytes in TIRFM 
3T3 L1 fibroblasts were grown and differentiated into adipocytes as described in 2.2.1.3 on Ibidi 
μ-dishes and imaged live in TIRFM after stimulation with 100 nM insulin. Images were acquired in 
5 min intervals with an exposure time of 500 ms and a frame rate of 2 Hz. Shown are 
representative images of a single cell at t = 0 min (immediately before insulin administration), 
t = 5 min, t = 15 min, t = 20 min, t = 25 min, and t = 30 min. Scalebar: 50 μm. 
 
Figure 3.10 Normalised Fluorescence Intensity in 3T3 L1 Adipocytes in TIRFM 
3T3 L1 fibroblasts were grown and differentiated into adipocytes as described in 2.2.1.3 on Ibidi 
μ-dishes and imaged live in TIRFM after stimulation with 100 nM insulin (blue) or remained in the 
basal state (red). Images were acquired in 5 min intervals with an exposure time of 500 ms and a 
frame rate of 2 Hz. Fluorescence intensity of the cell footprint was measured in each image and 
normalised to the value at t = 0 min, immediately before insulin stimulation. Blue line: Insulin 
stimulated (n = 12). Red line: Basal (n = 8). Data points are Mean ± SE. Black dashed line: 
mathematical modelling of the fluorescence intensity increase according to equation (3-4) with 
Fmax = 2.1 and r = 0.1. Black dotted line: Linear regression. 
As for HeLa cells, the fluorescence intensity was quantified within the footprint 
of the cell and normalised to the fluorescence intensity immediately prior to 
insulin administration. In control experiments, cell culture medium without 
insulin was added to the cell culture dish. This is shown in Figure 3.10. 
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As expected, the fluorescence intensity increased over time during insulin 
stimulation and more than doubled after 30 min of stimulation with 100 nM 
insulin. However, it is not clear whether the maximum had been reached at the 
end of the experiment, since images were only taken for 30 min. Interestingly, 
the fluorescence intensity decreased by less than 1 % in the control experiment. 
Different from the time course depicted in Figure 3.8, the data cannot be 
approximated by a logistic function with the same parameters (dashed line), in 
fact, a linear regression (dotted line) fits the data set almost perfectly. This is 
contradictory to the fluorescence intensity time courses in 3T3 L1 adipocytes 
reported by others, where the curve indeed follows a logistic function and the 
fluorescence intensity increases by 2-3 fold after 20-30 minutes of insulin 
stimulation (Dawicki-McKenna et al., 2012; S. Huang et al., 2007). Furthermore, 
the time courses for both cell lines are slower than that of 3T3 L1 adipocytes 
reported by others (Holman et al., 1994; Muretta et al., 2008) These differences 
are likely due to the home-built microscope set-up that did not allow for exact 
regulation of parameters such as temperature or CO2 content. 
3.2.3 Mobile and Static Vesicles in the TIRF Zone 
The results presented in this section were generated in collaboration with Dr 
Niall Geoghegan in the context of his PhD Thesis (Geoghegan, 2015). 
In time-lapse images of the TIRF experiments conducted during this study, single 
vesicles were clearly visible in the TIRF zone. The majority of them appeared 
static, while a smaller portion were moving around the field of vision, either 
approaching the cell surface, or moving along the xy plane. We were interested 
in the fraction of static and mobile GSVs and whether this changed in a time-
dependent manner in the presence of insulin. Further, we used this data as 
another reference point in the comparison of 3T3 L1 adipocytes and the 
potential cell model HeLa. 
GSVs were identified using algorithms of the ImageJ/Fiji platform. First, 
background fluorescence was removed by applying a rolling ball algorithm: for 
each pixel, the signal intensity of the pixels surrounding it was averaged and 
subtracted from the signal, which results in a smoother background (Sternberg, 
1983). The ball radius we used was 5 pixels. The image was processed further by 
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removing single pixel noise with the plugin “despeckle”. GSVs were defined by 
three criteria: (1) the particle contained a local intensity maximum (2) 75 % of 
the signal was contained within a radius of 5 pixels (3) the minimum size of the 
particle was 2 pixels. Particles that did not belong in these categories were 
treated as outliers and were excluded from the analysis with the help of the 
FindFoci algorithm (A. D. Herbert et al., 2014). Static and mobile GSVs were 
then identified in time lapse image stacks, where each frame had been treated 
as described. Stationary signals were filtered out from the image stack by 
subtracting an average projection of the stack pixel by pixel. The resulting stack 
contained only moving vesicles. This secondary stack was subtracted from the 
original image stack frame by frame, which yielded images of only stationary 
vesicles. GSVs could then be counted in different regions of interest (ROIs) in 
single images of each stack. The results are shown for three individual cells and 
ten 100 μm2 ROIs in Figure 3.11 for 3T3 L1 adipocytes and in Figure 3.12 for HeLa 
cells. Images were recorded for 2 min before and 15 min after stimulation with 
100 nM insulin. Addition of insulin occurred at t = 0 min. 
Figure 3.11 demonstrates impressively the translocation of GLUT4 vesicles to the 
cell surface in response to insulin in 3T3 L1 adipocytes. With the addition of 
insulin to the cell culture medium, the number of mobile vesicles increased 
dramatically within the first minute and stayed elevated for about 5 minutes. 
During this time, the majority of GSV translocation appeared to be taking place, 
before the number of mobile vesicles dropped back down to levels from the 
basal state (t < 0 min). The number of static vesicles on the other hand was 
steadily increasing, reflecting the arrival of new GSVs in the TIRF zone and 
tethering to the membrane. This data is consistent with observations by Stenkula 
et al. (2010), who found a sharp increase in fusion events within the first five 
minutes of insulin stimulation. 
Figure 3.12 shows the same experiment in HeLa cells. Similar to the data 
collected for 3T3 L1 adipocytes, the number of mobile vesicles increased 
considerably immediately after the addition of insulin. However, the increased 
activity lasted closer to 8 minutes in this cell type. Interestingly, the number of 
both, static and mobile GSVs then dropped to levels below those prior to insulin 
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stimulation. This may be the reason for the reduced increase in fluorescence 
intensity after addition of insulin compared to 3T3 L1 adipocytes. 
 
Figure 3.11 Static and Mobile GLUT4 Vesicles in 3T3 L1 Adipocytes 
3T3 L1 fibroblasts were grown and differentiated into adipocytes as described in 2.2.1.3 on ibidi 
μ-dishes and imaged live in TIRFM before and after stimulation with 100 nM insulin at t = 0 min. 
Images were acquired in 1 min intervals with an exposure time of 500 ms and a frame rate of 2 Hz. 
Counts of mobile and static vesicles were determined as described. Static vesicles are shown in 
red, mobile vesicles in black. N = 3 cells, 10 ROIs (100 μm2) per cell were analysed. Data points 
are Mean ± SD. 
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Figure 3.12 Static and Mobile GLUT4 Vesicles in HeLa Cells 
HeLa cells were grown on Ibidi μ-dishes and imaged live in TIRFM before and after stimulation with 
100 nM insulin at t = 0 min. Images were acquired in 1 min intervals with an exposure time of 
500 ms and a frame rate of 2 Hz. Counts of mobile and static vesicles were determined as 
described. Static vesicles are shown in red, mobile vesicles in black. N = 3 cells, 10 ROIs 
(100 μm2) per cell were analysed. Data points are Mean ± SD. 
3.3 Discussion 
The aim of this chapter was the characterisation of HeLa cells with respect to 
their ability to translocate HA-GLUT4-GFP in response to insulin and compare the 
cell line to the frequently used model cell line 3T3 L1.  
Overall, HA-GLUT4-GFP HeLa cells responded to an insulin stimulus in a similar 
manner as HA-GLUT4-GFP 3T3 adipocytes with respect to their ability to 
translocate the protein to the TIRF zone. In adipocytes the membrane associated 
fluorescence more than doubled, in HeLa cells, the increase was less prominent 
and averaged out at about 25 %. In unstimulated HeLa cells, fluorescence 
decreased strongly over time due to photobleaching. This appeared to be less of 
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an issue in 3T3 L1 adipocyte, where fluorescence intensity remained constant 
This may be due to a combination of higher expression levels of HA-GLUT4-GFP, 
higher levels of the protein in the vicinity of the membrane, and higher recycling 
rates, meaning that photobleached molecules are cleared from the cell surface 
more rapidly than in HeLa cells. One or a combination of these factors may have 
resulted in the fluorescence intensity remaining almost constant in the absence 
of insulin. An important aspect to consider in this observation is that there was 
only one successful HeLa control experiment, making it difficult to draw 
conclusions with regards to photobleaching, as another cell may have behaved 
differently. Similarly, it is important to mention that out of the 3T3 L1 control 
experiments, some single cells exhibited a fluorescence decrease of about 20 % 
in the absence of insulin, while others remained unchanged.  
One significant problem we came across when working with HeLa cells was that 
these cells were more prone to detaching off the culture dish during imaging 
than adipocytes, resulting in more failed experiments, which is also the reason 
for the lower number of data points for this cell line.  
Our TIRFM setup was not powerful enough to give more insight into the dynamics 
of GLUT4 in the plasma membrane. Single fusion events could occasionally be 
observed but the majority of time-lapse images showed GSVs that appeared 
mostly static. After 15 – 20 min of insulin stimulation in 3T3 L1 adipocytes the 
signal increased to an extent where single vesicles could not be identified 
anymore. In HeLa cells single vesicles were even less frequently observed. This 
may be due to differences in the GSV translocation machinery in this cell type. 
HeLa cells do not express endogenous GLUT4 or the insulin receptor and other, 
crucial components of the insulin signalling pathway may be missing too, 
resulting in different composition and structure of GSVs. The consequence may 
well be smaller vesicles that are below the detection limit of our TIRFM setup. 
Fusion of GSVs with the plasma membrane appeared unaffected, as HA-surface 
staining delivered results comparable to those of 3T3 L1 adipocytes. HeLa cells 
clearly respond to insulin stimulation with the translocation of HA-GLUT4-GFP 
containing vesicles to the surface and insertion of the protein in the plasma 
membrane as shown in section 3.2.1. 
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Image manipulation in ImageJ allowed a clearer display of single vesicles and the 
comparison of mobile versus static GSVs. This analysis showed again that HeLa 
cells were reacting in a similar way to an insulin stimulus with regards to their 
GSVs dynamics in the TIRF zone. The number of mobile GSVs near the membrane 
increased noticeably with insulin stimulation for a similar length of time and 
then dropped again. 
Overall, the results suggest that HeLa cells are indeed comparable to 3T3 L1 
adipocytes to some extend and may be a suitable model for preliminary screens 
in the study of GSV translocation. HeLa cells are easy to maintain, and genetic 
manipulation is straightforward and reproducible. Indeed, other groups have 
used the cell line in published studies (Camus et al., 2020; Haga et al., 2011; 
Sadler et al., 2013; Trefely et al., 2015). In addition, it is known that HeLa cells 
react to insulin stimulation with the phosphorylation of Akt and AS160 (Bogan, 
2012) and that they express sortilin (Camus et al., 2020). 
Overall, the comparison of HeLa cells and 3T3 L1 adipocytes could be expanded 
by an almost infinitive amount of experiments. Recycling kinetics of GLUT4 in 
HeLa cells, as carried out by Muretta et al. (2008) in 3T3 L1 adipocytes, would 
be particularly interesting. In a similar experiment, FACS analysis has been 
carried out by our group after completion of this work and added further 
evidence towards the comparability of the two cell lines. (S. Morris et al., 2020). 
The cell line can be used to deliver preliminary results. However, too little is 
known about the insulin signalling pathway and whether or not its components 
are present in HeLa cells to consider them a suitable substitute for adipocytes.  
A limitation of TIRFM itself is that despite its improved background elimination, 
it still does not differentiate between a fluorescent signal inside and outside the 
plasma membrane. The evanescent wave illuminates a region that is over 
100 nm deep. The thickness of the plasma membrane itself, however, is only 
about 10 nm (Freedman, 2012). This means that the vast majority of the 
illuminated field contains fluorescence that originates from molecules outside 
the plasma membrane. This complicates our experiments significantly, since 
insulin stimulation of HA-GLUT4-GFP 3T3 L1 adipocytes and HeLa cells leads to 
translocation of the fluorescent fusion protein to the plasma membrane. The 
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signal in the TIRF zone increased dramatically, but it is unclear which portion 
was derived from GSVs approaching the membrane and which from actually 
fused vesicles. Events in the plasma membrane are therefore still overlaid with a 
substantial amount of background fluorescence, even though TIRF eliminates 
signals from fluorescent molecules deeper inside the cell. This problem can be 
circumvented by using a different probe, such as IRAP-pHluorin (Jiang et al., 
2008; Stenkula et al., 2010) or VAMP2-pHluorin (Y. Xu et al., 2011). As described 
in section 1.7.3, pHluorin is a pH-sensitive fluorophore and only emits light when 
exposed to the neutral pH of the cell culture medium, but not in the acidic 
environment inside the GSVs. We have indeed developed a construct expressing 
IRAP-pHluorin that also translocated to the cell surface in response to insulin in 
HeLa cells. However, this probe was not used for TIRFM experiments, as it could 
not be expressed in high enough levels in 3T3 L1 adipocytes. 
Another way to overcome the issues surrounding background fluorescence is to 
label the HA-tag of HA-GLUT4-GFP on the surface of cells, as demonstrated in 
section 3.2.1. This excludes proteins that are not integrated in the plasma 
membrane and is an experiment that is routinely carried out in our laboratory to 
visualise and quantify GLUT4 exocytosis. Using surface labelling in TIRFM could 
lead to a better resolution of membrane integrated GLUT4, however this 
technique can only be used for fixed cells and does not allow for live imaging. In 
addition, this technique cannot be applied to the existing TIRFM setup, since the 
instrument only has a 481 nm laser available, but a different wavelength would 
be needed to excite the surface labelling. 
In conclusion, the TIRFM setup used in this work had some shortcomings that 
prevented us from carrying out further experiments concerning the dynamics of 
plasma membrane GLUT4. To find out more about the organisation of the 
transporter in the plasma membrane, we employed two different fluorescence 
microscopy-based techniques (see Chapter 4 and Chapter 5). In terms of the 
comparability of HeLa cells and 3T3 L1 adipocytes, we used these results as a 
basis for a study of SNARE proteins that affect intracellular GLUT4 trafficking, 
which is presented and discussed in Chapter 6.  
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Chapter 4 The Oligomeric State of GLUT4 in the 
Plasma Membrane 
4.1 Introduction 
4.1.1 Oligomerisation of Proteins 
Cell signalling pathways are largely depending on protein-protein interactions. In 
many cases, the same proteins interact with each other, forming dimers, 
trimers, tetramers or oligomers of even higher order (Cornish-Bowden & 
Koshland Jr, 1971). So called homooligomers are involved in different processes 
including gene expression, control of receptor, enzyme, or ion channel activity, 
and cell-cell interactions (Hashimoto & Panchenko, 2010). There are cases 
where the oligomeric state of a protein has a profound influence on its function. 
For example, the regulatory protein 14-3-3ζ binds to phosphoserine motifs in its 
dimeric form and phosphorylation of a serine residue domain prevents 
oligomerisation and subsequently the binding of its substrate (Woodcock et al., 
2003). G-protein coupled receptors (GPCRs) are another family of proteins that 
exist in different oligomeric states, which affects their function and in some 
cases even their location within the cell (Fotiadis et al., 2006; Gurevich & 
Gurevich, 2008). 
According to protein structure databases, most proteins can form oligomers with 
themselves (Henrick & Thornton, 1998), but experimental investigation of the 
oligomeric state of proteins has been challenging. Energy transfer methods like 
fluorescence resonance energy transfer (FRET) or bioluminescence resonance 
energy transfer (BRET) have been employed to argue that proteins are in very 
close proximity to each other (Floyd et al., 2003; Issafras et al., 2002). However, 
these methods are limited as they cannot differentiate between true oligomers 
and molecules that are only very close to each other (Gurevich & Gurevich, 
2008). Other microscopy based techniques, determine the oligomeric state of a 
protein by analysing the temporal fluctuation of fluorescence intensity of a 
fluorescent protein of interest (Yan Chen et al., 1999; Kask et al., 1999). These 
methods, however, are time-dependent and can only be carried out in live 
samples. 
Chapter 4 100 
 
Disulphide trapping by chemical crosslinking has been used to investigate the 
oligomeric state of GPCRs (Klco et al., 2003), but this method has the 
disadvantage that temporary interactions as opposed to true oligomerisations 
are crosslinked as well. BN-PAGE is a gel electrophoresis method that separates 
proteins and protein complexes in their native state, allowing the analysis of 
protein complexes and oligomers (Schägger et al., 1994). This method has been 
used for instance to determine the native oligomeric state of the plasma 
membrane based enzymes NTPDase1 and 2 (Failer et al., 2003) but it is an 
intricate and complicated technique that requires a lot of expertise. 
4.1.2 Spatial Intensity Distribution Analysis 
Spatial Intensity Distribution Analysis (SpIDA) was designed by Godin et al. to 
overcome the shortcomings of the aforementioned techniques. The protein of 
interest is expressed as a chimera with a fluorescent protein. Images are 
acquired using standard confocal laser scanning microscopy (CLSM) in either live 
cells or fixed samples and the fluorescence intensity is measured. On CLSMs this 
is usually done with an analogue photomultiplier tube that counts the number of 
collected photoelectrons (Paddock, 1999).The intensity of all pixels in an ROI is 
then plotted in an intensity histogram over which a Poissonian distribution is 
fitted. This distribution will look different for monomeric, oligomeric, or mixed 
populations and is used to calculate the quantal brightness ε of the fluorophore 
(Godin et al., 2011). ε is defined as the mean intensity in the point spread 
function (see Chapter 5.1) of a fluorescent unit (Godin et al., 2015). For SpIDA 
to work, it is crucial that the used fluorescent protein cannot form oligomers 
with itself, as regular GFP does. This is the case for monomeric eGFP, which has 
an Ala206Lys point mutation (von Stetten et al., 2012). If this is fused to the 
protein of interest, the intensity histogram and therefore ε will reflect the 
oligomeric state of the protein. First, it is therefore necessary to acquire images 
of monomeric eGFP and determine the monomeric quantal brightness ε0 (Godin 
et al., 2011). This in turn is dependent on the laser power of the instrumental 
setup (Marsango et al., 2017). The oligomeric state of the protein of interest is 
determined by the measured quantal brightness, which will be a multimer of ε0 
as demonstrated in Figure 4.1. 
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Figure 4.1 The Quantal Brightness ε Depends on the Oligomeric State of the Protein. 
The quantal brightness ε of a population of monomeric eGFP-tagged proteins is a multimer of the 
quantal brightness of the monomeric eGFP ε0. 
The quantal brightness ε of a primarily monomeric population will be equal to ε0, 
a dimeric population will be 2·ε0, a trimeric population 3·ε0 and so on. 
Since the development of SpIDA by Godin et al. the technique has been used in a 
number of published studies by the Milligan group in our institute to determine 
the quaternary structure of different GPCRs (Marsango et al., 2017; Pediani et 
al., 2016; Ward et al., 2015; Zakrys et al., 2014). In one study investigating M1 
muscarinic acetylcholine receptors it was found that about 75 % of these 
receptors in the plasma membrane are monomers in the basal state. Upon 
treatment with the antagonist pirenzepine the receptor oligomerises and the 
majority of receptors now exist as dimers or higher order oligomeric complexes 
(Pediani et al., 2016). Using simulated data, Godin et al. (2011) showed that the 
technique delivers reliable results for densities of up to 10,000 fluorophores per 
laser beam area. This means, SpIDA can be employed for the analysis of high-
density populations, as would be expected to be the case for GLUT4 in the 
plasma membrane. 
4.1.3 Hypothesis and Aims 
It has been shown that some GPCRs are delivered to their place in the plasma 
membrane in the form of oligomers (Prinster et al., 2006). We hypothesised that 
this may be the case for GLUT4 in GSVs and the clusters reported by Lizunov et 
al. and Gao et al. are in fact GLUT4 oligomers that break up into monomers 
upon insulin stimulation. 
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We used SpIDA to determine the oligomeric state of GLUT4 in HeLa cells and 3T3 
L1 adipocytes in the basal state and after insulin stimulation. For this, we 
transfected HeLa cells with a HA-GLUT4-eGFP construct and established a 3T3 L1 
cell line stably expressing HA-GLUT4-eGFP. Since SpIDA is still a relatively new 
method and not widely used, we validated the method by repeating the 
published work by Pediani et al. who investigated the change in oligomeric state 
of the M1 muscarinic receptor in response to the antagonist drug pirenzepine 
(Pediani et al., 2016). To confirm our results acquired by SpIDA, we carried out 
BN-PAGE of lysates from wild type 3T3 L1 adipocytes. 
4.2 Results 
4.2.1 Construction of a HA-GLUT4-eGFP Lentiviral Plasmid 
Our laboratory routinely uses HeLa and 3T3 L1 cell lines expressing HA-GLUT4-
GFP. However, the construct expressed in these cells contains standard GFP 
which is capable of forming oligomers with itself (von Stetten et al., 2012) and is 
therefore unsuitable for SpIDA. Hence, the first step was to construct a plasmid 
that contains HA-GLUT4 tagged with the monomeric eGFP described by von 
Stetten et al. However, 3T3 L1 cells are known to be difficult to transfect by 
traditional means (Ross et al., 2003) and introduction of DNA via a viral vector 
has been more successful (Carlotti et al., 2004).  
 
Figure 4.2 Maps of pCDH-CMV-MCS-EF1-Puro and pcDNA3.1 HA-GLUT4-eGFP 
Schematic map of the vector and insert plasmids with positions of used restriction sites (BamHI 
and NotI), antibiotic resistances and promoter) 
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For this reason, we decided to construct a lentiviral plasmid containing HA-
GLUT4-eGFP. As shown in Figure 4.2, we used the lentiviral vector pCDH with 
the CMV promoter and a puromycin resistance gene. In its multiple cloning site, 
this plasmid contains both a BamHI and a NotI restriction site. HA-GLUT4-eGFP 
was generated synthetically and introduced into the pcDNA3.1 vector flanked by 
the same restriction sites BamHI and NotI. Figure 4.3 and Figure 4.4 show the 
digested pCDH-CMV-MCS-EF1-Puro and the pcDNA3.1 HA-GLUT4-eGFP plasmid 
respectively. The negative control sample did not contain any endonucleases in 
the reaction mix and shows the typical band pattern of uncut, supercoiled 
plasmids, which run lower in the gel than their size would suggest. The single 
digests with BamHI and NotI lead to a single band the size of the linear plasmid 
at around 7 kb, demonstrating that the restriction sites were unique in both 
plasmids. When digested with both restriction endonucleases, pcDNA3.1 dropped 
out the HA-GLUT4-eGFP insert, which has a size of 2313 bp. The drop out in the 
pCDH plasmid is only 7 bp, which cannot be resolved in a 1 % agarose gel. This is 
why the double digested pCDH plasmid shows only a single band at around 7 kb. 
 
 
Figure 4.3 pCDH-CMV-MCS-EF1-Puro Digested with BamHI and NotI 
Representative restriction digests of pCDH-CMV-MCS-EF1-Puro using the enzymes shown on the 
figure performed as described in 2.2.4.4. Samples were analysed on 1 % agarose gels as 
described in section 2.2.4.3. The marker used was a 1 kb DNA ladder and the negative control was 
the reaction mix minus enzymes. 
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Figure 4.4 pcDNA3.1 HA-GLUT4-eGFP Digested with BamHI and NotI 
Representative restriction digests of pcDNA3.1 HA-GLUT4-eGFP using the enzymes shown on the 
figure performed as described in 2.2.4.4. Samples were analysed on 1 % agarose gels as 
described in section 2.2.4.3. The marker used was a 1 kb DNA ladder and the negative control was 
the reaction mix minus enzymes. Double digestion was expected to release the 2.3 kb GLUT4-GFP 
cDNA insert, as indicated by the arrow.  
The digested pCDH vector was combined with the HA-GLUT4-eGFP insert by 
molecular cloning as described in 2.2.4.5 and ten clones were picked for further 
analysis. The plasmid DNA was purified by Miniprep and digested with BamHI and 
NotI. Successful cloning should yield two bands: One at about 7 kb, which is the 
linearised pCDH vector, and the 2.3 kb HA-GLUT4-eGFP insert. Figure 4.5 shows 
the outcome of this experiment. Only sample 1 showed the desired band 
pattern. Sample 6 and 8 only showed one band at 7 kb, which is probably the 
empty pCDH vector, the single band in sample 7 is likely an empty pcDNA3.1 
plasmid. Samples 2-5, 9, and 10 have the band at 2.3 kb, but the vector only has 
a size of about 5 kb, which corresponds to an empty pcDNA3.1 plasmid. Sample 1 
was used for the generation of lentivirus. 
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Figure 4.5 pCDH HA-GLUT4-eGFP Clones 
Restriction digests of 10 Miniprep purified clones. Plasmids were digested with BamHI and NotI as 
described in 2.2.4.4 and analysed on a 1 % agarose gel as described in section 2.2.4.3. successful 
clones were expected to release the 2.3 kb GLUT4-GFP cDNA insert as indicated by the arrow and 
show the linearised pCDH plasmid at 7 kb. 
4.2.2 Production and Testing of Lentivirus 
Lentivirus was produced as described in 2.2.3. The presence of lentiviral 
particles in the packaging cell supernatants was confirmed using the Lenti-X 
GoStix tests. However, these tests only recognise the capsid protein p24 which 
would also be present in unfunctional viruses that do not contain the genetic 
information for HA-GLUT4-eGFP. In order to determine the functionality of the 
virus, HeLa cells were infected with the packaging cell supernatant, HA-surface 
stained and examined by confocal microscopy in the basal state and after insulin 
stimulation. Representative images of the infected cells are shown in Figure 4.6. 
Transfection efficiency was low and ranged between 5 % and 20 %, this was 
determined by microscopy as western blotting did not yield any results, 
suggesting that levels of HA-GLUT4-eGFP were too low for immunoblotting. Cells 
expressing the construct were usually found in clusters as seen in Figure 4.6, 
which are probably derived from single cells that were successfully transfected. 
The cells showed the typical perinuclear distribution of GLUT4 in the basal state 
and a more dispersed pattern with a bright blue HA-ring after insulin stimulation 
and the HA/G4 ratio in the basal state vs insulin stimulation confirms effective 
GLUT4 translocation in response to insulin. 
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Figure 4.6 HeLa Cells Infected with HA-GLUT4-eGFP Lentivirus 
HeLa cells were infected with lentiviral supernatant as described in 2.2.3.2. Cells were incubated in 
serum-free medium for 2 h prior to the experiment and stimulated with 100 nM insulin for 60 min or 
left untreated. Cells were then fixed and stained for surface HA as described in section 2.2.2.2. A: 
Representative image of basal cells B: Representative image of cells after stimulation with insulin 
C: HA/G4 ratio, Basal: 0.51 ± 0.12 (n = 30) Insulin: 1.00 ± 0.09 (n = 21). Mean ± SE. Unpaired two-
tailed t-test 95 % confidence intervals p = 0.0037 
Infection of 3T3 L1 cells could not be achieved with this lentivirus. Because the 
transfection efficiency was also very low in HeLa cells, we hypothesised that this 
may be due to a low virus titer. Attempts to increase this by ultracentrifugation 
or PEGylation failed, which is why we purchased a highly concentrated lentivirus 
from VectorBuilder made from the here described HA-GLUT4-eGFP construct. 
This custom-made lentivirus achieved a transfection efficiency of about 50 % in 
differentiated 3T3 L1 adipocytes at MOI = 200 (not shown) and we used this for 
the generation of a 3T3 L1 cell line stably expressing HA-GLUT4-eGFP, which was 
then used for SpIDA experiments. 
A B 
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4.2.3 Generation of a 3T3 L1 Cell Line Expressing HA-GLUT4-
eGFP 
The lentiviral HA-GLUT4-eGFP construct contains a puromycin resistance gene, 
which was used to apply selection pressure on the infected cells. The 
appropriate concentration of puromycin was determined by creating a kill curve. 
Varying concentrations of puromycin were added to confluent cultures of 
undifferentiated 3T3 L1 cells and cell viability was estimated by evaluating the 
cultures under a conventional light microscope after 3, 5, and 7 days of culture 
in the presence of the drug. The resulting kill curve is shown in Figure 4.7. 
Puromycin concentrations higher than 3 μg·ml-1 resulted in complete cell death 
after 3 days of culture. 2 μg·ml-1 puromycin killed the entire culture after 7 days 
and with 1 μg·ml-1 puromycin about 5 % of the culture survived after 7 days. The 
ideal concentration for applied selection pressure was therefore decided to be 
1.5 μg·ml-1 puromycin. 
  
Figure 4.7 Kill Curve of 3T3 L1 Cells Treated with Puromycin 
3T3 L1 fibroblasts were seeded in a 24 well plate and cultured until confluent. Confluent 3T3 L1 
cells were then treated with 0 - 6 μg·ml-1 puromycin, 3 wells for each concentration and cell viability 
was estimated by examination under a light microscope after 3, 5, and 7 days of culture. Puromycin 
containing medium was changed every other day. Puromycin concentrations higher than 3 μg·ml-1 
resulted in complete cell death after 3 days, these data points are therefore not shown. The 
experiment was only carried out once. 
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The 3T3 L1 cell line stably expressing HA-GLUT4-eGFP was generated as 
described in 2.2.3.3 and analysed by confocal microscopy as previously described 
in 4.2.2. Results are shown in Figure 4.8. Expression levels were very low and 
could only be picked up by confocal microscopy but not by immunoblotting. 
Single cells that expressed higher levels of HA-GLUT4-eGFP showed the typical 
perinuclear distribution and the blue HA ring after insulin stimulation. These 
cells were used for SpIDA. 
  
 
 
Figure 4.8 3T3 L1 Adipocytes Stably Expressing HA-GLUT4-eGFP 
The cell line was generated as previously described in this section. Cells were incubated in serum-
free medium for 2 h prior to the experiment and treated with 100 nM insulin for 20 min or left 
untreated. Cells were then fixed and stained for surface HA as described in section 2.2.2.2. A: 
Representative image of basal cells B: Representative image of cells after stimulation with insulin 
C: HA/G4 ratio, Basal: 0.27 ± 0.04 (n = 12) Insulin: 0.60 ± 0.10 (n = 4). Mean ± SE. Unpaired two-
tailed t-test 95 % confidence intervals p = 0.0053 
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4.2.4 Validation of the Method – Oligomeric State of the M1 
Muscarinic Receptor 
Pediani et al. used SpIDA to study the oligomeric state of the M1 muscarinic 
receptor. They generated a Flp-In T-REx 293 cell line stably expressing eGFP-
tagged human M1 after induction with doxycycline and performed SpIDA. They 
found that the majority of the receptor (69.1 %) in the basolateral membrane is 
monomeric and the remaining 30.9 % either dimeric or of higher oligomeric 
organisation. Treatment with the antagonistic M1 ligand pirenzepine then 
reversed this distribution and only 26.5 % of the receptor was monomeric 
(Pediani et al., 2016). We repeated this experiment with the same cell line that 
was used in this study, kindly provided by Dr Richard Ward and we found similar 
results that are shown in Figure 4.9. 
The quantal brightness of monomeric eGFP in this experimental setup with the 
laser power at 6 % had previously been determined and was ε0 = 25.24 (Pediani 
et al., 2016). By normalising the values of the single ε measurements of 
monomeric eGFP to ε0, the monomeric equivalent unit (MEU) of each 
measurement was obtained. Pediani et al. found that 75 % of all monomeric 
eGFP MEUs were below 1.274. Populations were therefore considered to be 
monomeric if their ε was less than 1.274·ε0. After induction of M1-eGFP 
expression with doxycycline, green fluorescent cells could be observed under the 
confocal microscope. The mean quantal brightness ε of these untreated cells 
was 28.24 ± 1.21 (Mean ± SE, n = 26). This value is very close to the quantal 
brightness of monomeric eGFP. The monomeric M1 population in untreated cells 
was 77 %. After treatment with the M1 antagonist pirenzepine, this decreased to 
40 % and the mean ε was 39.03 ± 2.88 (Mean ± SE, n = 25), significantly greater 
than in untreated cells as seen in Figure 4.9.  
With these results mirroring the published study by Pediani et al. we felt 
confident that the SpIDA experiments were carried out correctly. 
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Figure 4.9 Oligomeric State of the M1 Muscarinic Receptor 
Flp-In T-REx 293 cell line stably expressing eGFP-tagged human M1 were induced with 100 ng·ml-1 
doxycycline for 24 h and treated with 10 μM pirenzepine for 24 h or left untreated. Cells were 
imaged live. SpIDA was carried out as described in 2.2.8.2 A: Representative image of basolateral 
membrane of treated cells. B: Quantal brightness and mean fluorescence intensity of single ROIs. 
Filled symbols: untreated, open symbols: treated with 10 μM pirenzepine C: Distribution of 
monomeric (< 1.274) and higher oligomeric state (> 1.274) M1 in untreated cells. D: Distribution of 
monomeric (< 1.274) and higher oligomeric state (> 1.274) M1 in cells treated with 10 μM 
pirenzepine. E: Mean quantal brightness of untreated cells and cells treated with 10 μM 
pirenzepine. Untreated: 28.24 ± 1.21 (n = 26) Treated: 39.03 ± 2.88 (n = 25). Mean ± SE. Unpaired 
two-tailed t-test, 95 % confidence intervals p = 0.0011. 
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4.2.5 Oligomeric State of GLUT4 as by SpIDA 
SpIDA was carried out in both HeLa and 3T3 L1 cells to add to the comparison of 
the two cell types in Chapter 3. HeLa cells were infected with the lentivirus, and 
the previously described HA-GLUT4-eGFP 3T3 L1 cell line was used for SpIDA in 
adipocytes. The quantal brightness of monomeric eGFP in this experimental 
setup with the laser power at 2 % had previously been determined and was 
ε0 = 12.56 (Zakrys et al., 2014). 
  
 
 
Figure 4.10 Oligomeric State of GLUT4 in HeLa Cells 
HeLa cells were infected with lentiviral supernatant as described in 2.2.3.2. Cells were incubated in 
serum-free medium for 2 h prior to the experiment and treated with 100 nM insulin for 60 min or left 
untreated. Cells were imaged live. SpIDA was carried out as described in 2.2.8.2 A: Representative 
image of basolateral membrane of HeLa cells expressing HA-GLUT4-eGFP in the basal state. 
B: Representative image of basolateral membrane of HeLa cells expressing HA-GLUT4-eGFP after 
insulin stimulation. C: Mean quantal brightness in the basal state and after insulin stimulation. 
Basal: 67.50 ± 3.47 (n = 30) Insulin: 60.36 ± 3.40 (n = 30). Mean ± SE. Unpaired two-tailed t-test, 
95 % confidence intervals p = 0.1463. D: Quantal Brightness and mean fluorescence intensity of 
single ROIs. Filled symbols: Basal, open symbols: Insulin  
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Figure 4.10 shows the basolateral membrane of HeLa cells expressing the 
construct in the basal state (A) and after insulin stimulation (B). It is difficult to 
judge the effect of insulin on this cell type as these cells are less insulin 
sensitive, which has been discussed in Chapter 3. The mean fluorescence 
intensity in the analysed ROIs was not affected in this experiment (Figure 
4.10 D, x-axis) but HA-GLUT4-eGFP translocated to the cell surface in response 
to insulin in these cells as has been shown in Figure 4.6. 
The mean quantal brightness of HA-GLUT4-eGFP in this cell type was 67.50 in 
the basal state and 60.36 after insulin stimulation, which is not a significant 
difference. It is however substantially higher than ε0 and most ROIs indeed had 
values for ε that suggest that GLUT4 is expressed in complexes of high 
oligomeric order. According to Figure 4.10 D, complexes consisted of at least 
two and up to eight GLUT4 molecules and there was no difference between 
basal cells and cells that had been stimulated with insulin. 
HeLa cells do not express endogenous GLUT4 (Sadler et al., 2013) and it is 
conceivable that they lack other proteins that are part of the insulin signalling 
pathways. It is possible that our hypothesis that the oligomeric state of GLUT4 is 
influenced by insulin is still valid in adipocytes, but not in HeLa cells if the 
oligomerisation or de-oligomerisation requires other proteins that are not 
present in this cell type. We therefore conducted the same experiment in 3T3 L1 
adipocytes. The results are shown in Figure 4.11. 
Successful translocation of HA-GLUT4-eGFP in 3T3 L1 adipocytes was 
demonstrated in Figure 4.8 and the fluorescence intensity increased more visibly 
in this cell type than in HeLa cells. The mean quantal brightness was higher than 
in HeLa cells, with 84.99 in basal cells, but also remained the same after insulin 
stimulation, when the mean quantal brightness was 81.56. Similar to HeLa cells, 
the data suggests that GLUT4 is not monomeric in the cell membrane of 
adipocytes but exists as an oligomer. The size ranges from trimers to nonamers, 
which is larger than that observed in HeLa cells. The majority of ROIs measured 
a quantal brightness that corresponds to the size of a Heptamer, which is 
reflected in the data’s median shown in Figure 4.11 E. 
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Figure 4.11 Oligomeric State of GLUT4 in 3T3 L1 Adipocytes 
The 3T3 L1 cell line described in section 4.2.3 was used for this experiment. Cells were incubated 
in serum-free medium for 2 h prior to the experiment and treated with 100 nM insulin for 20 min or 
left untreated. Cells were imaged live. SpIDA was carried out as described in 2.2.8.2. 
A: Representative image of basolateral membrane of 3T3 L1 adipocytes expressing HA-GLUT4-
eGFP in the basal state. B: Representative image of basolateral membrane of 3T3 L1 adipocytes 
expressing HA-GLUT4-eGFP after insulin stimulation (100 nM, 20 min). C: Mean quantal 
brightness in the basal state and after insulin stimulation. Basal: 84.99 ± 4.65 (n = 17) Insulin: 
81.56 ± 3.84 (n = 15). Mean ± SE. Unpaired two-tailed t-test, 95 % confidence intervals p = 0.5800. 
D: Quantal Brightness and mean fluorescence intensity of single ROIs. Filled symbols: Basal, open 
symbols: Insulin. E: Comparison of oligomeric states in HeLa cells and in 3T3 L1 adipocytes. 
Shown are single data points as the oligomeric state, as well as the median. HeLa Basal: 5.69 
(n = 30) HeLa Insulin: 4.63 (n = 30) 3T3 L1 Basal: 7.16 (n = 17) 3T3 L1 Insulin: 6.90 (n = 15) 
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4.2.6 Oligomeric State of GLUT4 as by BN-PAGE 
Proteins subjected to BN-PAGE maintain their native conformation and stay in 
complexes. BN-PAGE does not allow the use of SDS as this would denature the 
proteins and protein complexes. However, GLUT4 is a membrane protein and 
therefore has to be solubilised by adding a mild detergent. For successful BN-
PAGE the choice of an appropriate detergent is crucial. This is particularly true 
for membrane proteins. The detergent has to be powerful enough to solubilise 
the membrane, but at the same time it has to be mild enough to leave the 
protein or protein complex of interest intact. The non-ionic detergents digitonin, 
Triton X-100, and n-dodecyl-β-D-maltoside are the most frequently used 
detergents for the separation of membrane proteins by BN-PAGE (Reisinger & 
Eichacker, 2008). We therefore decided to test two of these detergents, Triton 
X-100 (subsequently referred to as Triton) and digitonin, for the solubilisation of 
GLUT4 and following BN-PAGE. 
 
Figure 4.12 BN-PAGE of 3T3 L1 Lysates 
Lysates of 3T3 L1 adipocytes were prepared from cells in the basal state (B) and after stimulation 
with insulin (100 nM, 20min) (I) and incubated with 0.1 %, 0.2 %, 0.5 %, and 0 % Triton on ice as 
outlined in 2.2.6.1. Equal volumes of samples were run on a blue native gel (see section 2.2.6.2) 
alongside the BN-PAGE Marker (see 2.1.1) and immunoblotted for GLUT4 (see section 2.2.6.3). 
Protein concentrations in the samples were considered equal due to identical sample preparation. 
The marker was not visible on the x-ray film and was denoted manually after comparison with the 
nitrocellulose membrane. The immunoblot shown is a representative image from 3 repeats. 
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Samples were incubated with either digitonin or Triton at concentrations ranging 
from 0 % to 0.5 %. BN-PAGE and western blotting was carried out as described in 
2.2.6. Figure 4.12 shows a representative blot for Triton incubated samples, 
incubation with digitonin did not lead to a clean blot and is therefore not shown. 
The negative control sample with 0 % Triton did not show a signal, indicating 
that solubilisation with the detergent was successful. With increasing Triton 
concentration, a band of about 300-350 kDa became visible, indicating that this 
band was indeed a GLUT4 complex consisting of 6 to 7 monomers, since 
monomeric GLUT4 has a size of about 54 kDa (Fukumoto et al., 1989). 
4.3 Discussion 
SpIDA requires the expression of the protein of interest as a chimera with a 
fluorescent protein that does not form oligomers with itself, such as eGFP (von 
Stetten et al., 2012). Part of this project was therefore to generate an HA-
GLUT4-eGFP construct that can be expressed in HeLa cells and 3T3 L1 
adipocytes. This was complicated by the fact that 3T3 L1 adipocytes are 
notoriously difficult to transfect (Ross et al., 2003), which is why the construct 
had to be delivered by a lentivirus (Carlotti et al., 2004). We generated such a 
virus and successfully transfected both HeLa cells and 3T3 L1 cells with HA-
GLUT4-eGFP, however, expression levels in adipocytes were very low, which 
made carrying out SpIDA difficult. The reason for this appears to be the 
promoter in the host plasmid. Differentiated 3T3 L1 adipocytes suppress the CMV 
promoter, which makes it very difficult to obtain good expression levels (Brewer 
et al., 2014). While low expression levels complicate the detection of the 
protein by immunoblotting or even by microscopy, it also means that the cell 
trafficking systems are unlikely to be saturated with the HA-GLUT4-eGFP fusion 
protein. This means that the protein is more likely to be folded and undergo 
posttranslational modifications correctly, which makes experimental artefacts 
less probable (Tate, 2001). This is particularly advantageous in a study such as 
this one, as oligomerisation could be influenced by an altered quaternary 
structure of GLUT4, thus possibly leading to oligomerisation of the protein, when 
this would not be the case in correctly folded and glycosylated GLUT4 or vice 
versa. 
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Results from SpIDA and BN-PAGE both suggest that GLUT4 exists as a complex of 
high oligomeric order in the basolateral membrane of 3T3 L1 adipocytes and 
HeLa cells. Adipocytes contain predominantly hexamers, heptamers, and 
octamers, while most complexes in HeLa cells are slightly smaller, with more 
tetramers and pentamers being detected in this cell type. With regards to the 
comparison of the two cell types in the previous chapter, the data adds more 
depth. The HeLa cell line behaves similarly to 3T3 L1 adipocytes with respect to 
GLUT4 translocation as previously discussed. In addition, the protein also 
oligomerises, although to a lesser extent than in adipocytes. This may be due to 
other GLUT4 translocation machinery being missing in this cell type, which 
makes it tempting to assume that the oligomeric state of GLUT4 does play a role 
in GLUT4 trafficking.  
The results obtained by SpIDA are to be considered carefully, as the technique is 
not without limitations. For one, cells were imaged on a confocal microscope 
with the focal plane focused on what we considered to be the plasma 
membrane. As discussed in 3.1.1, the axial resolution in confocal microscopy is 
severely limited, which means that the obtained signal is not only from HA-
GLUT4-eGFP molecules located in the plasma membrane, but there will be a 
considerable amount of background fluorescence from GSVs approaching the 
membrane. This background signal may mask the dispersal of monomers in the 
plasma membrane. For this reason, a TIRF microscope may be more suitable for 
the analysis. However, this would have meant that we could not use the 
monomeric quantal brightness value ε0 previously obtained by Zakrys et al. who 
used the same instrument and experimental parameters for their study. The 
experiments necessary to determine all these parameters for a different 
experimental set-up would have gone beyond the scope of this study. In past 
publications, SpIDA has mostly been used to investigate monomers or dimers 
(Barbeau, Godin, et al., 2013; Pediani et al., 2016; Ward et al., 2015; Zakrys et 
al., 2014). Although the method is theoretically capable of dissolving higher 
oligomeric structures, it is limited in that respect (Barbeau, Swift, et al., 2013). 
Especially when the cell line is expressing the protein endogenously as is the 
case for 3T3 L1 adipocytes and GLUT4, oligomers could be made up of eGFP-
tagged GLUT4 and endogenous GLUT4, but only the fluorescently labelled 
molecules are taken into consideration. Heterooligomers pose a similar problem, 
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as non-labelled complex components are not detected. With regards to our 
findings that GLUT4 forms greater complexes in 3T3 L1 adipocytes than in HeLa 
cells this could mean that the complexes are actually even bigger in reality, 
either due to additional untagged GLUT4 or other proteins that are part of the 
complex. 
For the BN-PAGE experiments we used whole cell lysates instead of membrane 
fractions for practical reasons; protein complexes are often very sensitive and 
must be handled carefully. This experiment had to be carried out exclusively in 
the cold room at 4 °C and without stopping points, as freeze/thawing or sample 
preparation at room temperature led to breakup of the complexes and no signal 
was obtained on the resulting immunoblot. The fact that we used whole cell 
lysates essentially means that BN-PAGE has the same limitation as SpIDA on the 
CLSM, namely that the analysis is not restricted to the plasma membrane and 
potential dispersal effects may be masked. However, a subcellular fractionation 
in addition to the already very extensive process was considered too impractical. 
The sensitive nature of many protein complexes is what limits the technique the 
most. Proteins and protein complexes are very prone to denaturation. We 
experienced this problem when carrying out steps of the sample preparation 
outside the cold room at more than 4 °C. In this case we could not detect any 
bands in the immunoblot, suggesting that the GLUT4 complex is extremely 
unstable at higher temperatures. Another important parameter is the detergent 
that is used to solubilise membrane proteins. Often, a mild detergent such as 
digitonin is used to avoid protein denaturation. At the same time, the detergent 
has to be potent enough to sufficiently solubilise the hydrophobic membrane 
proteins. In the case of ATP synthase for example, the apparent oligomeric state 
depends on the concentration of Triton (Wittig et al., 2006). 
We have experienced all of these issues during our BN-PAGE experiments and 
even when finally successful, the resulting immunoblots only showed smeared, 
blotchy bands different from conventional SDS-PAGE immunoblots (as seen in 
Figure 4.12). Another shortcoming of this experiment is that we could not run a 
suitable control sample. We can therefore only assume that the observed bands 
are indeed GLUT4 complexes. The fact that the SpIDA experiments yielded the 
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same result makes this more plausible and SpIDA was carried out correctly as the 
method had been validated by duplicating the experiment from Pediani et al. 
The question remains why GLUT4 forms an oligomer of such high order. It is not 
a very surprising discovery, since about 35 % of cellular proteins are thought to 
be oligomeric with the average oligomeric state being tetrameric (Ali & 
Imperiali, 2005). Little research has been undertaken in the investigation of the 
quaternary structure of GLUT4, but homology modelling based on the crystal 
structure of GLUT1 has shown that GLUT4 is likely to form a pore through which 
glucose can travel, furthermore ATP- and cytochalasin B binding sites were 
identified (Mohan et al., 2009). This makes it unlikely that oligomerisation is 
needed for the functionality of the transporter. It is however plausible that 
GLUT4 molecules have a tendency to attract each other based on their tertiary 
structure and that the conditions in the membrane thermodynamically favour 
the association to oligomers. This would also explain the broad range of oligomer 
sizes and the oligomers may be smaller in HeLa cells due to the different 
membrane phospholipid composition. 
Indeed, GLUT1 has long been known to exist as an oligomer and its function is 
controlled by its oligomeric state (D. N. Herbert & Carruthers, 1991, 1992). 
Performing size exclusion chromatography, Herbert and Carruthers found that 
purified GLUT1 from erythrocytes exists as a mixture of homodimers and 
homotetramers. The native structure in vivo is understood to be tetrameric, 
stabilised by intramolecular, extracellular disulphide bonds (Zottola et al., 
1995), while purification in the presence of an alkaline reductant produces 
dimers. The ability of GLUT1 to transport glucose is indeed dependent on its 
oligomeric structure. While the GLUT1 dimer only exhibits one glucose binding 
site, the tetramer presents multiple binding sites. Interestingly, the dimer also 
presents more binding sites for the glucose transport inhibitor cytochalasin B 
then the tetrameric form (D. N. Herbert & Carruthers, 1992). Based on the fact 
that GLUT4 is structurally very similar to GLUT1, it is conceivable that it forms 
oligomers in a similar manner. 
This discovery in itself is interesting; however, insulin does not appear to have 
any influence on the size of the oligomers, which contradicts our hypothesis that 
GLUT4 clusters are in fact highly oligomerised GLUT4 complexes that break up 
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into monomers under the influence of insulin. Based on the limitations of SpIDA 
and BN-PAGE, it is important to note that the hypothesis cannot be rejected 
entirely. It is possible that particularly SpIDA is simply not powerful enough to 
detect the dispersal of GLUT4 complexes into monomers and monomeric GLUT4 
is too small to be detected by BN-PAGE, so this technique cannot be used as a 
dispersal assay and only served in this section as validation of the GLUT4 
oligomer size. 
Either way, SpIDA could not be used as a tool to visualise and quantify GLUT4 
dispersal. We therefore decided to attempt to do this with a much more potent 
microscopy technique and ventured into the for us unknown territories of super-
resolution microscopy.  
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Chapter 5 Clustering and Dispersal of GLUT4 in 
the Plasma Membrane 
5.1 Introduction 
5.1.1 Super Resolution Microscopy 
Chapter 3.1 has introduced the principles of fluorescence microscopy. 
Instruments such as confocal or TIRF microscopes enable advanced image 
acquisition with a small signal to noise ratio and little background fluorescence. 
However, the resolution is limited even in state-of-the-art light microscopes. 
Resolution is defined as the smallest distance between two points that can be 
resolved, which is illustrated in Figure 5.1. This is known as the diffraction limit. 
The signal coming from a fluorophore is visible as a blur around the source. 
Translated into the image plane, this is known as the point spread function 
(PSF). When the signal intensity is plotted along the xy plane, the PSF is 
visualised as a three-dimensional peak (Rottenfusser et al., 2019). Two points 
can be distinguished from each other if their PSFs are clearly distinguishable. 
When the peaks merge, it is not clear anymore whether the signal comes from 
one or more sources. 
 
Figure 5.1 Principle of Resolution 
Point sources emit light as circular intensity profiles. When the signal is plotted over the xy plane, 
this is visualised as peaks. The resolution is defined as the smallest distance d between two point 
sources that still results in separate peaks in the signal plot. 
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The diffraction limit is dependent on the wavelength λ of the light used as well 
as the numerical aperture (NA) of the objective. It was defined by Ernst Karl 
Abbe in 1873 (Abbe, 1873). According to the diffraction limit, the smallest 
resolvable distance d between two points is 
 
The value for NA typically lies between 1.4 and 1.6, the wavelength of the laser 
depends on the fluorophore that is excited. The excitation maximum for GFP for 
example is 488 nm (Patterson et al., 2001). For this example and a NA of 1.6. 
the resolution would be approximately 150 nm according to equation (5-1). 
However, this theoretical value does not take into consideration slight 
imperfections in the instrumental setup and background fluorescence. 
180 - 200 nm is a much more realistic value for most applications (Heintzmann & 
Ficz, 2006). Even with a perfect instrument and a high signal to noise ratio, the 
diffraction limit is a physical boundary that cannot be breached. The only way to 
accurately image structures that are below the resolution limit by light 
microscopy is therefore to circumvent the Abbe diffraction limit. This is done in 
super resolution microscopy. 
Super resolution microscopy techniques can be divided into two categories, 
depending on how the diffraction limit is evaded (B. Huang et al., 2010). In the 
first category, fluorescent properties are modulated by means of patterned 
illumination, which results in not all fluorophores emitting at the same time. 
Structured Illumination Microscopy (SIM) and Stimulated Emission Depletion 
(STED) Microscopy belong in this category. In SIM a grid pattern is superposed on 
the sample, which results in the interference of the signals and subsequently the 
occurrence of Moiré fringes. By rotating the grid pattern, a series of images is 
recorded, which can be reconstructed to an image with a resolution of about 
half the diffraction limit (Gustafsson, 2000). In STED, a depletion laser is used in 
addition to the excitation laser. This depletion laser is donut shaped and 
negatively interferes with the signal outside the focal point of the excitation 
laser, which effectively narrows the PSF (Hell & Wichmann, 1994). The second 
category of super resolution microscopy is also known as single molecule 
 d =
λ
2NA
 (5-1) 
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localisation microscopy (SMLM), which has been briefly mentioned in section 
1.7.5. SMLM avoids the Abbe diffraction limit altogether by focusing on 
localisation of single molecules whose PSFs do not overlap with those of 
neighbouring molecules. Once light is emitted by isolated molecules, the 
resolution is only limited by the localisation precision, which can be in the 
nanometre scale (Ober et al., 2004). The key difference is that the obtained 
data is not a true image of the sample but only a set of coordinates of detected 
localisations. Stochastic Optical Reconstruction Microscopy (STORM) (Rust et al., 
2006) and Fluorescence Photoactivation Localisation Microscopy (FPALM) (Betzig 
et al., 2006) belong in this category. 
5.1.2 Stochastic Optical Reconstruction Microscopy 
The position of a fluorophore could be determined at very high precision for a 
long time by fitting a Gaussian function over its PSF (Gelles et al., 1988). The 
localisation precision Δx can be approximated by 
 
with σ being the standard deviation of the PSF and n being the number of 
photons collected (Thompson et al., 2002). 
The localisation accuracy, however, does not directly translate to a high 
resolution, since the density of fluorophores in stained biological samples is 
usually too high and PSFs overlap, making it impossible to localise single 
molecules. SMLM techniques such as STORM circumvent this problem by using 
fluorophores that can switch on and off, which appears as blinking during 
imaging. Figure 5.2 illustrates the principle of the technique. When imaging the 
specimen over a long time, only a fraction of fluorophores is switched on in each 
frame, which can be localised with high precision. Stochastically, each frame 
contains a different subset of fluorophores. Combining the localisations of all 
frames allows reconstruction of the image with a resolution of up to 20 nm (Rust 
et al., 2006). The resolution is not restricted by the diffraction limit of light 
anymore, but only by how accurately the position of a single fluorophore can be 
determined (B. Huang et al., 2010). 
 ∆x =
σ
√n
 (5-2) 
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Figure 5.2 Principle of STORM and other SMLM Techniques 
A: High density of fluorophores means that their PSFs overlap and the resolution is limited by the 
Abbe diffraction limit. B-E: Selective activation of isolated fluorophores over a number of frames F: 
Localisations of single molecules represented in a scatterplot 
STORM was first described by Rust et al. in 2006. The group employed a pair of 
cyanine dyes, Cy5 and Cy3 that can act as a photoswitch (Bates et al., 2005; 
Heilemann et al., 2005). Cy5 fluoresces in response to 633 nm red laser light and 
can also be transferred to a stable dark state at high laser power. In the 
presence of Cy3, 532 nm green laser light brings Cy5 back into the excited state, 
but at much lower density, allowing the localisation of isolated molecules. The 
photoswitch can cycle between the dark and the excited state several hundred 
times before photobleaching and a resolution of up to 20 nm could be achieved 
(Rust et al., 2006). 
Albeit a remarkable discovery, the technique could not be applied easily to 
biological samples due to the necessity of both dyes being in close proximity to 
each other, making labelling complicated (Bates et al., 2007). The group around 
Markus Sauer found that conventional cyanine dyes, such as Alexa Fluor 647, had 
in fact the ability to switch between the dark and the excited state in the 
absence of an activator fluorophore, provided the laser light that returns the 
fluorophore to the excited state is sufficiently powerful, namely about 200 times 
higher than that reported by Rust et al. They termed their improved technique 
A B C 
D E F 
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direct STORM (dSTORM) (Heilemann et al., 2008). In fact, most publications that 
refer to STORM in their experimental section, have in fact carried out dSTORM 
experiments.  
The cycling between the fluorescent light state and the dark state is enabled by 
the principle of electrons being transferred between what is called the ground, 
the singlet and the triplet state. The principle is illustrated in Figure 5.3. When 
an electron is excited by taking up energy, it leaves the ground state and enters 
the singlet state. During de-excitation, when the electron returns to the ground 
state, the energy is released by fluorescence. Alternatively, if the laser power is 
high enough, the electron can undergo intersystem crossing (ISC) and enter the 
so-called triplet state. Returning from the triplet to the ground state results in 
phosphorescence, which is also visible as emitted light and cannot be 
distinguished from fluorescence by eye (Jameson, 2014; Noomnarm & Clegg, 
2009). Heilemann et al. found that adding a reducing agent with thiol groups, 
such as MEA, quenches the triplet state and therefore phosphorescence, which 
retains the electron in the dark state. Subsequent oxidation relocates the 
electron into the ground state, from where the cycle starts again (Heilemann et 
al., 2009; van de Linde, Krstić, et al., 2011). 
 
Figure 5.3 Principle of Photoswitching 
Excitation of the fluorophore promotes an electron from the singlet ground state S0 into the excited 
singlet state S1. From there, it can either return to the ground state, resulting in fluorescence, or 
undergo intersystem crossing (ISC) into the triplet state T. A thiol group reduces the fluorophore to 
a radical anion T·-, which quenches phosphorescence. Molecular oxygen oxidises the anion and it 
can return to the ground singlet state S0, from where it can be excited again (Heilemann et al., 
2009). 
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The optimal blinking rate, at which the activated fluorophores in each frame are 
further apart than the diffraction limit was found by varying the laser intensity, 
thiol, and oxygen concentration (van de Linde, Löschberger, et al., 2011). 
Compared with FPALM and other super resolution microscopy techniques, 
dSTORM offers many advantages. The instrumental setup is relatively simple and 
cheap, requiring only a standard fluorescence microscope with lasers of 
sufficient power (5 – 30 kW cm-2). The execution of the experiment itself is very 
straightforward as well, as illustrated in 2.2.2.3 and 2.2.7.3 (van de Linde, 
Löschberger, et al., 2011). Antibodies tagged with conventional fluorescent dyes 
such as Alexa Fluor 647, can be used for the staining of virtually any intracellular 
target, whereas FPALM requires the expression of a photoswitchable fusion 
protein (Hess et al., 2006). This is an immense advantage for cells such as 3T3 L1 
adipocytes, which are very difficult to genetically manipulate (Ross et al., 2003). 
Furthermore, photoswitchable fluorophores used for dSTORM are brighter than 
fluorescent proteins and can cycle between the dark and the light state 
hundreds of times, while photoswitchable proteins bleach quickly (Jensen & 
Crossmann, 2014). 
Since the development of SMLM, and more specifically, STORM and dSTORM, the 
technique has allowed exciting insights into cellular processes that have not 
been possible to image by light microscopy before. The imaging of nuclear pore 
complexes (Löschberger et al., 2014), HIV-1 envelope proteins at the plasma 
membrane of infected T-cells (Muranyi et al., 2013), and chromatin structures at 
different stages of mitosis (J. Xu et al., 2018) are only a few examples of the 
successful implementation of dSTORM. Furthermore, the method has been used 
to gain insights into the clustering of the glucose transporters GLUT1 (Yan et al., 
2018) and GLUT4 (Gao et al., 2017), which has been described in more detail in 
section 1.7.5. 
5.1.3 Cluster Analysis 
Super resolution microscopy, particularly SMLM has allowed visualisation of 
cluster-forming proteins, of which some were previously unknown to exhibit this 
characteristic (Lang & Rizzoli, 2010). While large clusters are often apparent in 
the reconstructed images, small clusters can be difficult to distinguish from 
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randomly distributed points. It is therefore necessary to mathematically analyse 
and quantify the spatial point pattern that is obtained in SMLM. In this study, 
this was achieved using two different methods: Ripley’s K function analysis and 
Bayesian cluster analysis. 
5.1.3.1 Ripley’s K Function Analysis 
Ripley’s K function analysis was first published by Brian Ripley in 1976 (Ripley, 
1976) and is described as  
n is the number of points, NPi is the number of points within a distance r of 
another point and A is the area. When a number of points n is distributed in an 
area A, it can be determined with the help of equation (5-3) whether these 
points are either randomly distributed, or comparatively scattered or clustered 
(Kiskowski et al., 2009). A circle with the radius r is drawn around each point 
and the points that lie within this circle are counted. The K values are plotted 
against r and the resulting graph indicates the type of distribution. For a random 
distribution, this graph is a parabola, for more clustered points it becomes 
steeper and for more scattered points it becomes flatter. The L value is the 
normalised K value and is derived from equation (5-3) by 
The L value plotted over r produces a straight line if the points follow a random 
distribution. In case of clustering, the graph is bent (Kiskowski et al., 2009). 
Ripley’s K function analysis is very easy to realise, and data can be obtained 
rapidly. It is the method of choice when it comes to cluster analysis and is very 
commonly used in many fields of biology (Gao et al., 2017; Hess et al., 2005; 
Prior et al., 2003). 
 K(r) =
1
n
∑Npi(r)/A
n
i=1
 (5-3) 
 L(r) = √K(r)/π (5-4) 
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5.1.3.2 Bayesian Cluster Analysis 
SMLM data points come with a value that describes their precision, which is 
called uncertainty (Ovesný et al., 2014; Thompson et al., 2002). This value is not 
considered for Ripley’s and other popular types of cluster analysis. The group of 
Dylan Owen therefore developed an approach based on Bayesian cluster analysis 
to analyse SMLM data (Griffié et al., 2016). Based on the K function, their 
program generates several thousand of cluster proposals, which are evaluated 
against the original data set. The cluster model that approximates the data best 
is chosen to represent it (Rubin-Delanchy et al., 2015). While this approach 
delivers more precise results than Ripley’s K function analysis, it is also very 
time consuming and requires much more computing power. 
5.1.4 Hypothesis and Aims 
One key aim of this work was to find an assay that allows light microscopic 
visualisation and quantification of GLUT4 clusters in basal 3T3 L1 adipocytes and 
dispersal of the transporter in response to insulin. Conventional TIRFM was not 
powerful enough to resolve the clusters in the membrane and SpIDA showed that 
the clustering is not dependant on the oligomeric state of GLUT4. By going 
beyond the diffraction limit using STORM, we hoped to achieve a resolution low 
enough to resolve GLUT4 clusters in the plasma membrane and use this as an 
assay for the quantification of their dispersal. Subsequently, we made further 
inquiries into the molecular mechanisms behind the dispersal. For this, we 
investigated the role of EFR3 in the clustering mechanism as outlined in sections 
1.7.7 and 1.8. Once STORM was established as a suitable assay, we knocked 
down EFR3 in 3T3 L1 adipocytes and analysed the altered clustering 
characteristics of the transporter. We also carried out experiments with the 
lectin Galectin-3. It has been shown that this protein directly binds to the insulin 
receptor and causes insulin resistance in mice as well as in cell models (P. Li et 
al., 2016). With the help of STORM, we investigated, whether Galectin-3 also has 
an influence on the clustering behaviour, which would give further insights into 
the nature of GLUT4 clustering. 
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5.2 Results 
5.2.1 Insulin Regulates GLUT4 Dispersal 
The cell line used in this chapter was the same HA-GLUT4-GFP 3T3 L1 cell line 
that was used in Chapter 3. In section 3.2.1, specifically Figure 3.6 the cells’ 
response to insulin was outlined. HA-GLUT4-GFP translocated to the cell surface 
and integrated itself in the plasma membrane as expected. This could be 
visualised by HA surface staining and quantified by measuring the fluorescence 
intensity of the blue HA ring around the cells. 
  
 
  
Figure 5.4 STORM Images of Surface GLUT4 in Basal and Insulin Stimulated 3T3 L1 
Adipocytes 
HA-GLUT4-GFP 3T3s were incubated in serum-free medium for 2 h prior to the experiment and 
stimulated with 100 nM insulin for 20 min or left untreated. Cells were then fixed and stained for 
surface HA as described in section 2.2.2.3. dSTORM image acquisition and analysis was carried 
out as described in section 2.2.7.3. Raw datasets were processed using the ImageJ plugin 
ThunderSTORM (see 2.2.8.4) to obtain scatterplots showing single molecules. A: Representative 
scatterplot of a basal cell. Scalebar: 5 μm. B: Magnified section of image A. C: Representative 
scatterplot of an insulin stimulated cell. Scalebar: 5 μm D: Magnified section of image C. 
A B 
C D 
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Figure 5.5 STORM Localisation Density in Basal and Insulin Stimulated 3T3 L1 Adipocytes 
HA-GLUT4-GFP 3T3s were incubated in serum-free medium for 2 h prior to the experiment and 
stimulated with 100 nM insulin for 20 min or left untreated. Cells were then fixed and stained for 
surface HA as described in section 2.2.2.3. dSTORM image acquisition and analysis was carried 
out as described in section 2.2.7.3. Raw datasets were processed using the ImageJ plugin 
ThunderSTORM and the localisation density was determined using the ImageJ plugin 
LocFileVisualizer (see 2.2.8.4). 10 ROIs where the localisations appeared homogenous were 
chosen per cell to carry out this analysis. Basal: 1158 ± 70 (n = 80) Insulin: 2283 ± 120 (n = 80). 
Mean ± SE. Unpaired two-tailed t-test 95 % confidence intervals p < 0.0001. This experiment was 
repeated four times with similar results. 
Essentially the same experiment was carried out for STORM and the obtained 
data was subjected to cluster analysis. Under STORM conditions, the footprint of 
the cells was well defined and initial background blinking could be mostly 
eliminated by simultaneously turning on the 405 nm laser at low power together 
with the 640 nm excitation laser. Figure 5.4 shows the spatial pattern of a HA-
GLUT4-GFP 3T3 L1 adipocyte in the basal state and another cell after insulin 
stimulation as well as a zoomed in image of each cell. The reconstructed images 
show single molecules as well as clusters of HA-GLUT4-GFP. Under basal 
conditions, there were notably more clusters and denser clusters, whereas the 
insulin stimulated cells showed a more dispersed pattern and more single 
molecules.  
As insulin stimulation leads to GLUT4 translocation in adipocytes, the signal 
density was expected to be higher in stimulated cells. This was confirmed by 
determination of the localisation density in μm-2 and the result is shown in 
Figure 5.5. The localisation density almost doubled from 1158 localisations per 
μm2 in the basal state to 2283 per μm2 after insulin stimulation. It is important 
to note that the localisation density is not an accurate measurement of antigen 
concentration, which is explained in more detail in section 5.3. 
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The STORM data underwent Bayesian cluster analysis. For this, 3 x 3 μm sized 
ROIs of STORM images were analysed to determine the percentage of molecules 
in clusters, the number of clusters per ROI, the mean number of molecules per 
cluster, and the mean radius of clusters in nm. The frequency distributions of 
the obtained results are shown in Figure 5.6. In the vast majority of ROIs in basal 
cells, 50 % of molecules were found in clusters, with fewer ROIs showing 25 % 
and 75 % of molecules in clusters. After insulin stimulation, only slightly more 
than half of the ROIs showed 50 % of molecules in clusters and some ROIs did not 
include any clusters at all, indicating that more molecules were dispersed in the 
insulin stimulated state. Similarly, the frequency distribution for the number of 
clusters per ROI shifted towards the right after insulin stimulation, which shows 
that more ROIs contained indeed fewer clusters in the insulin stimulated state 
than under basal conditions. The clusters themselves exhibited less molecules 
per cluster after insulin treatment, indicating that they decreased in size. A 
result which was also reflected in the frequency distribution of the mean cluster 
radius. More clusters were smaller than 50 nm after insulin stimulation than in 
the basal state. A few ROIs showed large clusters, some of them of more than 
350 nm radius. These clusters could either be artefacts of the Bayesian 
approach, or signify dispersing clusters, which would be less compact and 
therefore appear larger. 
Bayesian cluster analysis such as that shown in Figure 5.6 delivered interesting 
results and compelling evidence that insulin stimulation indeed leads to dispersal 
of GLUT4 out of clusters in the plasma membrane. However, the approach based 
on the protocol provided by Griffié et al. (2016) was immensely time-consuming 
and not practicable for large data sets. For this reason, we decided to rely on 
Ripley’s K function analysis for further investigations.  
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Figure 5.6 Bayesian Cluster Analysis of Basal and Insulin Stimulated 3T3 L1 Adipocytes  
HA-GLUT4-GFP 3T3s were incubated in serum-free medium for 2 h prior to the experiment and 
stimulated with 100 nM insulin for 20 min or left untreated. Cells were then fixed and stained for 
surface HA as described in section 2.2.2.3. dSTORM image acquisition and analysis was carried 
out as described in section 2.2.7.3. Raw datasets were processed using the ImageJ plugin 
ThunderSTORM (see 2.2.8.4) and the raw data was subjected to Bayesian cluster analysis. 
Basal cells: Black, left, n = 8; Insulin stimulated: White, right, n = 9. 4 ROIs of 3x3 µm size per 
cell were analysed. The bar graphs shown here are frequency distributions, the values shown on 
the x-axes are the bin centres of these frequency distributions. Chi Square tests with 95 % 
confidence intervals were carried out to determine whether differences between the distributions 
were significant A: Percentage of molecules in clusters, bin width: 25 %, p = 0.002. B: Number of 
clusters per ROI, bin width: 10, p < 0.0001. C: Mean number of molecules per cluster, bin width: 
20, p = 0.0001. D: Mean radius of clusters in nm, bin width: 50 nm, p < 0.0001. This experiment 
was repeated twice with similar results. 
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Figure 5.7 Ripley's K-Function Analysis of Basal and Insulin Stimulated 3T3 L1 Adipocytes 
HA-GLUT4-GFP 3T3s were incubated in serum-free medium for 2 h prior to the experiment and 
stimulated with 100 nM insulin for 20 min or left untreated. Cells were then fixed and stained for 
surface HA as described in section 2.2.2.3. dSTORM image acquisition and analysis was carried 
out as described in section 2.2.7.3. Raw datasets were processed using the ImageJ plugin 
ThunderSTORM (see 2.2.8.4) and the obtained data was subjected to Ripley’s K-function analysis 
with the minimum radius 10 nm, step radius 10 nm, and maximum radius 200 nm. Displayed is the 
L value Basal cells: Blue, n = 8; Insulin stimulated: Red, n = 9. Data Points are Mean ± SE. This 
experiment was repeated four times with similar results. A: L values. The curves were compared by 
an unpaired two-tailed t-test with 95 % confidence intervals p = 0.0011 B: L values with linear 
trendline and corresponding R2. 
The results obtained by Ripley’s K function analysis for basal and insulin 
stimulated 3T3 L1 adipocytes are summarised in Figure 5.7. As described in 
section 5.1.3.1, the obtained L value plotted over the radius results in a straight 
line for randomly distributed points. A clustered distribution, on the other hand, 
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delivers a curved graph. For simplicity, the degree of curvature of the two 
graphs was approximated by calculating a linear trendline and its R2 value. R2 is 
an indicator of how well a trendline fits the data set: The closer R2 is to 1, the 
better the fit. In our case, this means that the curvature of the graph is stronger 
when R2<<1. The blue graph in Figure 5.7 represents the L value obtained from 
basal cells and is strongly curved, with R2 = 0.66 suggesting a clustered 
distribution of GLUT4 in the cell membrane. Results for insulin stimulated cells 
are shown in red. This graph is also curved, however, less so than the basal 
(blue) one, signified by its greater R2 = 0.85, indicating a less clustered 
distribution of molecules. The curves were compared by an unpaired two-tailed 
t-test and showed a significant difference, confirming this observation. As the K 
value, and therefore the L value, is a function of the reciprocal number of points 
(see equation (5-3)), the apparent maximum of the plotted L value is higher for 
a smaller number of localisations. The difference in maxima in Figure 5.7 is 
therefore due to the increased number of HA-GLUT4-GFP molecules and 
subsequently the increased number of localisations. 
5.2.2 Galectin-3 Inhibits GLUT4 Clustering 
Lectins are proteins that bind to specific carbohydrates, in the case of Galectins, 
these are β-galactoside sugars. Galectins are expressed by many tissues, but 
even though there are many glycoconjugates containing a β-galactoside sugar, in 
vitro binding assays have shown that the interactions of galectins with their 
targets are more specific (Barondes et al., 1994). Galectin-3 is highly expressed 
in and secreted by macrophages, which are known to be elevated in adipose 
tissue of obese and insulin resistant individuals (Weisberg et al., 2003). The 
presence of macrophages in this tissue is linked to inflammation, which is 
related to obesity-induced insulin resistance (Patsouris et al., 2008). 
Based on these findings, Galectin-3 was investigated with regards to its ability to 
bind the insulin receptor and it was found that this interaction can induce 
insulin-resistance in 3T3 L1 adipocytes (P. Li et al., 2016). Quantification of this 
data is shown in Figure 5.8 E. Although a reduction in basal HA-staining is 
apparent from this graph, it is important to note that the very low HA-staining 
intensity in the absence of insulin means the HA/GFP ratio is skewed by small 
alterations in a small signal. Nevertheless, our data confirms that Galectin-3 
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reduces the magnitude of insulin-stimulated GLUT4 translocation, consistent 
with an effect on glucose transport published by others (P. Li et al., 2016).We 
therefore investigated whether Galectin-3 also has an influence on the clustering 
of GLUT4 in the plasma membrane. From section 5.2.1, it is known that GLUT4 
dispersal in the membrane is controlled by insulin. Galectin-3 may reduce this 
dispersal, which could result in re-endocytosis of the clustered transporter. This 
would explain the results in Figure 5.8. We carried out STORM, followed by 
ThunderSTORM image processing and Ripley’s K function analysis. The result is 
depicted in Figure 5.9. Similar to Figure 5.7, the L values for the control basal 
cells show the typical curvature of clustered points, whereas the graph for 
insulin stimulated cells is less curved and approximates more a straight line, 
which indicates dispersal. Again, this was verified by R2 values, which was much 
larger for the insulin stimulated cells than for the basal data set.  
The graphs for Galectin-3 treated cells both show a similar progression. Both 
data sets have a similar number of localisations, which is reflected in the 
maxima and both show a similar dispersal pattern, which is related to the 
curvature of the graphs and hence the R2 value of the linear regression. Carrying 
out t-test on the curves confirmed this observation. According to these graphs, 
Galectin-3 treatment lead to inhibited GLUT4 translocation, which was already 
apparent from Figure 5.8. In addition, the dispersal in the plasma membrane 
appeared to be disrupted. Galectin was found to inhibit insulin-stimulated 
glucose uptake in 3T3 L1 adipocytes (P. Li et al., 2016). To confirm this result, 
we focused on the effect of Galectin-3 on the translocation of HA-GLUT4-GFP to 
the plasma membrane of 3T3 L1 adipocytes. Figure 5.8 A-D shows confocal 
images of HA-surface stained 3T3 L1 adipocytes in the basal and insulin 
stimulated state with and without Galectin-3 treatment. Comparing the 
HA/GLUT4 ratios clearly shows that Galectin-3 treated adipocytes exhibited 
reduced insulin-stimulated HA-GLUT4-GFP translocation.  
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Figure 5.8 HA-Surface Staining in Galectin-3 Treated 3T3 L1 Adipocytes 
HA-GLUT4-GFP 3T3 L1 adipocytes were serum starved in the presence of 1.25 μg·ml-1 Galectin-3 
for 4 h or without Galectin-3 (control) and then stimulated with 100 nM insulin for 20 min or left 
untreated. Cells were then fixed and stained for surface HA as described in section 2.2.2.2. A: 
Representative image of control basal cells B: Representative image of control cells stimulated with 
insulin C: Representative image of Galectin-3 treated basal cells D: Representative image of 
Galecin-3 and insulin treated cells E: HA/G4 ratio, Basal: 0.10 ± 0.02 (n = 15) Insulin: 0.52 ± 0.03 
(n = 15). Gal3 Basal: 0.04 ± 0.02 (n = 15) Gal3 Insulin: 0.36 ± 0.03 (n = 15) Mean ± SE. Unpaired 
two-tailed t-test 95 % confidence intervals: Basal vs Insulin p < 0.0001, Gal3 Basal vs Gal3 Insulin 
p < 0.0001, Basal vs Gal3 Basal p = 0.0413, Insulin vs Gal3 Insulin p = 0.0006. 
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Figure 5.9 Ripley's K-Function Analysis of Galectin-3 Treated Basal and Insulin Stimulated 
3T3 L1 Adipocytes 
HA-GLUT4-GFP 3T3 L1 adipocytes were serum starved in the presence of 1.25 μg·ml-1 Galectin-3 
for 4 h or without Galectin-3 (control) and then stimulated with 100 nM insulin for 20 min or left 
untreated. Cells were then fixed and stained for surface HA as described in section 2.2.2.3. 
dSTORM image acquisition and analysis was carried out as described in section 2.2.7.3. Raw 
datasets were processed using the ImageJ plugin ThunderSTORM (see 2.2.8.4) and the data was 
subjected to Ripley’s K-function analysis with the minimum radius 10 nm, step radius 10 nm, and 
maximum radius 200 nm. Displayed is the L value. Basal: Blue, Insulin stimulated: Red, Control: 
Solid line, Galectin-3 treated: Dashed line, n = 8. Data Points are Mean ± SE. This experiment was 
repeated twice with similar results. A: L values. The curves were compared by unpaired two-tailed 
t-tests with 95 % confidence intervals. Basal control vs Insulin control: p = 0.0004, Basal Galectin-3 
vs Insulin Galectin-3: p = 0.4022 (not significant).B: L values with linear trendline and 
corresponding R2.  
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5.2.3 EFR3a Knock-Down in 3T3 L1 Adipocytes 
Previously, a robust electroporation method had been established in our group, 
with which EFR3a could be efficiently knocked down in differentiated 3T3 L1 
adipocytes (Laidlaw, 2018). The protocol was used in this section. The knock-
down efficiency and a potential effect on levels of other GSV components 
GLUT4, Syntaxin16 (Stx16), and SNAP23 were determined via immunoblotting. In 
a negative control experiment, electroporation was carried out with water 
instead of siRNA to account for possible effects of the procedure on protein 
concentrations. A representative immunoblot as well as levels of the proteins of 
interest normalised to the level of the housekeeping protein GAPDH are shown in 
Figure 5.10. 
Consistent with Laidlaw (2018) a 50 % knock-down of EFR3a could be achieved by 
electroporation. As expected, levels of GAPDH remained constant, so this 
protein could be used to normalise and quantify levels of the GSV proteins and 
EFR3a. GLUT4, Stx16, and SNAP23 did not change and levels of these proteins 
remained constant. 
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Figure 5.10 EFR3a Knock-Down in 3T3 L1 Adipocytes 
EFR3a knock-down was carried out as described in section 2.2.1.7 in HA-GLUT4-GFP 3T3 L1 
adipocytes. In a control experiment water was used instead of siRNA. 72 h later, knock-down 
efficiency was determined by immunoblotting for EFR3a as described in 2.2.5. Immunoblots for 
Stx16, SNAP23, and GLUT4 were carried out to examine the effect of EFR3a knock-down on other 
GSV components. GAPDH was used as a housekeeping protein. A: Representative Immunoblots. 
Marker, three replicates of the control sample, three replicates of EFR3a knock-down. Complete 
immunoblots can be found in the Appendix B: Signal ratio of each protein of interest to the 
housekeeping protein GAPDH and normalised to the negative control experiment. The experiment 
was carried out four times with similar results. Signal GAPDH ratio: EFR3a: 0.58 ± 0.03 p < 0.0001, 
GLUT4: 0.75 ± 0.20 p = 0.2506, Stx16: 1.01 ± 0.06 p = 0.8021, SNAP23: 0.97 ± 0.09 p = 0.7429. 
Unpaired two-tailed t-test 95 % confidence intervals. 
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5.2.4 EFR3a Controls Insulin Regulated GLUT4 Dispersal 
The clustering behaviour of GLUT4 in EFR3a knock-down cells was investigated 
via STORM. Electroporation is a very aggressive transfection technique that kills 
a fraction of the cells and can have other adverse effects. For example, 
electroporated cells are often smaller than untreated cells, whether this is due 
to electroporation or if electroporation kills predominantly big cells, is unknown. 
To rule out possible effects of electroporation on the dispersal behaviour, the 
negative control cells in this experiment also underwent electroporation. In this 
case, purified water was added instead of siRNA and the rest of the treatment 
was unaltered. 
The result of the cluster analysis is summarised in Figure 5.11. The control cells 
behaved as expected from Figure 5.7. The L value for basal cells was strongly 
curved which is reflected in the low R2 value, indicating a clustered distribution. 
Insulin stimulated cells on the other hand, showed a more linear graph with a 
lower maximum, which is the result of a more dispersed distribution of a higher 
number of points. 
Knock-down of EFR3a did not affect the basal L values, which still curved 
strongly. Interestingly, L values for insulin stimulated cells showed an almost 
identical distribution, suggesting that insulin stimulated dispersal of GLUT4 was 
completely inhibited by EFR3a knock-down. Statistical analysis of the curves via 
t-tests confirmed the observation.  
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Figure 5.11 Ripley's K-Function Analysis of EFR3a Knock-Down Basal and Insulin 
Stimulated 3T3 L1 Adipocytes 
EFR3a knock-down was carried out as described in section 2.2.1.7 in HA-GLUT4-GFP 3T3 L1 
adipocytes. In a control experiment water was used instead of siRNA. After 72 h, cells were 
incubated in serum-free medium for 2 h prior to the experiment and stimulated with 100 nM insulin 
for 20 min or left untreated. Cells were then fixed and stained for surface HA as described in 
section 2.2.2.3. dSTORM image acquisition and analysis was carried out as described in section 
2.2.7.3. Raw datasets were processed using the ImageJ plugin ThunderSTORM (see 2.2.8.4) and 
the data was subjected to Ripley’s K-function analysis with the minimum radius 10 nm, step radius 
10 nm, and maximum radius 200 nm. Displayed is the L value. Basal: Blue, Insulin stimulated: Red, 
Control: Solid line, EFR3a knock-down: Dashed line, n = 10. Data Points are Mean ± SE. This 
experiment was repeated three times with similar results. A: L values. The curves were compared 
by unpaired two-tailed t-test with 95 % confidence intervals. Basal control vs Insulin control: 
p = 0.0061, Basal Efr3a kd vs Insulin Efr3a kd: p = 0.7955 (not significant). B: L values with linear 
trendline and corresponding R2.  
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5.3 Discussion 
Using STORM to go beyond the diffraction limit allowed us to visualise and 
analyse clusters of GLUT4 in the plasma membrane of 3T3 L1 adipocytes for the 
first time in our laboratory. With the techniques discussed in 2.2.2.3, 2.2.7.3, 
and 2.2.8.4, a robust assay was established in our group that offers the 
possibility to assay the dispersal of GLUT4 in the membrane in response to 
insulin. 
The method, however, is not without flaws and artefacts are common in STORM 
imaging. Depending on the sample preparation, different clustering behaviours 
can be witnessed (Whelan & Bell, 2015), which is why careful and consistent 
sample preparation was especially important during this work. The quantified 
results reported in this chapter, especially cluster sizes obtained by Bayesian 
cluster analysis and localisation densities, are to be viewed critically.  
The nature of antibody staining provides another basis for false clustering. More 
than one antibody can bind to a protein, in addition, each antibody can be 
tagged with more than one fluorophore, which is often desirable in conventional 
fluorescence microscopy, as it amplifies the signal. When primary and secondary 
antibodies are used as in conventional fluorescence microscopy, the clustering 
effect of the antibody binding is magnified immensely. An additional problem is 
faced when the structures of interest are very dense and large antibodies 
sterically hinder themselves, so that labelling cannot be carried out efficiently 
(Kamiyama & Huang, 2012). These issues can be partially circumvented by using 
fab fragments or nanobodies for labelling (Ries et al., 2012), but these smaller 
probes are only available for a small number of targets at the moment, HA not 
being one of them. Another source of clustering artefacts is the blinking 
behaviour of the fluorophores as this allows for multiple localisations of one and 
the same fluorophore (Annibale et al., 2011). The localisation density is also 
subject to imaging parameters, such as laser power and number of frames. 
However, all these parameters were kept consistent throughout each data set. 
Since this work focused on the changing clustering behaviour between two 
states, basal and insulin stimulated, issues around clustering artefacts were less 
critical as long as sample preparation was carried out simultaneously for all 
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samples of each data set. It is, however, important to note that the reported 
results of this work are always considered in a comparative manner and never as 
absolute values. This is particularly vital for localisation densities and cluster 
sizes. 
Confirming the published results from Gao et al. (2017), we found that GLUT4 is 
predominantly located in clusters in the plasma membrane of 3T3 L1 adipocytes, 
which disperse upon insulin stimulation. By applying the technique to Galectin-3 
treated and EFR3a knock-down cells, we hoped to gain further insights into the 
molecular mechanisms behind the dispersal. 
With their discovery that Galectin-3 causes insulin resistance in mice and also in 
cell models such as 3T3 L1 adipocytes, Li et al. (2016) provided a link between 
inflammatory diseases and insulin resistance. They showed that Galectin-3 
knockout in mice led to decreased levels of inflammation as well as improved 
insulin sensitivity. In 3T3 L1 adipocytes and L6 myocytes, they found that insulin 
stimulated glucose uptake is significantly diminished after Galectin-3 treatment 
in a dose-dependent manner. Our results indicate that this is due to both 
corrupted GLUT4 translocation and impaired dispersal in the membrane, since 
both mechanisms are disrupted following Galectin-3 treatment. Galectin-3 binds 
directly to the insulin receptor and thus inhibits its autophosphorylation as well 
as the stimulation and phosphorylation of the downstream targets PDK1 and Akt 
respectively (P. Li et al., 2016). Our findings substantiate the hypothesis that 
insulin regulates glucose uptake by dispersal of GLUT4 in the membrane and 
dispersal appears to be directly enabled by the signalling cascade initiated by 
insulin binding to its receptor. 
EFR3 is a protein that has been characterised in adipocytes and extensively 
studied in our laboratory in the context of insulin mediated glucose uptake by 
Laidlaw (2018). There are two homologues, EFR3a and b (Bojjireddy et al., 
2014), and 3T3 L1 adipocytes express predominantly EFR3a (Laidlaw, 2018). 
Laidlaw found the protein localised in the plasma membrane of this cell type 
and there was no redistribution following insulin stimulation, indicating that 
whatever role EFR3a plays in GLUT4 trafficking, is limited to the plasma 
membrane and EFR3a does not translocate to the plasma membrane as GSV or 
other vesicle cargo. Overexpression of EFR3a lead to increased GLUT4 
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translocation in HeLa cells and 3T3 L1 adipocytes, overexpression of a dominant 
negative mutant, on the other hand, inhibited insulin-stimulated GLUT4 
translocation. In addition, the knock-down of EFR3a in 3T3 L1 adipocytes lead to 
significantly diminished glucose uptake in response to insulin. 
The work discussed in this chapter adds to these results. EFR3a knock-down by 
electroporation delivered a similar extend of knock-down as reported by Laidlaw 
(50 – 60 %, Laidlaw 2018). In addition, levels of the GSV proteins GLUT4, 
Syntaxin16, IRAP, and SNAP23 after EFR3a knock-down were determined in order 
to study the effect EFR3a has on the expression of these proteins and by 
inference GSV formation. EFR3a knock-down did not have a significant effect on 
the levels of either of these proteins in whole cell lysates. This suggests that 
EFR3a acts independently from the GSV machinery and that none of these 
proteins compensate for the lack of EFR3a. It is important to note that the level 
of the plasma membrane SNARE SNAP23, known to be important for fusion of 
GSVs with the plasma membrane was also unaffected by EFR3a knock-down, 
indicating that a generalised defect in the plasma membrane is unlikely to be in 
evidence. However, to exclude a role for any of these proteins entirely, further 
tests would be necessary. Subcellular fractionation and visualisation of the 
protein distribution by microscopy are two experiments that would add more 
depth to this result. 
We investigated the dispersal behaviour of GLUT4 in EFR3a knock-down cells and 
found that there was virtually no difference between basal and insulin 
stimulated cells. This was an exciting result, showing that EFR3a plays an 
important role in the clustering of GLUT4 in the cell membrane. Control 
experiments in which electroporation was carried out without the addition of 
siRNA had the same outcome as untreated cells, demonstrating that 
electroporation alone did not have an effect on GLUT4 clustering and dispersal 
in the membrane. The inhibition of dispersal is therefore very likely to be an 
effect of the EFR3a knock-down and it makes sense that the clustering is 
controlled by a membrane localised protein such as EFR3a. The fact that EFR3a 
knock-down also leads to inhibited glucose uptake makes it tempting to suggest 
that insulin sensitivity and therefore glucose uptake are controlled by clustering 
of GLUT4 in the plasma membrane of adipocytes. It appears as if the ability of 
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GLUT4 to transport glucose into the cell is diminished when the transporter is 
located in clusters, this may be due to a sterical hindrance of clustered GLUT4 
preventing the inward-outward conformational changes known to accompany 
transport (Barrett et al., 1999), but it could also be simply the fact that 
clustered GLUT4 is less evenly distributed, which allows for less contact with 
extracellular glucose molecules. Further experiments are necessary to answer 
these questions. The results presented in this chapter support our working 
hypothesis outlined in section 1.8: Knock-down of EFR3a inhibits GLUT4 
dispersal. This suggests that EFR3a is in fact the key component in the 
machinery involved in PI4P production, allowing PI4KIIIα to be active at the 
plasma membrane.  
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Chapter 6 SNARE Proteins Regulating 
Intracellular GLUT4 Trafficking 
6.1 Introduction 
6.1.1 The ERGIC is Involved in the GSC formation in Human Cells 
Chapter 1.4 described the cycling of GLUT4 between the GSC, the Golgi and 
endosomes, which is well characterised. Less is known about the initial 
formation of the GSC, which has been the subject of a recent study from this 
group, the Bryant group and the group of Frances Brodsky (Camus et al., 2020). 
Camus et al. found a link between GLUT4 cycling, GSC formation, and different 
clathrin isoforms. The isoform CHC17 is known to be involved in the re-
endocytosis of GLUT4 and protein sorting at the TGN in all mammals (Brodsky, 
2012). The clathrin isoform CHC22, however, is not as universally expressed. It is 
found at high levels in human myocytes and at lower levels in adipocytes, but it 
is not expressed in mouse cells, including 3T3 L1 adipocytes, a widely-used cell 
model for studying GLUT4 trafficking (Wakeham et al., 2005). Brodsky and 
colleagues showed that CHC22 colocalises with GLUT4 and other GSV proteins, 
such as GGA, VAMP2, and IRAP in HeLa cells. Furthermore, knock-down of CHC22 
in human myocytes results in reduced GLUT4 levels, a lower insulin-response, 
and apparent loss of the GSC (Vassilopoulos et al., 2009). These findings lead to 
the proposal that CHC22 plays a role in GLUT4 trafficking towards the GSC in 
human, but not in rodent, cells. In a recent study, Brodsky’s group found that 
CHC22 also interacts and/or colocalises with markers of the ERGIC, specifically 
p115, but there is no interaction or colocalisation with the Golgi marker GM130. 
Furthermore, CHC22 colocalised with newly synthesised GLUT4 in the 
perinuclear region, but was not observed in the GSC (Camus et al., 2020). These 
studies revealed that trafficking of GLUT4 requires CHC22 acting early in the 
secretory pathway at the ERGIC to deliver newly synthesised GLUT4 into GSVs. In 
these studies, it was observed that ERGIC membranes containing CHC22 were in 
close proximity to internalised GLUT4 after insulin-mediated release and 
compartments marked by Syntaxin 6. Hence, we believe that the pathway for 
delivery of newly synthesised GLUT4 (involving the ERGIC and CHC22) connects 
with GLUT4 re-internalised from endosomes in close proximity within the cell. 
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Figure 6.1 Model of Intracellular GLUT4 Trafficking in Human Cells 
1: GLUT4 is synthesised in the ER and traffics to the ERGIC. 2: Direct trafficking of GLUT4 into 
GSVs bypassing the Golgi and utilising CHC22, p115, and IRAP (orange box). 3: Endocytosis of 
GLUT4 4: intracellular GLUT4 recycling (see Figure 1.3), with multiple proteins being involved 
including IRAP, GGA etc, see orange box 5: GSVs translocate to the plasma membrane upon 
insulin stimulation. Figure provided by Gwyn Gould. 
Based on biochemical analysis, Camus et al. developed the model schematised in 
Figure 6.1: GLUT4 is newly synthesised in the ER and traffics together with IRAP 
and sortilin to the ERGIC. CHC22 then mediates the formation of the GSC, from 
where GSVs can translocate to the plasma membrane upon insulin stimulation. 
Re-endocytosis is then facilitated by the clathrin isoform CHC17 and GLUT4 
cycles between endosomes, the Golgi, the GSC, and the plasma membrane as 
previously discussed, involving a range of molecules including GGA, sortilin, IRAP 
and tankyrase (Sadler et al., 2019). 
6.1.2 SNAREs Involved in Intracellular Trafficking 
GLUT4 synthesis begins with the transcription of its gene, SLC2A4, to mRNA, 
which is then translated into an amino acid sequence by ribosomes bound to the 
ER. Subsequently, the protein is folded and glycosylated at its highly conserved 
exofacial glycosylation site in the ER and undergoes further post-translational 
modifications in the Golgi, which affect its function and trafficking in response 
to insulin (Sadler et al., 2013). In their recent study, Camus et al. (2020) have 
introduced the ERGIC as another organelle that is involved in GLUT4 synthesis. 
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SNARE proteins are employed when trafficking between these three organelles, 
the ER, the Golgi, and the ERGIC. Section 1.6.2 introduced SNARE proteins as key 
regulators of membrane fusion. SNARE proteins involved in the fusion of GSVs 
with the plasma membrane are clearly a crucial component of insulin signalling. 
However, SNARE proteins facilitating intracellular fusion of vesicle and target 
membranes must not be underestimated. Syntaxin 6 and 16 have been identified 
to play a critical role in intracellular GLUT4 trafficking. By overexpressing a 
dominant negative inhibitor of endogenous Syntaxin 6, it could be shown that 
this SNARE is involved in a step that sequesters GLUT4 away from the recycling 
pool with the plasma membrane (Perera et al., 2003). A similar study found that 
GLUT4 travels through a domain of the TGN enriched with Syntaxin 6 and 
Syntaxin 16, suggesting that these two SNAREs are involved in an intracellular 
sorting step of the glucose transporter (Shewan et al., 2003). Other SNAREs that 
are involved in these processes remain to be discovered. 
 
Figure 6.2 Intracellular Localisation of ERGIC-related SNARE proteins 
The SNARE proteins Bet1, Bet1L, GOSR1, GOSR2, SEC22A, SEC22B, SEC22C, Stx5, and 
Ykt6 and their intracellular localisation with regards to the ER, ERGIC, and Golgi. 
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The SNARE proteins BET1, BET1L, GOSR1, GOSR2, SEC22A, SEC22B, SEC22C, Stx5, 
and Ykt6 are known to be involved in ERGIC trafficking (Adnan et al., 2019; 
Appenzeller-Herzog & Hauri, 2006; Inoue et al., 2016; Linders et al., 2019; 
Zhang & Hong, 2001). Their intracellular location is outlined in Figure 6.2. 
6.1.3 Hypothesis and Aims 
This chapter seeks to evaluate the possible role of the previously mentioned 
SNARE proteins in GLUT4 sorting, extending the study of Camus et al. (2020) The 
involvement of the syntaxins Stx6 and Stx16 in GLUT4 trafficking is well 
characterised (Bryant & Gould, 2011; Hamilton, 2011; Perera et al., 2003; 
Shewan et al., 2003) hence they are also included in this analysis by way of 
comparison. 
Since GSC formation appears to be different in murine and human cells, this 
investigation could not be carried out in 3T3 L1 adipocytes but rather was 
undertaken in a human cell line. Additionally, 3T3 L1 adipocytes or other models 
for GLUT4 trafficking are difficult to genetically manipulate and were therefore 
deemed unsuitable for a larger scale screening as carried out in this study. Based 
on the results in Chapter 3 and the study by Camus et al., we used a stably 
expressing HA-GLUT4-GFP HeLa cell line for our investigations. Knock-down of 
aforementioned SNARE proteins was performed via lipofectamine transfection of 
siRNA duplexes and the degree of colocalisation of the GFP tagged GLUT4 with 
markers of the ER, the Golgi, and the ERGIC was determined using microscopy. 
In addition, the total GLUT4 content and intracellular dispersal patterns were 
compared. We used siRNA duplexes provided by Jeremy Simpson; the Simpson 
group have employed and validated this siRNA library for a genome-wide 
screening to identify proteins of the early secretory pathway (J. C. Simpson et 
al., 2012). 
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6.2 Results 
6.2.1 GLUT4 Colocalisation 
Knock-down of a SNARE protein that is involved in intracellular GLUT4 trafficking 
might be expected to result in an altered distribution of GLUT4 between the 
intracellular organelles. The following sections concentrate on the colocalisation 
of GFP-tagged GLUT4 with markers of the ERGIC (ERGIC-53), the ER (ID3), and 
the Golgi (GM130). These experiments were carried out employing conventional 
CLSM. 
6.2.1.1 GLUT4 Colocalisation with the ERGIC 
Using the ImageJ plugin JaCoP (Bolte & Cordelières, 2006), colocalisation 
between GLUT4 and the ERGIC marker ERGIC-53 was determined. For each 
experiment, 5 to 10 images were recorded that contained approximately 10 to 
20 cells each. Each experiment was carried out in 4 biological replicates. 
Representative images for ERGIC staining in the negative control experiment and 
the block control are shown in Figure 6.3. 
 
 
 
Figure 6.3 ERGIC and DAPI Staining of HA-GLUT4-GFP HeLa Cells (negative control) 
HA-GLUT4-GFP HeLa cells were cultured on a 96 well plate with glass bottom as outlined in 
section 2.2.1.1. siRNA knock-down was carried out as described in 2.2.1.6, shown here is an 
image of the negative control cells, where siRNA was replaced by water. Cells were fixed and 
stained with an antibody for the ERGIC marker ERGIC-53 and the nucleus was stained with DAPI 
as described in 2.2.2.1. Images were acquired on a confocal microscope and show GLUT4-GFP, 
the ERGIC staining, the nucleus staining (DAPI) and a merge of all three channels. 
A: Representative image of ERGIC staining B: Zoomed in image from A to show colocalisation C: 
Representative image of block control without primary antibody.  
GLUT4-GFP ERGIC-53 
DAPI Merge 
ERGIC-53 
Merge 
A C 
B 
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Figure 6.3 A shows the ERGIC-53 staining we typically observed in HeLa cells. 
DAPI was used for the staining of the nuclei. Similar to the ER, the ERGIC is 
broadly distributed within the entire cell. This is in fact atypical; typically, the 
ERGIC staining is more prominent in the perinuclear region. The atypical staining 
here may be attributed to lower antibody concentrations. The green channel 
shows the distribution of GFP-tagged GLUT4, which is also present throughout 
the cell and predominantly expressed in the perinuclear region. Figure 6.3 B 
shows a representative control experiment, in which the cells were not 
incubated with the primary antibody. This experiment was carried out to control 
that blocking of the sample was sufficient to prevent any staining derived from 
non-specific binding of the secondary antibody.  
The data from all four separate experiments were pooled and normalised to the 
average of the negative control and 2-way ANOVA was carried out to determine 
statistical significance. The result is summarised in Figure 6.4. If values are 
significantly higher than the negative control after SNARE knock-down, this 
indicates an accumulation of GLUT4 in the ERGIC possibly due to the respective 
SNARE enabling downstream trafficking of GLUT4.  
 
Figure 6.4 GLUT4/ERGIC Colocalisation 
HA-GLUT4-GFP HeLa cells were cultured on a 96 well plate with glass bottom as outlined in 
section 2.2.1.1. siRNA knock-down was carried out as described in 2.2.1.6. Cells were fixed and 
stained with an antibody for the ERGIC marker ERGIC-53 and two consecutive images were 
acquired by confocal microscopy. Colocalisation of GLUT4-GFP and ERGIC-53 was determined 
using the ImageJ plugin JaCoP (see 2.2.8.3). Between 5 and 10 sets of images were analysed per 
knock-down and each experiment was carried out in four biological replicates. The data of all four 
experiments was pooled and normalised to the average value of the negative control experiment 
and 2-way ANOVA with 95 % confidence intervals was carried out for statistical analysis. GOSR1: 
p = 0.0115 
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Similarly, lower colocalisation values suggest that GLUT4 is accumulating 
upstream of the ERGIC with the respective SNARE protein being involved in this 
part of GLUT4 trafficking. According to Figure 6.4, only the knock-down of 
GOSR1 lead to significant decrease of colocalisation of GLUT4 and ERGIC-53, 
suggesting that this SNARE protein is involved in GLUT4 trafficking upstream of 
the ERGIC. The knock-down of Stx6 also lead to a notable decrease in 
colocalisation, however, with p = 0.07, this did not reach statistical significance. 
6.2.1.2 GLUT4 Colocalisation with the ER 
Similar to the ERGIC staining, Figure 6.5 A shows HA-GLUT4-GFP HeLa cells 
stained with the ER marker ID3. As expected, the staining is broadly dispersed 
within the cells and the control experiment in panel B shows that there is no 
non-specific binding of the secondary antibody. 
Similar to the experiment shown in Figure 6.4, colocalisation of GLUT4 with the 
ER was determined. The results are summarised in Figure 6.6. Decreased 
colocalisation values, compared to the negative control, would suggest that the 
respective SNARE is involved in GLUT4 trafficking upstream of the ER, whereas 
increased colocalisation is an indicator for a role downstream between the ER 
and the ERGIC. The raw data of all four experiments were pooled and depicted 
as fold change compared to the negative control experiment. Statistical analysis 
using 2-way ANOVA did not show any significant changes of the colocalisation of 
GLUT4 and the ER-marker ID3 after knock-down of the investigated SNAREs. 
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Figure 6.5 ER and DAPI Staining of HA-GLUT4-GFP HeLa Cells (negative control)  
HA-GLUT4-GFP HeLa cells were cultured on a 96 well plate with glass bottom as outlined in 
section 2.2.1.1. siRNA knock-down was carried out as described in 2.2.1.6, shown here is an 
image of the negative control cells, where siRNA was replaced by water. Cells were fixed and 
stained with an antibody for the ER marker ID3 and the nucleus was stained with DAPI as 
described in 2.2.2.1. Images were acquired on a confocal microscope and show GLUT4-GFP, the 
ER staining, the nucleus staining (DAPI) and a merge of all three channels. A: Representative 
image of ER staining B: Zoomed in image from A to show colocalisation C: Representative image 
of block control without primary antibody.  
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Figure 6.6 GLUT4/ER Colocalisation 
HA-GLUT4-GFP HeLa cells were cultured on a 96 well plate with glass bottom as outlined in 
section 2.2.1.1. siRNA knock-down was carried out as described in 2.2.1.6. Cells were fixed and 
stained with an antibody for the ER marker ID3 and two consecutive images were acquired by 
confocal microscopy. Colocalisation of GLUT4-GFP and ID3 was determined using the ImageJ 
plugin JaCoP (see 2.2.8.3). Between 5 and 10 sets of images were analysed per knock-down and 
each experiment was carried out in four biological replicates. The data of all four experiments was 
pooled and normalised to the average value of the negative control experiment and 2-way ANOVA 
with 95 % confidence intervals was carried out for statistical analysis. There were no significant 
changes compared to the negative control. 
GLUT4-GFP ID3 
DAPI Merge 
ID3 
Merge 
A C 
B 
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6.2.1.3 GLUT4 Colocalisation with the Golgi 
Finally, colocalisation of GFP-tagged GLUT4 with GM130, a marker of the Golgi, 
was investigated in a third set of experiments. Figure 6.7 shows the Golgi 
staining, which is notably different from the ERGIC and ER staining in Figure 6.3 
and Figure 6.5, respectively. As expected, the Golgi is localised in a perinuclear 
region and is not as widely distributed as other organelles. The control 
experiment in panel B showed once again that there was very limited non-
specific binding of the secondary antibody. Colocalisation data was obtained as 
previously described and is summarised in Figure 6.8. Decreased colocalisation 
compared to the negative control after knock-down would argue for an 
accumulation of GLUT4 upstream of the Golgi, while an increase would signify an 
involvement of the respective SNARE downstream of the Golgi. The experiment 
was carried out in four biological replicates and the data was pooled and 
normalised to the average colocalisation value of the negative control. 
Statistical analysis was conducted by 2-way ANOVA and the result is depicted in 
Figure 6.8. According to this data, the knock-down of Ykt6 lead to a significant 
increase in colocalisation of GLUT4 and the Golgi, indicating that the SNARE 
protein is involved in GLUT4 trafficking downstream of the Golgi. 
 
 
 
Figure 6.7 Golgi and DAPI Staining of HA-GLUT4-GFP HeLa Cells (negative control) 
HA-GLUT4-GFP HeLa cells were cultured on a 96 well plate with glass bottom as outlined in 
section 2.2.1.1. siRNA knock-down was carried out as described in 2.2.1.6, shown here is an 
image of the negative control cells, where siRNA was replaced by water. Cells were fixed and 
stained with an antibody for the Golgi marker GM130 and the nucleus was stained with DAPI as 
described in 2.2.2.1. Images were acquired on a confocal microscope and show GLUT4-GFP, the 
Golgi staining, the nucleus staining (DAPI) and a merge of all three channels. A: Representative 
image of Golgi staining B: Zoomed in image from A to show colocalisation C:  Representative 
image of block control without primary antibody.  
GLUT4-GFP GM130 
DAPI Merge 
A 
GM130 
Merge 
C 
B 
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Figure 6.8 GLUT4/Golgi Colocalisation 
HA-GLUT4-GFP HeLa cells were cultured on a 96 well plate with glass bottom as outlined in 
section 2.2.1.1. siRNA knock-down was carried out as described in 2.2.1.6. Cells were fixed and 
stained with an antibody for the Golgi marker GM130 and two consecutive images were acquired 
by confocal microscopy. Colocalisation of GLUT4-GFP and GM130 was determined using the 
ImageJ plugin JaCoP (see 2.2.8.3). Between 5 and 10 sets of images were analysed per knock-
down and each experiment was carried out in four biological replicates. The data of all four 
experiments was pooled and normalised to the average value of the negative control experiment 
and 2-way ANOVA with 95 % confidence intervals was carried out for statistical analysis. Ykt6: 
p = 0.0036. 
6.2.2 Total GLUT4 Levels after SNARE Knock-Down 
We were interested in the total levels of GLUT4 after the knock-down of the 
aforementioned SNAREs. Traditionally, levels would be determined via western 
blot analysis. However, we chose to remain true to the central microscopy 
theme of this thesis and calculated the total GLUT4 levels as a ratio of the 
GLUT4-GFP fluorescence over DAPI signal (nucleus staining). The results of four 
separate experiments are shown in Figure 6.9. An augmented GLUT4/DAPI ratio 
signify increased GLUT4 expression, possibly as a compensation mechanism for 
disturbed intracellular GLUT4 trafficking. Reduced values on the other hand, 
indicate diminished GLUT4 levels, which could be due to impaired GLUT4 
synthesis. 
Chapter 6 156 
 
 
Figure 6.9 Total GLUT4 Levels after siRNA Knock-Down 
HA-GLUT4-GFP HeLa cells were cultured on a 96 well plate with glass bottom as outlined in 
section 2.2.1.1. siRNA knock-down was carried out as described in 2.2.1.6. Cells were fixed and 
the nucleus stained with DAPI. Total GLUT4 levels were compared by determining the ratio of 
DAPI signal over GLUT4-GFP signal. Between 5 and 10 sets of images were analysed per knock-
down. Data of all four experiments was pooled and normalised to the average value of the negative 
control experiment. 2-way ANOVA with 95 % confidence intervals was carried out for statistical 
analysis. GOSR1: p = 0.0115. 
The experiment was repeated four times and the data points were normalised to 
the average negative control GLUT4/DAPI ratio, which is shown in Figure 6.9. 
Statistical analysis by 2-way ANOVA revealed a significant increase of 
GLUT4/DAPI ratio, and hence an increase in GLUT4 expression, after knock-down 
of GOSR1. 
6.2.3 Intracellular GLUT4 Distribution After SNARE Knock-Down 
The intracellular distribution of GLUT4 was examined visually after knock-down 
of those SNARE proteins that had been identified in 6.2.1 and 6.2.2, namely 
GOSR1 and Ykt6. Images of negative control cells as well as knock-down cells are 
depicted in Figure 6.10. Additionally, single cells were selected from each 
knock-down as well as from the negative control and an intensity profile of the 
GLUT4-GFP signal of each cell was generated in ImageJ, which is also shown. 
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Figure 6.10 Intracellular GLUT4 Distribution 
HA-GLUT4-GFP HeLa cells were cultured on a 96 well plate with glass bottom as outlined in 
section 2.2.1.1. siRNA knock-down and staining was carried out as described in 2.2.1.6 and 
2.2.2.1. Images show GLUT4-GFP, the ERGIC or Golgi staining, the nucleus staining (DAPI) and a 
merge of all three channels. Perinuclear GLUT4 concentration is highlighted by white arrows. 
Single cells were randomly selected and intensity profiles of the GLUT4 signal was generated 
along the white arrow using ImageJ. A: negative control B: GOSR1 knock-down C: Ykt6 knock-
down.  
A2
1 
GLUT4-GFP ERGIC-53 
DAPI Merge 
GLUT4-GFP ERGIC-53 
DAPI Merge 
A1 
B1 B2 
GLUT4-GFP GM130 
DAPI Merge 
C1 C2 
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Figure 6.10 A1 shows the typical intracellular distribution of GLUT4 in the basal 
state. A large fraction of the protein is located in the perinuclear region, which 
is depicted by white arrows. The fluorescence intensity profile through the cross 
section of a single cell shows the same, with a strong intensity peak in the 
perinuclear region and smaller peaks closer to the plasma membrane. Consistent 
with studies in other cell types, including adipocytes (Dawson et al., 2001; O. J. 
Martin et al., 2006; Powell et al., 1999), GLUT4 is also widely dispersed 
throughout the cell in punctae, likely corresponding to small vesicles. 
Knock-down of involved SNARE proteins was suspected to have an effect on 
GLUT4 distribution within the cell. Representative images of cells after knock-
down of GOSR1 and Ykt6 are shown in panels B and C. The knock-down of 
GOSR1, which was characterised by decreased colocalisation of GLUT4 and the 
ERGIC appeared to have little visual effect on the intracellular distribution of 
GLUT4, although it could be argued that the perinuclear GLUT4 cluster is 
somewhat denser than in the negative control. An impression that is deepened 
by the intensity profile that shows a much wider perinuclear region GLUT4-GFP 
intensity peak. GOSR1 knock-down also resulted in increased total GLUT4 levels, 
which is also evident in Figure 6.10 B, where the GFP signal is visibly more 
pronounced than in the negative control image in panel A, even though 
acquisition parameters were not changed between the two data sets. 
Knock-down of Ykt6 had a similar effect and GLUT4 appears to be more 
concentrated in the periphery of the nucleus than in the control. This 
observation is in accordance with the finding that GLUT4/Golgi colocalisation is 
increased after Ykt6 knock-down.  
6.3 Discussion 
In Chapter 3, the suitability of HeLa cells as a cell model for GLUT4 trafficking 
was investigated. Here, the cell line was used as a model for an initial screen of 
SNARE proteins potentially affecting intracellular GLUT4 trafficking. 
Out of the eleven SNARE proteins that were investigated, knock-down of GOSR1 
and Ykt6 showed altered characteristics in HeLa cells. Knocking down GOSR1 
resulted in decreased colocalisation of GLUT4 with the ERGIC and increased 
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levels of total GLUT4, Stx6 also showed lower colocalisation, although this did 
not reach statistical significance. Ykt6 knock-down lead to increased GLUT4 
colocalisation with the Golgi. 
Total GLUT4 levels were measured as GLUT4-GFP signal in relation to the DAPI-
nucleus staining, which was presumed to be unaffected by siRNA knock-down. 
This was also the reason why we did not carry out HA staining, as this requires 
the same channel as needed for DAPI staining. It has to be kept in mind that this 
type of analysis method for measuring total GLUT4 levels is at best semi-
quantitative and for more reliable results western blotting of whole cell lysates 
or qPCR should be carried out, which could also be employed to verify the result 
presented here. Alternatively, FACS analysis would likely be more accurate by 
analysing larger numbers of cells in each experiment. These caveats 
notwithstanding, the data presented here, is a good primary indication of which 
SNARE proteins might affect the expression levels of GLUT4 and could direct 
future research endeavours. 
The colocalisation experiments highlighted GOSR1, Stx6 and Ykt6 as potential 
participants in intracellular GLUT4 trafficking. After knock-down of GOSR1 and 
Stx6, GLUT4 content is reduced in the ERGIC. Images of GOSR1 knock-down cells 
suggest that GLUT4 is more concentrated in the perinuclear region. However, 
there is no increased colocalisation with the Golgi, which is located in the same 
position. These results suggest that GOSR1 is involved in the trafficking upstream 
of the ERGIC, however, since the Golgi colocalisation is not affected, this would 
imply that GOSR1 is not part of the GSC Golgi recycling pathway. GOSR1 is 
located in the cis-Golgi and involved in ER to Golgi trafficking (Subramaniam et 
al., 1996; Zhang & Hong, 2001), which we now know includes the ERGIC. It is 
plausible that GLUT4 traffics between the ER and the ERGIC with the help of a 
SNARE complex including GOSR1. Our results are in accordance with the findings 
presented by Camus et al., which suggest a role of the ERGIC in the formation of 
the GSC in human cells. Since GSC formation is not affected by depletion of 
GM130, Camus et al. also suggest a bypass of the Golgi in line with our 
observations, and hypothesise that this may be due to a delayed maturation of 
carbohydrate side chains, which had previously been observed (Camus et al., 
2020; Hudson et al., 1992). Knock-down of the SNARE protein not only leads to 
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an accumulation of GLUT4 in the ERGIC, but also results in increased levels of 
total GLUT4. This may be a compensation mechanism of the cells to increase 
GLUT4 expression when trafficking between the ER and the ERGIC and therefore 
translocation of the transporter to the GSC is impaired. However, there are 
other possible explanations for the increased GLUT4-GFP fluorescence intensity. 
GLUT4 may be accumulating in a different compartment as a result of the GOSR1 
knock-down, leading to an accumulated fluorescence signal that is falsely 
interpreted. Alternatively, it is possible that degradation of GLUT4 is decreased 
due to reduced de-novo synthesis of GLUT4. 
Our data, albeit not statistically significant, support the role of Stx6 in 
intracellular GLUT4 trafficking proposed by previous studies from our group, 
consistent with Stx6 localisation to the TGN region (Perera et al., 2003). 
The knock-down of Ykt6 demonstrated an increase in Golgi colocalisation. This 
suggests an involvement of the SNARE protein in GLUT4 trafficking downstream 
of the Golgi. Previous studies have shown that Ykt6 is associated with the Golgi. 
Zhang and Hong (2001) found Ykt6 predominantly in the cis-Golgi, where they 
attributed a role in ER-Golgi trafficking to the protein, and found it forming a 
SNARE complex with Stx5, GOSR1, and BET1. Tai et al. (2004) on the other hand, 
argued its involvement in transport between the TGN and early/recycling 
endosomes, where they suggested Ykt6 forms part of a SNARE complex consisting 
of Stx5, GOSR1 and GS15. Our data supports Tai et al.’s findings and it is 
possible that GLUT4 is trafficked between the TGN and the endosomal system 
with the help of Ykt6. 
The results reported in this chapter must be viewed critically. Only initial 
experiments could be carried out due to time constraints. For the future, 
however it is important to repeat these experiments using stricter controls. For 
one, knock-down of the proteins of interest should be verified by means of 
western blotting. Lack of reliable respective antibodies lead to the decision to 
forgo this important test. However, the oligonucleotide pairs used for siRNA 
knock-down were the same used by Simpson et al. (2012) and we strictly 
followed their protocol for knock-down experiments. 
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For siRNA knock-down, short oligonucleotide sequences are used to induce 
interference with the target mRNA, this is often associated with off-target 
effects, in which parts of the relatively short sequences bind to other, irrelevant 
mRNA. Such off-target effects are called microRNA-like off-target effects and 
were first described when a screening of siRNAs that meant to interfere with one 
certain mRNA lead to multiple different phenotypes because of unspecific 
binding to other sequences (Jackson & Linsley, 2010). To avoid this type of off-
target effects, it is important to carry out the knock-down with more than one 
siRNA sequence. In this study, two sequences were used for each knock-down, 
but a higher number is advantageous. Further important control experiments 
include rescue experiment controls, in which the knocked-down SNARE is 
reintroduced by transfection. 
With regards to the colocalisation data, it is important to note that there cannot 
be “true colocalisation”, as this would mean that two proteins are located in the 
same position at the same time, which is impossible. When two signals 
colocalise, it is in fact their PSFs that are overlapping. Colocalisation therefore 
depends on spatial resolution of the microscope. For LSM, this means two 
“colocalised” molecules are within ~200 nm of each other, which is in biological 
terms a significant distance. 
The data collected for this chapter is by no means conclusive for GLUT4 
trafficking, because HeLa cells do not express endogenous GLUT4 and may 
exhibit distinct subtle differences to muscle and adipocytes, the normal sites of 
GLUT4 expression. However, since the genetically modified HA-GLUT4-GFP HeLa 
cell line behaves similarly to the preferred cell model 3T3 L1 and also in light of 
the findings by Camus et al., who argue for distinct trafficking mechanisms in 
human cells, it can be used as a tool for pre-screening of an siRNA library as 
reported here. Narrowing down the siRNA library previously consisting of eleven 
SNARE proteins potentially involved in intracellular GLUT4 trafficking to a 
smaller number provides a significant advantage for subsequent studies in more 
relevant models, which can focus on a smaller number of targets and thus save 
resources and time. With regards to the findings reported in this chapter, the 
SNARE proteins GOSR1, Stx6, and Ykt6 are suggested to be investigated further. 
Knock-down or knock-out of those three, as opposed to eleven, proteins can be 
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carried out preferably in a human adipocyte or myocyte cell line and effects on 
GLUT4 trafficking, translocation and total levels can be investigated by means of 
microscopy or more traditional biochemistry techniques. 
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Chapter 7 Discussion 
7.1 Summary of Results 
The objective of this work can be split into two main branches. Firstly, the 
dynamics of GLUT4 in the plasma membrane upon insulin stimulation were 
investigated by means of different microscopy approaches. The second aim of 
this work was to compare the human HeLa cell line with 3T3 L1 adipocytes and 
determine whether this could be used as a suitable model for GLUT4 trafficking. 
With regards to plasma membrane dynamics, we had established the working 
hypothesis that GLUT4 clusters in the plasma membrane are maintained by 
unphosphorylated PI. Insulin stimulation leads to activation of PI4KIIIα through 
mobilisation of EFR3a and subsequent phosphorylation of PI to PI4P, which 
releases GLUT4 from the clusters (see Figure 1.9). To test this hypothesis, we 
sought to develop a microscopy-based assay that would allow us to quantify the 
clustering and dispersal of GLUT4 in the plasma membrane. Using SpIDA and BN-
PAGE, we tested whether the clustering behaviour is related to the oligomeric 
state of the transporter. We found that GLUT4 is indeed highly oligomeric, 
however, the degree of oligomerisation did not change upon insulin stimulation. 
TIRFM offered exciting insights into the dynamics of GLUT4 in the vicinity of the 
plasma membrane but the method was not powerful enough to resolve single 
clusters of GLUT4 after insulin stimulation. 
Using dSTORM, we managed to visualise clusters of GLUT4 and quantification by 
Bayesian cluster analysis and Ripley’s K function analysis indeed showed that 
insulin stimulation induces dispersal of GLUT4 from clusters. The hypothesis that 
EFR3 is involved in the dynamics of GLUT4 in the plasma membrane was first 
derived from the finding that Δhxt fgy1-1 fgy4X mutant strains of Saccharomyces 
cerevisiae depleted of all endogenous GLUTs could translocate GLUT4 to the cell 
surface and grow on glucose medium (Wieczorke et al., 2003). The mammalian 
homologue to fgy1-1 is EFR3 and this protein had been investigated extensively 
by Laidlaw (2018) in the context of insulin stimulated glucose uptake and GLUT4 
translocation to the plasma membrane. Laidlaw found that EFR3a knock-down 
has an inhibitory effect on glucose uptake in 3T3 L1 adipocytes and 
overexpression of the protein leads to increased plasma membrane located 
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GLUT4. We built on this research by knocking down EFR3a in 3T3 L1 adipocytes 
and subjected these modified cells to dSTORM. The exciting result was that 
EFR3a knock-down indeed resulted in disturbed GLUT4 dispersal, suggesting that 
our hypothesis that EFR3a facilitates GLUT4 dispersal in response to insulin (see 
section 1.8) was correct. In addition to this, we found that Galectin-3 inhibits 
not only GLUT4 translocation but also dispersal in the plasma membrane. 
Finally, we investigated the suitability of HeLa cells as a model for GLUT4 
trafficking by means of confocal and TIRF microscopy and found that the cell 
line does behave similarly to the commonly used cell line 3T3 L1 with regards to 
insulin induced GLUT4 translocation to the plasma membrane. The results 
presented in Chapter 4 add to these findings, since GLUT4 forms highly 
oligomerised complexes in both cell types. Based on these findings, we carried 
out a preliminary screening of SNARE proteins that may be involved in 
intracellular GLUT4 trafficking between the ER, the ERGIC, and the Golgi in HeLa 
cells and found a potential role for the SNAREs GOSR1 and Ykt6 as knock-down of 
these proteins affected intracellular distribution of GLUT4. 
For this work, a number of different microscopes were used. CLSM was employed 
to carry out SpIDA and for acquiring HA surface stained images of HA-GLUT4-GFP 
expressing cells. With the help of TIRFM we investigated the dynamics of GLUT4 
in the vicinity of the plasma membrane. dSTORM, a powerful SMLM technique, 
finally allowed us to visualise single GLUT4 molecules in the plasma membrane 
of 3T3 L1 adipocytes and characterise the clustering behaviour of the 
transporter. Each technique came with its own advantages and disadvantages. 
CLSM is a standard microscopy technique that is easy to carry out and most 
laboratories (including ours) have access to such an instrument. Its resolution is 
diffraction limited, which means it cannot resolve GLUT4 clusters and even 
though its resolution in the z plane is improved compared to standard 
epifluorescence microscopy, there is still a significant amount of background 
signal, which makes it difficult to focus on the plasma membrane. This issue is 
improved in TIRFM, where only a thin layer adjacent to the coverslip is 
illuminated by the evanescent wave created by TIR. This allows elimination of 
background fluorescence but does not limit the signal to the plasma membrane. 
Our homebuilt TIRFM setup came with its own unique challenges that were 
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mostly of an engineering nature, e.g. the manipulation of the critical angle was 
difficult due to the position of the screw gauge. dSTORM was clearly the method 
of choice to resolve single molecules of plasma membrane GLUT4. Sample 
preparation and the technique itself was relatively straightforward, however, it 
did require travelling to an external imaging facility. As opposed to CLSM and 
TIRFM, dSTORM had to be carried out in fixed cells, which meant that the 
dynamics of cluster dispersal in response to insulin eluded us. 
7.2 Results in the Context of Existing Literature 
Type 2 Diabetes belongs to the world’s most common diseases and its prevalence 
is on the rise (Tareque et al., 2016). Current medication for type 2 diabetes 
treats the main symptom of the illness, which is to lower blood glucose levels, 
often by increasing insulin sensitivity, or failing that, insulin has to be 
administered externally (Maruthur et al., 2016). There is no cure and since the 
molecular reasons for the outbreak of the disease are still unknown, there is no 
medication to treat the cause of type 2 diabetes. 
Intracellular GLUT4 trafficking as well as insulin induced GLUT4 translocation are 
well characterised (Bryant et al., 2002; S. Huang & Czech, 2007; Leto & Saltiel, 
2012; Saltiel & Kahn, 2001; Tavaré et al., 2001) but only few studies shed light 
on the dynamics of GLUT4 in the plasma membrane itself (Bai et al., 2007; Gao 
et al., 2017; S. Huang et al., 2007; Jiang et al., 2008; C. H. Li et al., 2004; 
Lizunov et al., 2005; Lizunov, Lee, et al., 2013; Lizunov, Stenkula, et al., 2013; 
Stenkula et al., 2010; Y. Xu et al., 2011). Lizunov et al. (2013) were the first to 
propose clustering of the transporter in the membrane and dispersal upon insulin 
stimulation. Using dSTORM, we confirmed these findings and while this work was 
carried out, Gao et al. (2017) published similar findings, also using dSTORM.  
A lot of basic research is still to be conducted to unravel the complexities of 
GLUT4 trafficking and basic research is the foundation of drug development. 
Without understanding the molecular mechanisms of a disease, it is not possible 
to develop a directed approach to alleviate it. In this work, HA-GLUT4-GFP 
expressing HeLa cells were studied as a potential cell model and deemed 
suitable to carry out preliminary screening tests. Using a cell line that is as easy 
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to maintain and genetically manipulate as HeLa cells has the great advantage 
that a substantial number of experiments can be carried out relatively easily. 
Previously, VAMP2 and VAMP4 have been found to play important roles in the 
delivery of GSVs to the plasma membrane and to the GSC, respectively, in 3T3 
L1 adipocytes (Sadler, 2014). Knocking down VAMP2 in HeLa cells results in 
significantly reduced GLUT4 translocation to the plasma membrane, while 
VAMP4 knock-down also leads to impairment, albeit not significantly (S. Morris et 
al., 2020). This example shows that knock-down experiments in HeLa cells can 
give conclusive results with regards to GLUT4 trafficking. Screening of HA-
GLUT4-GFP HeLa cells that are depleted of different VAMP isoforms would have 
focussed on VAMP2 and VAMP4 in simple experiments quickly and without the 
difficulties that come with genetic manipulation of cell lines such as 3T3 L1.  
7.3 Future Directions 
7.3.1 GLUT4 Clustering and EFR3a 
Our hypothesis is that the insulin-induced dispersal of GLUT4 in the plasma 
membrane of adipocytes is defective in individuals with type 2 diabetes and we 
propose this mechanism as a potential new drug target. The finding that knock-
down of EFR3a inhibits GLUT4 dispersal is the first step in this direction. We 
showed that dSTORM can be used as an effective and reproducible tool to 
visualise the clustering of GLUT4 in the plasma membrane and quantify its 
dispersal upon insulin stimulation with the means of cluster analysis. This assay 
opens up an immense variety of possible research approaches. Gao et al. (2017) 
used it to carry out a number of interesting experiments. They investigated 
GLUT4 clustering in insulin resistant 3T3 L1 adipocytes and found that clustering 
is enhanced in those cells. They found the same for F5QQI mutated cells. In 
order to investigate whether GLUT4 clusters are related to lipid rafts, they 
treated basal F5QQA-GLUT4 mutant 3T3 L1 adipocytes with methyl-β-
cyclodextrin and found that this led to a reduction of clustering to levels similar 
to those in wild-type adipocytes. 
To define the role of EFR3a further, it would be of great interest to investigate 
the effect of EFR3a overexpression, which would be expected to result in 
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decreased clustering. Another obvious experiment is the knock-down or 
overexpression of PI4KIIIα and its effect on GLUT4 clusters. Our hypothesis 
suggested that GLUT4 clusters are maintained by pools of PI. This offers another 
interesting approach. As part of her work, Laidlaw implemented a pseudojanin 
system, which allows the targeted manipulation of PI, by dephosphorylating the 
4’ and/or 5’ phosphate. The proteins FKBP (FK506 Binding Protein 12) and FRB 
(FKBP rapamycin binding protein) can bind to each other in the presence of 
rapamycin. In the system, the FKBP component is fused to the pseudojanin 
phosphatase, which can dephosphorylate the 4’ and/or 5’ phosphate of PI. By 
fusing the second component, FRB, with a membrane anchor, such as LYN11, the 
pseudojanin is directed to the plasma membrane after induction with 
rapamycin, allowing the direct manipulation of PI patches (Hammond et al., 
2014; Laidlaw, 2018). In combination with the dSTORM assay presented here, 
this could be an interesting experiment to further test our hypothesis. 4’ 
phosphorylation of PI should result in dispersal of GLUT4 even in the absence of 
insulin or after knock-down of PI4KIIIα. 
We showed that the knock-down of EFR3a in 3T3 L1 adipocytes results in 
impaired GLUT4 dispersal after insulin stimulation and Gao et al (2017) showed 
that insulin resistance is related to deficient GLUT4 dispersal. It would be 
interesting to explore GLUT4 dispersal and the role of EFR3a in other cell types. 
An obvious one would be muscle cells, such as C2C12, where GLUT4 is also 
expressed. Interestingly this myocyte cell line lacks an insulin-responsive GSC 
(Tortorella & Pilch, 2002) and muscle cells respond with GLUT4 translocation to 
exercise (Z. Li et al., 2018). It would be interesting to investigate whether 
GLUT4 also clusters in the plasma membrane of C2C12 myotubes and whether it 
disperses in response to exercise. This could be investigated in combination with 
optoelectric stimulation. For this approach, C2C12 cells are transfected with a 
light-sensitive variant of channelrhodopsin, which allows induction of 
contractility by stimulation with light pulses (Ambrosi et al., 2014; Asano et al., 
2015). 
Other obvious models are primary cells and tissue samples of healthy humans 
and type 2 diabetics. Is GLUT4 dispersal defective in diabetics? Is EFR3a 
expressed in adipose tissue of diabetics at lower levels than in healthy test 
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subjects? If the answer to both these questions is yes, EFR3a could be 
investigated as a potential new drug target. An active component that rescues 
the phenotype of impaired GLUT4 dispersal would need to be investigated in 
terms of its ability to rescue insulin stimulated glucose uptake for example in 
EFR3a knock-down 3T3 L1 adipocytes. 
7.3.2 HeLa Cells as Model for GLUT4 Trafficking 
In Chapter 6 a preliminary screening was carried out to find SNARE proteins 
involved in intracellular GLUT4 trafficking. GOSR1 and Ykt6 were found to be 
involved in the trafficking between the ER, the ERGIC, and the Golgi. These 
results can build the basis for more detailed research that concentrates on the 
exact role of GOSR1 and Ykt6. As discussed in section 6.3, the results have to be 
verified in larger-scale screenings, e.g. FACS or plate reader analysis and a 
similar study in a more relevant cell model, such as 3T3 L1 adipocytes, would be 
advisable too, to confirm the involvement of these SNAREs in GLUT4 trafficking. 
Yeasts offer another interesting platform, GOSR1 and Ykt6 can be knocked out 
and effects on cell growth (is knock-out lethal?) and glucose metabolism can be 
investigated. Furthermore, it would be interesting to study which other SNAREs 
are associated with GOSR1 and Ykt6 in SNARE complexes and what effect the 
disturbance of these complexes has on intracellular GLUT4 trafficking as well as 
GLUT4 translocation to and dispersal in the plasma membrane in response to 
insulin. 
GSV kinetics near the plasma membrane may not be completely comparable in 
HeLa cells and 3T3 L1 adipocytes, but insulin stimulation clearly leads to 
translocation of GLUT4 in both cell types, which makes them a valuable model 
for screenings such as the one carried out in this work. Recent findings suggest 
that GLUT4 trafficking indeed differs in human and in murine cells (Camus et al., 
2020), arguing that a human cell line such as HeLa may be even more suitable 
for some investigations. 
As a next step, and to bring the two strands of this work together, dSTORM 
experiments should be carried out in HA-GLUT4-GFP HeLa cells to determine 
whether GLUT4 clusters and disperses in the same way as in 3T3 L1 adipocytes. 
Laidlaw (2018) found that HeLa cells express EFR3a, so this is indeed plausible. 
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It would be easy to establish a stable EFR3a knock-out HeLa cell line, on which 
potential active ingredients could be tested as discussed previously. 
7.4 Conclusions 
The main objective of this work was to develop a microscopy-based assay to 
visualise and quantify the clustering and dispersal of GLUT4 in the plasma 
membrane. Using dSTORM, this aim has been met. Additionally, advances have 
been made in uncovering the molecular mechanisms behind these dynamics and 
EFR3a was identified as potential key component.  
The second aim of this work was to establish a HeLa cells expressing HA-GLUT4-
GFP as a model cell line to study GLUT4. HA-GLUT4-GFP HeLa cells have been 
characterised with regards GLUT4 dynamics near the plasma membrane and 
deemed suitable as a model cell line for preliminary screenings, of which we 
carried out one to identify SNARE proteins involved in intracellular GLUT4 
trafficking. 
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Figure 8.1 Full GAPDH Blot from Figure 5.10 
 
Figure 8.2 Full EFR3a Blot from Figure 5.10 
 
Figure 8.3 Full GLUT4 Blot from Figure 5.10 
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Figure 8.4 Full Stx16 Blot from Figure 5.10 
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